TWI893109B - Polymerizable liquid crystal material and polymerized liquid crystal film - Google Patents
Polymerizable liquid crystal material and polymerized liquid crystal filmInfo
- Publication number
- TWI893109B TWI893109B TW110115201A TW110115201A TWI893109B TW I893109 B TWI893109 B TW I893109B TW 110115201 A TW110115201 A TW 110115201A TW 110115201 A TW110115201 A TW 110115201A TW I893109 B TWI893109 B TW I893109B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- groups
- atoms
- polymerizable
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K2019/0444—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
- C09K2019/0448—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/30—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
- C09K19/3001—Cyclohexane rings
- C09K19/3066—Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
- C09K19/3068—Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers chain containing -COO- or -OCO- groups
- C09K2019/3077—Cy-Cy-COO-Ph
Landscapes
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Liquid Crystal Substances (AREA)
- Polarising Elements (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
本發明係關於一種可聚合的LC材料,其包含一或多種雙反應性或多反應性液晶原基化合物及一或多種式I化合物, 其中個別基團具有如申請專利範圍中所給出之含義中之一者。此外,本發明亦係關於一種用於製備該可聚合的LC材料之方法;一種可自對應可聚合的LC材料獲得之具有經改良的熱穩定性及UV穩定性之聚合物膜;一種製備此類聚合物膜之方法;以及此類聚合物膜及該可聚合的LC材料在光學、電光學、裝飾或安全裝置中之用途。 The present invention relates to a polymerizable LC material comprising one or more bireactive or polyreactive mesogen compounds and one or more compounds of formula I, wherein the individual groups have one of the meanings given in the patent claims. Furthermore, the present invention relates to a method for preparing the polymerizable LC material; a polymer film with improved thermal and UV stability obtainable from the corresponding polymerizable LC material; a method for preparing such a polymer film; and the use of such a polymer film and the polymerizable LC material in optics, electro-optics, decoration, or security devices.
已知可聚合的液晶材料在先前技術中用於製備具有均勻定向之各向異性聚合物膜。此等膜通常藉由以下製備:將可聚合的液晶混合物之薄層塗佈至基板上,使混合物配向成均勻定向且使混合物聚合。膜之定向可為平面的(亦即,其中液晶分子實質上平行於該層定向)、垂直的(與該層成直角或垂直於該層)或傾斜的。Polymerizable liquid crystal materials are known to be used in the prior art to prepare anisotropic polymer films with uniform orientation. These films are typically prepared by applying a thin layer of a polymerizable liquid crystal mixture to a substrate, aligning the mixture into a uniform orientation, and polymerizing the mixture. The film's orientation can be planar (i.e., in which the liquid crystal molecules are oriented substantially parallel to the layer), homeotropic (at right angles or perpendicular to the layer), or tilted.
此類光學膜描述於例如EP 0 940 707 B1、EP 0 888 565 B1及GB 2 329 393 B1中。Optical films of this type are described, for example, in EP 0 940 707 Bl, EP 0 888 565 Bl and GB 2 329 393 Bl.
在室溫下穩定之可聚合的液晶(LC)材料可在經受增加之溫度時降解。舉例而言,當加熱一段時間時,諸如分散或延遲之光學特性降低,且因此光學膜之效能隨時間推移而降低。特定言之,此可造成低聚合度及聚合物中之對應高含量的殘餘自由基、聚合物收縮及/或熱氧化降解。Polymerizable liquid crystal (LC) materials that are stable at room temperature can degrade when subjected to elevated temperatures. For example, when heated for a period of time, optical properties such as dispersion or retardation degrade, and the performance of the optical film decreases over time. Specifically, this can result in a low degree of polymerization and a correspondingly high level of residual free radicals in the polymer, polymer shrinkage, and/or thermooxidative degradation.
熱氧化降解為在高溫下由氧化反應催化之聚合物網絡的崩解。如通常已知,可使用抗氧化劑添加劑或短抗氧化劑以在聚合物經受增加的溫度時降低聚合物之熱氧化降解。當由於高溫而將光學膜用於內嵌應用時,此尤其重要。特定言之,當在LC單元中退火聚醯亞胺層時,光學膜必須具耐受性。就此而言,文獻WO 2009/86911 A1及JP 5354238 B1描述包含可商購的抗氧化劑Irganox®1076之可聚合的液晶(LC)材料。Thermooxidative degradation is the disintegration of a polymer network catalyzed by oxidation reactions at high temperatures. As is generally known, antioxidant additives or short-term antioxidants can be used to reduce the thermooxidative degradation of polymers when they are subjected to elevated temperatures. This is particularly important when optical films are used in embedded applications due to the high temperatures. In particular, optical films must be resistant to annealing of polyimide layers in LC cells. In this regard, documents WO 2009/86911 A1 and JP 5354238 B1 describe polymerizable liquid crystal (LC) materials containing the commercially available antioxidant Irganox® 1076.
由於所使用LC材料,上述材料具有明顯缺點,諸如所得聚合物膜之UV穩定性或熱耐久性仍不夠高,其對VIS光之透光度受到限制,其需要使用其他添加劑,或其應用帶寬受到限制。Due to the LC materials used, the above materials have obvious disadvantages, such as the UV stability or thermal durability of the resulting polymer films are still not high enough, their transmittance to VIS light is limited, they require the use of other additives, or their application bandwidth is limited.
因此,仍需要新穎且較佳改良之可聚合的液晶材料或混合物,其並不展現先前技術材料之缺陷,或若如此,則僅在較小程度上展現該等缺陷。Therefore, there is still a need for new and better improved polymerizable liquid crystal materials or mixtures which do not exhibit the disadvantages of the prior art materials, or if so, exhibit these disadvantages only to a lesser extent.
有利地,此類可聚合的LC材料應較佳適用於製備不同的均勻配向之聚合物網路(諸如聚合物膜),且應較佳地同時: - 展示對基板之有利黏著力, - 對VIS光高度透光, - 展現隨時間推移而減少之著黃色(黃化)且 - 展示有利的高溫穩定性或耐久性,且另外, - 展示有利的高UV穩定性或熱耐久性,且另外, - 均勻配向的聚合物膜應藉由用於大批量生產之相容的、通常已知的方法來生產。 Advantageously, such polymerizable LC materials should be suitable for preparing different uniformly aligned polymer networks (e.g., polymer films) and should preferably simultaneously: - exhibit favorable adhesion to the substrate, - be highly transparent to VIS light, - exhibit reduced yellowing over time, and - exhibit favorable high-temperature stability or durability, and, in addition, - exhibit advantageously high UV stability or thermal durability, and, in addition, - the uniformly aligned polymer films should be producible by compatible, generally known methods for mass production.
熟習此項技術者自以下詳細描述立即顯而易見本發明之其他目標。Other objects of the present invention will become apparent to those skilled in the art from the following detailed description.
出人意料地,本發明之發明人已發現,上文要求目標中之一或多者、較佳所有均可藉由使用如技術方案1之可聚合的LC材料較佳同時達成。Surprisingly, the inventors of the present invention have found that one or more, preferably all, of the above-claimed objects can be achieved, preferably simultaneously, by using a polymerizable LC material as described in claim 1.
總體而言,本發明係關於一種可聚合的LC材料,其包含一或多種雙反應性或多反應性液晶原基化合物,及
一或多種式I化合物,其濃度較佳在1 ppm至2500 ppm、較佳至2000 ppm、較佳至1500 ppm、尤其較佳至1000 ppm之範圍內,較佳在1 ppm至500 ppm之範圍內,尤其較佳在1 ppm至250 ppm之範圍內,
其中
R
11在每次出現時彼此獨立地表示H、F、具有1至20個C原子之直鏈或分支鏈烷基鏈,其中一個-CH
2-基團或,若存在,複數個-CH
2-基團可經-O-或-C(=O)-置換,但兩個相鄰-CH
2-基團不能經-O-置換,且一個或,若存在,複數個-CH
2-基團可經-CH=CH-或-C≡C-置換,且其中一個H原子或複數個H原子可經F、OR
13、N(R
13)(R
14)或R
15置換,
R
11較佳表示H或烷基,尤其較佳為烷基,尤其較佳為正烷基且極佳為正丁基,
R
12在每次出現時彼此獨立地表示具有1至20個C原子之直鏈或分支鏈烷基鏈,其中一個-CH
2-基團或複數個-CH
2-基團可經-O-或-C(=O)-置換,但兩個相鄰-CH
2-基團不能經-O-置換;含有環烷基或烷基環烷基單元的烴基且其中一個-CH
2-基團或複數個-CH
2-基團可經-O-或-C(=O)-置換,但兩個相鄰-CH
2-基團不能經-O-置換,且其中一個H原子或複數個H原子可經F、OR
13、N(R
13)(R
14)或R
15置換;或芳族或雜芳族烴基,其中一個H原子或複數個H原子可經F、OR
13、N(R
13)(R
14)或R
15置換,
R
12較佳表示H、非分支鏈烷基或分支鏈烷基,尤其較佳為H或非分支鏈烷基,
R
13在每次出現時彼此獨立地表示具有1至10個C原子之直鏈或分支鏈烷基或醯基,較佳為正烷基或具有6-12個C原子之芳族烴或羧酸基,
R
14在每次出現時彼此獨立地表示具有1至10個C原子之直鏈或分支鏈烷基或醯基,較佳為正烷基或具有6-12個C原子之芳族烴或羧酸基,
R
15在每次出現時彼此獨立地表示具有1至10個C原子之直鏈或分支鏈烷基,其中一個-CH
2-基團或複數個-CH
2-基團可經-O-或-C(=O)-置換,但兩個相鄰-CH
2-基團不能經-O-置換,
S
11及S
12在每次出現時彼此獨立地表示具有1至20個C原子之伸烷基,其為分支鏈或較佳為直鏈,較佳為具有1-20個C原子、較佳1-10個C原子,尤其較佳具有1至8個C原子的-(CH
2-)
n,其中一個-CH
2-基團或(若存在)複數個-CH
2-基團可經-O-或-C(=O)-置換,但兩個相鄰-CH
2-基團不能經-O-置換,且一個或(若存在)複數個-CH
2-基團可經-CH=CH-或-C≡C-置換,且其中一個H原子或複數個H原子可經F、OR
13、N(R
13)(R
14)或R
15置換,或表示單鍵,
X
11表示C,
Y
11至Y
14各自彼此獨立地表示甲基或乙基,尤其較佳地全部表示甲基或乙基且極佳為甲基,
Z
11至Z
14在每次出現時彼此獨立地表示-O-、-(C=O)-、-O-(C=O)-、-(C=O)-O-、-O-(C=O)-O-、-(N-R
13)-、-N-R
13-(C=O)-或單鍵,若S
11為單鍵,則Z
11及Z
12兩者不同時表示-O-,且然而若S
12為單鍵,則Z
13及Z
14兩者不同時表示-O-,且然而若-X
11[-R
11]
o-為單鍵,則Z
12及Z
13兩者不同時為-O-,
Z
11較佳表示-O-,
Z
13較佳表示單鍵,
n * p 表示3至10、較佳至8之整數,
p 表示1或2,
o 表示(3-p),
在p = 1之情況下,
n 表示3、4、5、6或8,尤其較佳為4、6或8,極佳為4或6,及
m 表示(10-n),及
在p = 2之情況下,
n 表示2至4之整數,較佳為2或3,尤其較佳為3,且
m 表示(4-n),
此外,本發明亦係關於一種生產可聚合的LC材料之對應方法,其至少包含將一或多種雙反應性或多反應性液晶原基化合物及一或多種式I化合物混合的步驟。Furthermore, the present invention also relates to a corresponding method for producing a polymerizable LC material, comprising at least the step of mixing one or more bireactive or polyreactive mesogen compounds and one or more compounds of formula I.
本發明進一步係關於一種自如上文及下文所描述之可聚合的LC材料可獲得、較佳獲得之聚合物網路或聚合物膜,且係關於一種產生如上文及下文所描述之聚合物膜的方法。The invention further relates to a polymer network or polymer film obtainable, preferably obtainable, from a polymerizable LC material as described above and below, and to a method for producing a polymer film as described above and below.
本發明進一步係關於一種增加自如上文及下文所描述之可聚合的LC材料可獲得、較佳獲得之聚合物膜之UV穩定性的方法,其係藉由在聚合之前將式I化合物添加至可聚合的LC材料中。The invention further relates to a method for increasing the UV stability of polymer films obtainable, preferably obtainable, from polymerizable LC materials as described above and below by adding a compound of formula I to the polymerizable LC material before polymerization.
本發明進一步係關於如上文及下文所描述之聚合物膜或可聚合的LC材料之用途,其用於光學、電光學、資訊儲存、裝飾及安全應用,如液晶顯示器、投影系統、偏光器、補償器、配向層、圓形偏光器、濾色器、裝飾影像、液晶顏料、具有空間上變化之反射色彩的反射膜、多色影像、如身分證或信用卡或鈔票之不可偽造文件。The present invention further relates to the use of polymer films or polymerizable LC materials as described above and below for optical, electro-optical, information storage, decorative and security applications, such as liquid crystal displays, projection systems, polarizers, compensators, alignment layers, circular polarizers, color filters, decorative images, liquid crystal pigments, reflective films with spatially varying reflective colors, multicolor images, and unforgeable documents such as identity cards, credit cards or banknotes.
本發明進一步係關於一種光學組件或裝置、偏光器、圖案化延遲器、補償器、配向層、圓形偏光器、濾色器、裝飾影像、液晶透鏡、液晶顏料、具有空間上變化之反射色彩的反射膜、用於裝飾或資訊儲存之多色影像,其包含一或多種如上文及下文所描述之聚合物網路或聚合物膜或可聚合的LC材料。The present invention further relates to an optical component or device, a polarizer, a patterned retarder, a compensator, an alignment layer, a circular polarizer, a color filter, a decorative image, a liquid crystal lens, a liquid crystal pigment, a reflective film with spatially varying reflective color, and a multicolor image for decoration or information storage, comprising one or more polymer networks or polymer films or polymerizable LC materials as described above and below.
本發明進一步係關於一種液晶顯示器,其包含一或多種如上文及下文所描述之聚合物膜或可聚合的LC材料或光學組件。The invention further relates to a liquid crystal display comprising one or more polymer films or polymerizable LC materials or optical components as described above and below.
本發明進一步係關於用於安全用途、具有價值的不可偽造物品或文件(如身分證或信用卡或鈔票)之鑑別、核對或安全標記的彩色或多色影像,其包含如上文及下文所描述之聚合物網絡或聚合物膜或可聚合的LC材料或光學組件。The invention further relates to a color or multicolor image for the identification, verification or security marking of an unforgeable article or document of value (such as an identity card or credit card or banknote) for security purposes, comprising a polymer network or polymer film or polymerizable LC material or optical component as described above and below.
術語及定義如本文中所使用,術語「聚合物」應理解為意謂涵蓋一或多種不同類型之重複單元(分子之最小組成單元)之主鏈的分子,且包括通常已知之術語「寡聚物」、「共聚物」、「均聚物」及其類似者。另外,應理解,術語聚合物除聚合物自身以外包括來自伴隨此聚合物合成之引發劑、催化劑及其他元素的殘餘物,其中此等殘餘物應理解為不共價併入於該聚合物中。另外,此等殘餘物及其他元素雖然通常在聚合後純化過程期間移除,但通常與聚合物混合或共混,使得當聚合物在容器之間或在溶劑或分散介質之間轉移時其通常與聚合物一起保留。 As used herein, the term "polymer" is understood to mean a molecule comprising a backbone of one or more different types of repeating units (the smallest building block of a molecule), and includes the commonly known terms "oligomer,""copolymer,""homopolymer," and the like. Furthermore, it is understood that the term polymer includes, in addition to the polymer itself, residues from initiators, catalysts, and other elements accompanying the synthesis of the polymer, wherein such residues are understood to be not covalently incorporated into the polymer. Furthermore, such residues and other elements, while typically removed during post-polymerization purification processes, are typically mixed or blended with the polymer so that they typically remain with the polymer when it is transferred between containers or between solvents or dispersion media.
如本發明中所使用之術語「(甲基)丙烯酸聚合物」包括獲自丙烯酸單體之聚合物、可獲自甲基丙烯酸單體之聚合物及可獲自此類單體之混合物的對應共聚物。As used herein, the term "(meth)acrylic polymer" includes polymers obtained from acrylic monomers, polymers obtainable from methacrylic monomers, and corresponding copolymers obtainable from mixtures of such monomers.
術語「聚合」意謂藉由使多個可聚合的基團或含有此類可聚合的基團之聚合物前驅體(可聚合的化合物)鍵結在一起形成聚合物之化學製程。The term "polymerization" refers to the chemical process of forming a polymer by bonding together a plurality of polymerizable groups or polymer precursors (polymerizable compounds) containing such polymerizable groups.
術語「膜」及「層」包括具有機械穩定性之剛性或可撓性、自撐式或獨立的膜,以及位於支撐基板上或兩個基板之間的塗層或層。The terms "film" and "layer" include mechanically stable, rigid or flexible, self-supporting or freestanding films, as well as coatings or layers positioned on a supporting substrate or between two substrates.
術語「液晶」或「LC」係關於在溶液中在一定溫度範圍內(熱致性LC)或在一定濃度範圍內(溶致性LC)具有液晶介相之材料。此等材料強制性地含有液晶原基化合物。The term "liquid crystal" or "LC" refers to materials that exhibit a liquid crystal phase in solution within a certain temperature range (thermotropic LC) or within a certain concentration range (lyotropic LC). These materials must contain a mesogen compound.
術語「液晶原基化合物」及「液晶化合物」意謂包含一或多種棒狀(棒形或板形/板條形)或圓盤型(碟形)液晶原基基團之化合物。術語「液晶原基基團」意謂能夠誘導液晶相(或介相)行為之基團。包含液晶原基基團之化合物自身未必展現液晶介相。亦有可能其僅在與其他化合物之混合物中,或在聚合液晶原基化合物或材料或其混合物時展示液晶介相。此包括低分子量非反應性液晶化合物、反應性或可聚合液晶化合物及液晶聚合物。The terms "mesogenic compound" and "liquid crystal compound" refer to compounds containing one or more rod-shaped (rod-shaped or plate-shaped/lath-shaped) or disc-shaped (disc-shaped) mesogenic groups. The term "mesogenic group" refers to a group that is capable of inducing liquid crystal (or mesophase) behavior. A compound containing a mesogenic group may not exhibit a liquid crystal mesophase on its own. It may also exhibit a liquid crystal mesophase only in a mixture with other compounds or when polymerizing a mesogenic compound or material or a mixture thereof. This includes low molecular weight non-reactive liquid crystal compounds, reactive or polymerizable liquid crystal compounds, and liquid crystal polymers.
棒狀液晶原基基團通常包含由一或多個彼此直接地連接或經由鍵聯基團連接之芳族或非芳族環狀基團組成的液晶原基核,視情況包含連接至液晶原基核之末端的端基,且視情況包含一或多個連接至液晶原基核之長邊的側基,其中此等端基及側基通常選自例如碳基或烴基、極性基團(如鹵素、硝基、羥基等)或可聚合的基團。The rod-shaped mesogen group generally comprises a mesogen core composed of one or more aromatic or non-aromatic cyclic groups directly linked to each other or linked via a linker group, optionally comprising end groups linked to the ends of the mesogen core, and optionally comprising one or more pendant groups linked to the long sides of the mesogen core, wherein these end groups and pendant groups are generally selected from, for example, carbon or alkyl groups, polar groups (such as halogen, nitro, hydroxyl, etc.) or polymerizable groups.
術語「反應性液晶原基」意謂可聚合的液晶原基或液晶化合物,較佳為單體化合物。此等化合物可用作純化合物或用作反應性液晶原基與充當光引發劑、抑制劑、界面活性劑、穩定劑、鏈轉移劑、非可聚合化合物等之其他化合物的混合物。The term "reactive mesogen" refers to a polymerizable mesogen or liquid crystal compound, preferably a monomeric compound. These compounds can be used as pure compounds or as mixtures of reactive mesogens with other compounds that act as photoinitiators, inhibitors, surfactants, stabilizers, chain transfer agents, non-polymerizable compounds, etc.
具有一個可聚合的基團之可聚合的化合物亦稱作「單反應性」化合物,具有兩個可聚合的基團之化合物稱作「雙反應性」化合物,且具有超過兩個可聚合的基團之化合物稱作「多反應性」化合物。不具有可聚合的基團之化合物亦稱作「非反應性或非可聚合」化合物。A polymerizable compound with one polymerizable group is also called a "monoreactive" compound, a compound with two polymerizable groups is called a "direactive" compound, and a compound with more than two polymerizable groups is called a "polyreactive" compound. A compound without a polymerizable group is also called a "non-reactive or non-polymerizable" compound.
術語「非液晶原基化合物或材料」意謂不含有如上文所定義之液晶原基基團之化合物或材料。The term "non-mesogenic compound or material" means a compound or material that does not contain a mesogenic group as defined above.
可見光為波長在約400 nm至約740 nm範圍內之電磁輻射。紫外(UV)光為波長在約200 nm至約450 nm範圍內之電磁輻射。Visible light is electromagnetic radiation with a wavelength between about 400 nm and about 740 nm. Ultraviolet (UV) light is electromagnetic radiation with a wavelength between about 200 nm and about 450 nm.
輻照度(E e)或輻射功率定義為電磁輻射(dθ)入射於表面上每單位面積(dA)之功率: E e= dθ/dA。 Radiant intensity (E e ) or radiant power is defined as the power per unit area (dA) of electromagnetic radiation (dθ) incident on a surface: E e = dθ/dA.
輻射曝光或輻射劑量(H e)為每時刻(t)之輻照度或輻射功率(E e): H e= E e∙ t。 Radiation exposure or radiation dose (H e ) is the irradiance or radiation power (E e ) per time instant (t): He = E e ∙ t.
所有溫度,諸如液晶之熔點T(C,N)或T(C,S)、自近晶(S)相至向列(N)相之轉變T(S,N)及澄清點T(N,I),均以攝氏度給出。所有溫度差均以不同度數給出。All temperatures, such as the melting point of liquid crystals (T(C,N) or T(C,S), the transition from the smectic (S) phase to the nematic (N) phase (T(S,N), and the clearing point (T(N,I)), are given in degrees Celsius. All temperature differences are given in degrees.
術語「澄清點」意謂在具有最高溫度範圍之介相與各向同性相之間發生轉變之溫度。The term "clearing point" refers to the temperature at which the transition occurs between the mesophase with the highest temperature range and the isotropic phase.
術語「引向器」為先前技術中已知的且意謂液晶或RM分子之長分子軸(在棒狀化合物之情況下)或短分子軸(在圓盤型化合物之情況下)的較佳定向方向。在單軸排序此類各向異性分子之情況下,引向器為各向異性之軸。The term "director" is known in the art and refers to the preferred orientation direction of the long molecular axis (in the case of rod-shaped compounds) or the short molecular axis (in the case of discotic compounds) of liquid crystal or RM molecules. In the case of uniaxially aligned anisotropic molecules, the director is the axis of anisotropy.
術語「配向」或「定向」係關於材料之各向異性單元(諸如小分子或大分子之片段)沿稱為「配向方向」之共同方向的配向(定向排序)。在液晶或RM材料之配向層中,液晶引向器與配向方向一致,使得配向方向對應於材料之各向異性軸的方向。The term "alignment" or "direction" refers to the alignment (directional ordering) of anisotropic units (such as small molecules or fragments of macromolecules) of a material along a common direction called the "alignment direction." In the alignment layer of a liquid crystal or RM material, the liquid crystal director is aligned with the alignment direction, so that the alignment direction corresponds to the direction of the anisotropy axis of the material.
舉例而言在材料之層中,液晶或RM材料之術語「均勻定向」或「均勻配向」意謂液晶或RM分子之長分子軸(在棒狀化合物之情況下)或短分子軸(在圓盤型化合物之情況下)實質上沿相同方向定向。換言之,液晶引向器之線為平行的。For example, the term "homogeneously oriented" or "homogeneously aligned" of a liquid crystal or liquid crystal material means that the long molecular axes (in the case of rod-shaped compounds) or short molecular axes (in the case of discotic compounds) of the liquid crystal or liquid crystal molecules are oriented in substantially the same direction within a layer of material. In other words, the lines of the liquid crystal directors are parallel.
術語「垂直結構」或「垂直定向」係指其中光軸實質上垂直於膜平面之膜。The term "vertical structure" or "vertical orientation" refers to a film in which the optical axis is substantially perpendicular to the plane of the film.
術語「平面結構」或「平面定向」係指其中光軸實質上平行於膜平面之膜。The terms "planar structure" or "planar orientation" refer to films in which the optical axis is substantially parallel to the plane of the film.
術語「負(光學)分散」係指顯示反向雙折射分散之雙折射或液晶材料或層,其中雙折射率(Δn)之量值隨波長(λ)增加而增加。亦即,|Δn (450) |<|Δn (550)|或Δn (450)/Δn (550) < 1,其中Δn (450)及Δn (550)為分別在450 nm及550 nm之波長下量測之材料的雙折射率。相反,「正(光學)分散」意謂具有|Δn (450)|>|Δn (550)|或Δn (450)/Δn (550)>1之材料或層。亦參見例如A. Uchiyama, T. Yatabe 「Control of Wavelength Dispersion of Birefringence for Oriented Copolycarbonate Films Containing Positive and Negative Birefringent Units」. J. Appl. Phys. 第42卷第6941-6945頁(2003)。The term "negative (optical) dispersion" refers to a birefringent or liquid crystal material or layer that exhibits reverse birefringent dispersion, where the magnitude of the birefringence (Δn) increases with increasing wavelength (λ). That is, |Δn (450)| < |Δn (550)| or Δn (450)/Δn (550) < 1, where Δn (450) and Δn (550) are the birefringence of the material measured at wavelengths of 450 nm and 550 nm, respectively. Conversely, "positive (optical) dispersion" refers to a material or layer having |Δn (450)| > |Δn (550)| or Δn (450)/Δn (550) > 1. See also, for example, A. Uchiyama, T. Yatabe “Control of Wavelength Dispersion of Birefringence for Oriented Copolycarbonate Films Containing Positive and Negative Birefringent Units”. J. Appl. Phys. Vol. 42, pp. 6941-6945 (2003).
由於給定波長下之光學延遲定義為如上文所描述之雙折射率與層厚度的乘積[R(λ)=Δn(λ) .d],因此光學分散可藉由比率Δn(450)/Δn(550)表示為「雙折射分散」,或藉由比率R(450)/R(550)表示為「延遲分散」,其中R(450)及R(550)為分別在450 nm及550 nm之波長下量測之材料的延遲。由於層厚度d不隨波長而改變,因此R (450)/R (550)等於Δn (450)/Δn (550)。因此,具有負分散或反向分散之材料或層具有R (450)/R (550)<1或|R (450)|<|R (550)|,且具有正分散或正常分散之材料或層具有R (450)/R (550)>1或|R (450)|>|R (550)|。 Since the optical retardation at a given wavelength is defined as the product of the birefringence and the layer thickness [R(λ) = Δn(λ) . d] as described above, the optical dispersion can be expressed as "birefringent dispersion" by the ratio Δn(450)/Δn(550), or as "retardation dispersion" by the ratio R(450)/R(550), where R(450) and R(550) are the retardations of the material measured at wavelengths of 450 nm and 550 nm, respectively. Since the layer thickness d does not vary with wavelength, R(450)/R(550) is equal to Δn(450)/Δn(550). Therefore, a material or layer with negative dispersion or reverse dispersion has R (450)/R (550)<1 or |R (450)|<|R (550)|, and a material or layer with positive dispersion or normal dispersion has R (450)/R (550)>1 or |R (450)|>|R (550)|.
在本發明中,除非另外陳述,否則「光學分散」意謂延遲分散,亦即比率R(450)/R(550)或短R 450/550。 In the present invention, unless otherwise stated, "optical dispersion" means delayed dispersion, that is, the ratio R(450)/R(550) or short R 450/550 .
術語「高分散」意謂分散之絕對值展示與1之較大偏差,而術語「低分散」意謂分散之絕對值展示與1之較小偏差。因此,「高負分散」意謂分散值顯著小於1,且「低負分散」意謂分散值僅略微小於1。The term "high dispersion" means that the absolute value of the dispersion exhibits a large deviation from 1, while the term "low dispersion" means that the absolute value of the dispersion exhibits a small deviation from 1. Thus, "high negative dispersion" means that the dispersion value is significantly less than 1, and "low negative dispersion" means that the dispersion value is only slightly less than 1.
可使用光譜橢圓偏光儀(例如由J. A. Woollam Co.製造的M2000光譜橢圓偏光儀)量測材料之延遲(R(λ)),此儀器能夠量測雙折射樣品(例如石英)在典型370 nm至2000 nm之波長範圍內的光學延遲(以奈米計)。根據此資料,有可能計算出材料之分散(R(450)/R(550)或Δn(450)/Δn(550))。The retardation of a material (R(λ)) can be measured using a spectroscopic elliptical polarimeter (e.g., the M2000 Spectroscopic Elliptical Polarimeter manufactured by J. A. Woollam Co.). This instrument is capable of measuring the optical retardation (in nanometers) of birefringent samples (e.g., quartz) over a wavelength range typically between 370 nm and 2000 nm. From this data, it is possible to calculate the dispersion of the material (R(450)/R(550) or Δn(450)/Δn(550)).
用於進行此等量測之方法在2006年10月由N. Singh呈現於National Physics Laboratory (London, UK),且標題為「Spectroscopic Ellipsometry, Part1-Theory and Fundamentals, Part 2 - Practical Examples and Part 3 - measurements」。根據量測程序所描述之手動延遲量測(Retardation Measurement) (RetMeas) (2002)及Guide to WVASE (2002) (Woollam可變角度光譜橢圓偏光儀( Woollam Variable Angle Spectroscopic Ellipsometer))由J. A. Woollam Co. Inc (Lincoln, NE, USA)出版。除非另外陳述,否則此方法用於測定本發明中所描述之材料、膜及裝置的延遲。 The method used to perform these measurements was presented by N. Singh at the National Physics Laboratory (London, UK) in October 2006, under the title "Spectroscopic Ellipsometry, Part 1 - Theory and Fundamentals, Part 2 - Practical Examples and Part 3 - Measurements." The measurement procedures described in Manual Retardation Measurement (RetMeas) (2002) and Guide to WVASE (2002) (Woollam Variable Angle Spectroscopic Ellipsometer ) were published by JA Woollam Co. Inc. ( Lincoln , NE, USA). Unless otherwise stated, this method was used to determine the retardation of the materials, films, and devices described in this invention.
術語「A板」係指使用單軸雙折射材料層之光學延遲器,其中其非尋常軸平行於該層之平面定向。The term "A-plate" refers to an optical retarder that uses a layer of uniaxial birefringent material with its extraordinary axis oriented parallel to the plane of the layer.
術語「C板」係指使用單軸雙折射材料之層的光學延遲器,其中其非尋常軸垂直於該層之平面定向。The term "C-plate" refers to an optical retarder using a layer of uniaxial birefringent material with its extraordinary axis oriented perpendicular to the plane of the layer.
在包含具有均勻定向之光學單軸雙折射液晶材料的A/C板中,膜之光軸由非異常軸之方向給出。包含具有正雙折射之光學單軸雙折射材料的A (或C)板亦稱作「正A (或C)板」或「+A (或+C)板」。In an A/C plate containing an optically uniaxial birefringent liquid crystal material with uniform orientation, the optical axis of the film is oriented in a direction other than the extraordinary axis. An A (or C) plate containing an optically uniaxial birefringent material with positive birefringence is also referred to as a "positive A (or C) plate" or a "+A (or +C) plate."
視圓盤狀材料之定向而定,包含具有負雙折射之光學單軸雙折射材料(諸如圓盤狀各向異性材料)之膜的A (或C)板亦稱作「負A (或C)板」或「-A (或C)板」。由在光譜之UV部分中具有反射譜帶之膽固醇型棒狀材料製成的膜亦具有負C板之光學特性。A (or C) plates made of films of optically uniaxial birefringent materials (such as anisotropic disc-shaped materials) with negative birefringence, depending on the orientation of the disc-shaped material, are also referred to as "negative A (or C) plates" or "-A (or C) plates." Films made of cholesteryl rod-shaped materials with a reflection band in the UV portion of the spectrum also exhibit the optical properties of negative C plates.
如下定義雙折射率Δn Δn = n e-n o其中n e為非尋常折射率且n o為尋常折射率,且平均有效折射率n av.由以下方程式給出: n av.= ((2n o 2+ n e 2)/3) ½ The birefringence Δn is defined as follows: Δn = ne -no , where ne is the extraordinary refractive index and no is the ordinary refractive index, and the average effective refractive index nav. is given by: nav. = ( ( 2n02 + ne2 )/3) 1/2
可使用Abbe折射計量測平均有效折射率n av.及尋常折射率n o。隨後可由上文方程式計算Δn。 The average effective refractive index n av. and the ordinary refractive index n o can be measured using an Abbe refractometer. Δn can then be calculated using the above equation.
除非上下文另外明確指示,否則如本文中所使用,術語之複數形式在本文中應理解為包括單數形式,且反之亦然。Unless the context clearly indicates otherwise, as used herein, plural forms of terms are to be understood as including the singular form and vice versa.
除非另外明確陳述,否則所有物理特性均已根據或根據「Merck Liquid Crystals, Physical Properties of Liquid Crystals」, Status Nov. 1997, Merck KGaA, Germany測定,且給定溫度為20℃。光學各向異性(Δn)係在589.3 nm之波長下測定。Unless expressly stated otherwise, all physical properties have been measured according to or in accordance with "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status Nov. 1997, Merck KGaA, Germany, and are given at 20° C. The optical anisotropy (Δn) is measured at a wavelength of 589.3 nm.
在存疑之情況下,應該應用如C. Tschierske, G. Pelzl及S. Diele, Angew. Chem. 2004, 116, 6340-6368中給出之定義。In case of doubt, the definition given in C. Tschierske, G. Pelzl and S. Diele, Angew. Chem. 2004, 116, 6340-6368 should be applied.
除非另外明確陳述,否則在給出的通式中,以下術語具有以下含義: 「碳基」表示含有一或多個碳原子之單價或多價有機基團,其不含其他原子(諸如-C≡C-)或視情況含有一或多個其他原子,諸如N、O、S、P、Si、Se、As、Te或Ge (例如羰基等)。「烴基」表示碳基,其另外含有一或多個H原子及視情況選用之一或多個雜原子(諸如N、O、S、P、Si、Se、As、Te或Ge)。 Unless expressly stated otherwise, in the given general formulae, the following terms have the following meanings: "Carbonyl" means a monovalent or polyvalent organic group containing one or more carbon atoms, which contains no other atoms (e.g., -C≡C-) or, if appropriate, contains one or more other atoms, such as N, O, S, P, Si, Se, As, Te, or Ge (e.g., carbonyl). "Hydrocarbonyl" means a carbonyl group which additionally contains one or more hydrogen atoms and, if appropriate, one or more impurity atoms (e.g., N, O, S, P, Si, Se, As, Te, or Ge).
碳基或烴基可為飽和或不飽和基團。不飽和基團為例如芳基、烯基或炔基。具有超過3個C原子之碳基或烴基可為直鏈、分支鏈及/或環狀且可含有螺鍵聯或縮合環。A carbonyl or alkyl group can be saturated or unsaturated. Unsaturated groups are, for example, aryl, alkenyl, or alkynyl. Carbonyl or alkyl groups with more than three carbon atoms can be linear, branched, and/or cyclic and may contain spiro linkages or condensed rings.
較佳的碳基及烴基為具有1至40個,較佳1至25個,尤其較佳1至18個C原子的視情況經取代之烷基、烯基、炔基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基及烷氧基羰氧基;具有6至40個,較佳6至25個C原子的視情況經取代之芳基或芳氧基;或具有6至40個,較佳6至25個C原子的視情況經取代之烷基芳基、芳基烷基、烷基芳氧基、芳基烷氧基、芳基羰基、芳氧基羰基、芳基羰氧基及芳氧基羰氧基。Preferred carbon and alkyl groups are optionally substituted alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy groups having 1 to 40, preferably 1 to 25, and particularly preferably 1 to 18 C atoms; optionally substituted aryl or aryloxy groups having 6 to 40, preferably 6 to 25 C atoms; or optionally substituted alkylaryl, arylalkyl, alkylaryloxy, arylalkoxy, arylcarbonyl, aryloxycarbonyl, arylcarbonyloxy and aryloxycarbonyloxy groups having 6 to 40, preferably 6 to 25 C atoms.
更佳的碳基及烴基為C 1-C 40烷基、C 2-C 40烯基、C 2-C 40炔基、C 3-C 40烯丙基、C 4-C 40烷基二烯基、C 4-C 40聚烯基、C 6-C 40芳基、C 6-C 40烷基芳基、C 6-C 40芳基烷基、C 6-C 40烷基芳氧基、C 6-C 40芳基烷氧基、C 2-C 40雜芳基、C 4-C 40環烷基、C 4-C 40環烯基等。尤其較佳為C 1-C 22烷基、C 2-C 22烯基、C 2-C 22炔基、C 3-C 22烯丙基、C 4-C 22烷基二烯基、C 6-C 12芳基、C 6-C 20芳基烷基及C 2-C 20雜芳基。 More preferred carbon groups and alkyl groups are C1- C40 alkyl, C2 - C40 alkenyl, C2 - C40 alkynyl, C3-C40 allyl, C4 - C40 alkyldienyl , C4 - C40 polyalkenyl, C6- C40 aryl, C6 - C40 alkylaryl, C6 - C40 arylalkyl, C6 - C40 alkylaryloxy, C6 - C40 arylalkoxy, C2 - C40 heteroaryl, C4 - C40 cycloalkyl, C4 - C40 cycloalkenyl, and the like. Particularly preferred are C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkynyl, C 3 -C 22 allyl, C 4 -C 22 alkyldienyl, C 6 -C 12 aryl, C 6 -C 20 arylalkyl and C 2 -C 20 heteroaryl.
更佳的碳基及烴基為具有1至40個,較佳1至25個C原子,更佳1至12個C原子之直鏈、分支鏈或環狀烷基,其未經取代或經F、Cl、Br、I或CN單取代或多取代,且其中一或多個不相鄰的CH 2基團可以使得O及/或S原子彼此不直接連接之方式各自彼此獨立地經-C(R x)=C(R x)-、-C≡C-、-N(R x)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-置換。 More preferred carbon and alkyl groups are linear, branched or cyclic alkyl groups having 1 to 40, preferably 1 to 25, more preferably 1 to 12 C atoms, which are unsubstituted or mono- or polysubstituted with F, Cl, Br, I or CN, and in which one or more non-adjacent CH2 groups can be independently replaced by -C( Rx )=C( Rx )-, -C≡C-, -N(Rx)-, -O-, -S-, -CO-, -CO- O- , -O-CO-, or -O-CO-O- in such a manner that the O and/or S atoms are not directly connected to each other.
在上文,R x較佳表示H、鹵素、具有1至25個C原子之直鏈、分支鏈或環狀烷基鏈,其中另外,一或多個不相鄰的C原子可經-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-置換,且其中一或多個H原子可經氟、具有6至40個C原子的視情況經取代之芳基或芳氧基或具有2至40個C原子的視情況經取代之雜芳基或雜芳氧基置換。 In the above, Rx preferably represents H, a halogen, a linear, branched or cyclic alkyl chain having 1 to 25 C atoms, wherein in addition, one or more non-adjacent C atoms may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, and wherein one or more H atoms may be replaced by fluorine, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
較佳烷基為例如甲基、乙基、正丙基、異丙基、正丁基、異丁基、二級丁基、三級丁基、2-甲基丁基、正戊基、二級戊基、正己基、2-乙基己基、正庚基、正辛基、正壬基、正癸基、正十一基、正十二基、十二烷基、三氟甲基、全氟正丁基、2,2,2-三氟乙基、全氟辛基、全氟己基等。Preferred alkyl groups include, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, di-butyl, tertiary butyl, 2-methylbutyl, n-pentyl, di-pentyl, n-hexyl, 2-ethylhexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, dodecyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, and perfluorohexyl.
較佳烯基為例如乙烯基、丙烯基、丁烯基、戊烯基、環戊烯基、己烯基、環己烯基、庚烯基、環庚烯基、辛烯基、環辛烯基等。Preferred alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, and cyclooctenyl.
較佳炔基為例如乙炔基、丙炔基、丁炔基、戊炔基、己炔基、辛炔基等。Preferred alkynyl groups include ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl and the like.
較佳烷氧基為例如甲氧基、乙氧基、2-甲氧基乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、二級丁氧基、三級丁氧基、2-甲基丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基、正十一烷氧基、正十二烷氧基等。Preferred alkoxy groups include methoxy, ethoxy, 2-methoxyethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, di-butoxy, tertiary butoxy, 2-methylbutoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, n-nonyloxy, n-decyloxy, n-undecyloxy, and n-dodecyloxy.
較佳胺基為例如二甲胺基、甲胺基、甲基苯胺基、苯胺基等。Preferred amino groups include dimethylamino, methylamino, methylanilino, and anilino.
芳基及雜芳基可為單環或多環,亦即其可具有一個環(諸如苯基)或兩個或更多個環,其亦可經稠合(諸如萘基)或共價連接(諸如聯苯),或含有稠合環及連接環之組合。雜芳基含有一或多個較佳選自O、N、S及Se之雜原子。Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e., they can have one ring (e.g., phenyl) or two or more rings, which can also be fused (e.g., naphthyl) or covalently linked (e.g., biphenyl), or contain a combination of fused and linked rings. Heteroaryl groups contain one or more heteroatoms, preferably selected from O, N, S, and Se.
較佳為具有6至25個C原子之單環、雙環或三環芳基及具有2至25個C原子之單環、雙環或三環雜芳基,其視情況含有稠合環且視情況經取代。此外,較佳為5員、6員或7員芳基及雜芳基,其中另外,一或多個CH基團可以使得O原子及/或S原子彼此不直接連接之方式經N、S或O置換。Preferred are monocyclic, bicyclic or tricyclic aryl groups having 6 to 25 carbon atoms and monocyclic, bicyclic or tricyclic heteroaryl groups having 2 to 25 carbon atoms, which optionally contain fused rings and are optionally substituted. Furthermore, preferred are 5-, 6- or 7-membered aryl and heteroaryl groups, in which one or more CH groups may be replaced by N, S or O in such a way that the O atoms and/or S atoms are not directly connected to each other.
較佳芳基為例如苯基、聯苯、聯三苯、[1,1':3',1'']聯三苯-2'-基、萘基、蒽、聯萘、菲、芘、二氫芘、䓛、苝、稠四苯、稠五苯、苯并芘、茀、茚、茚并茀、螺二茀等。Preferred aryl groups include phenyl, biphenyl, terphenyl, [1,1':3',1'']terphenyl-2'-yl, naphthyl, anthracene, binaphthyl, phenanthrene, pyrene, dihydropyrene, chrysene, perylene, fused tetraphenyl, fused pentacene, benzopyrene, fluorene, indene, indenofluorene, and spirobifluorene.
較佳雜芳基為例如5員環,諸如吡咯、吡唑、咪唑、1,2,3-三唑、1,2,4-三唑、四唑、呋喃、噻吩、硒吩、㗁唑、異㗁唑、1,2-噻唑、1,3-噻唑、1,2,3-㗁二唑、1,2,4-㗁二唑、1,2,5-㗁二唑、1,3,4-㗁二唑、1,2,3-噻二唑、1,2,4-噻二唑、1,2,5-噻二唑、1,3,4-噻二唑;6員環,諸如吡啶、嗒𠯤、嘧啶、吡𠯤、1,3,5-三𠯤、1,2,4-三𠯤、1,2,3-三𠯤、1,2,4,5-四𠯤、1,2,3,4-四𠯤、1,2,3,5-四𠯤;或縮合基團,諸如吲哚、異吲哚、吲哚𠯤、吲唑、苯并咪唑、苯并三唑、嘌呤、萘咪唑、菲咪唑、吡啶咪唑、吡𠯤咪唑、喹喏啉咪唑、苯并㗁唑、萘并㗁唑、蒽并㗁唑、菲并㗁唑、異㗁唑、苯并噻唑、苯并呋喃、異苯并呋喃、二苯并呋喃、喹啉、異喹啉、喋啶、苯并-5,6-喹啉、苯并-6,7-喹啉、苯并-7,8-喹啉、苯并異喹啉、吖啶、啡噻𠯤、啡㗁 𠯤、苯并嗒𠯤、苯并嘧啶、喹喏啉、吩𠯤、㖠啶、氮雜咔唑、苯并咔啉、啡啶、啡啉、噻吩并[2,3b]噻吩、噻吩并[3,2b]噻吩、二噻吩并噻吩、異苯并噻吩、二苯并噻吩、苯并噻二唑并噻吩或此等基團之組合。雜芳基亦可經烷基、烷氧基、硫烷基、氟、氟烷基或其他芳基或雜芳基取代。Preferred heteroaryl groups are, for example, 5-membered rings such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxadiazole, isoxadiazole, 1,2-thiazole, 1,3-thiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole; 6-membered rings such as pyridine, pyrimidine, pyrimidine, pyridine, 1,3,5-triazole, 1,2,4-triazole, 1,2,3-oxadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole; triazole, 1,2,4,5-tetramethyleneimine, 1,2,3,4-tetramethyleneimine, 1,2,3,5-tetramethyleneimine; or condensed groups such as indole, isoindole, indolizole, indazole, benzimidazole, benzotriazole, purine, naphthalene imidazole, phenimidazole, pyridinimidazole, pyriimidazole, quinoxaline imidazole, benzotriazole, oxazole, naphthazole, anthraxazole, phenanthazole, isoazole, benzothiazole, benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pteridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, benzoisoquinoline, acridine, phenathiophene, phenanthiophene, benzopyrimidine, quinoxaline, phenanthiophene, azodiazole, benzocarboline, phenanthridine, phenanthroline, thieno[2,3b]thiophene, thieno[3,2b]thiophene, dithienothiophene, isobenzothiophene, dibenzothiophene, benzothiadiazolethiophene, or a combination of these groups. The heteroaryl group may also be substituted by an alkyl group, an alkoxy group, a sulfanyl group, a fluorine group, a fluoroalkyl group, or other aryl or heteroaryl groups.
(非芳族)脂環族基及雜環基涵蓋飽和環(亦即,排他性地含有單鍵之彼等環)及部分不飽和環(亦即,亦可含有多重鍵之彼等環)兩者。雜環含有一或多個較佳選自O、N、S及Se之雜原子。(Non-aromatic) cycloaliphatic and heterocyclic groups include both saturated rings (i.e., those containing exclusively single bonds) and partially unsaturated rings (i.e., those containing multiple bonds). Heterocyclic rings contain one or more heteroatoms preferably selected from O, N, S and Se.
(非芳族)脂環族基及雜環基可為單環,亦即僅含有一個環(諸如環己烷);或多環,亦即含有複數個環(諸如十氫萘或二環辛烷)。尤其較佳為飽和基團。此外,較佳為具有3至25個C原子之單環、雙環或三環基團,其視情況含有稠合環且視情況經取代。此外,較佳為5員、6員、7員或8員碳環基,其中另外,一或多個C原子可經Si置換,及/或一或多個CH基團可經N置換,及/或一或多個不相鄰的CH 2基可經-O-及/或-S-置換。 (Non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e., containing only one ring (e.g., cyclohexane), or polycyclic, i.e., containing multiple rings (e.g., decahydronaphthalene or bicyclooctane). Saturated groups are particularly preferred. Furthermore, monocyclic, bicyclic, or tricyclic groups having 3 to 25 carbon atoms, optionally containing fused rings and optionally substituted, are preferred. Furthermore, 5-, 6-, 7-, or 8-membered carbocyclic groups are preferred, wherein one or more carbon atoms may be replaced by Si, and/or one or more CH groups may be replaced by N, and/or one or more non-adjacent CH2 groups may be replaced by -O- and/or -S-.
較佳之脂環族基及雜環基為例如5員基團,諸如環戊烷、四氫呋喃、四氫硫代呋喃、吡咯啶;6員基團,諸如環己烷、環己矽烷、環己烯、四氫哌喃、四氫硫代哌喃、1,3-二㗁烷、1,3-二噻烷、哌啶;7員基團,諸如環庚烷;及稠合基團,諸如四氫萘、十氫萘、茚烷、雙環[1.1.1]戊烷-1,3-二基、雙環[2.2.2]辛烷-1,4-二基、螺[3.3]庚烷-2,6-二基、八氫-4,7-甲橋茚烷-2,5-二基。Preferred alicyclic groups and heterocyclic groups include, for example, 5-membered groups such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, and pyrrolidine; 6-membered groups such as cyclohexane, cyclohexasilane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1,3-dioxane, 1,3-dithiane, and piperidine; 7-membered groups such as cyclohexane, cyclohexasilane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1,3-dioxane, and piperidine. such as cycloheptane; and fused groups such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, octahydro-4,7-methanoindan-2,5-diyl.
芳基、雜芳基、(非芳族)脂環族基及雜環基視情況具有一或多個取代基,其較佳選自包含以下之群:矽基、磺酸基、磺醯基、甲醯基、胺、亞胺、腈、巰基、硝基、鹵素、C 1-12烷基、C 6-12芳基、C 1-12烷氧基、羥基或此等基團之組合。 The aryl group, heteroaryl group, (non-aromatic) alicyclic group and heterocyclic group may have one or more substituents, preferably selected from the group consisting of a silyl group, a sulfonic acid group, a sulfonyl group, a formyl group, an amine, an imine, a nitrile, a hydroxyl group, a nitro group, a halogen group, a C 1-12 alkyl group, a C 6-12 aryl group, a C 1-12 alkoxy group, a hydroxyl group or a combination of these groups.
較佳取代基為例如促溶性基團,諸如烷基或烷氧基;拉電子基團,諸如氟、硝基或腈;或用於增加聚合物之玻璃轉移溫度(Tg)之取代基,特定言之龐大基團,諸如三級丁基或視情況經取代之芳基。Preferred substituents are, for example, solubilizing groups such as alkyl or alkoxy groups; electron-withdrawing groups such as fluorine, nitro or nitrile; or substituents for increasing the glass transition temperature (Tg) of the polymer, in particular bulky groups such as tertiary butyl or optionally substituted aryl groups.
較佳取代基(在下文亦稱作「L」)為例如F、Cl、Br、I、-OH、-CN、-NO 2、-NCO、-NCS、-OCN、-SCN、-C(=O)N(R x) 2、-C(=O)Y x、-C(=O)R x、-C(=O)OR x、-N(R x) 2,其中R x具有上文所提及之含義,且上文Y x表示鹵素、視情況經取代之矽基、具有4至40個,較佳4至20個環原子的視情況經取代之芳基或雜芳基,及具有1至25個C原子之直鏈或分支鏈烷基、烯基、炔基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中一或多個H原子可視情況經F或Cl置換。 Preferred substituents (hereinafter also referred to as "L") are, for example, F, Cl, Br, I , -OH, -CN, -NO2, -NCO, -NCS, -OCN, -SCN, -C(=O)N( Rx ) 2 , -C(=O) Yx , -C(=O) Rx , -C(=O) ORx , -N( Rx ) 2 , wherein Rx has the meanings mentioned above, and Y x represents a halogen, an optionally substituted silyl group, an optionally substituted aryl or heteroaryl group having 4 to 40, preferably 4 to 20 ring atoms, and a linear or branched alkyl group, alkenyl group, alkynyl group, alkoxy group, alkylcarbonyl group, alkoxycarbonyl group, alkylcarbonyloxy group or alkoxycarbonyloxy group having 1 to 25 carbon atoms, wherein one or more H atoms may be optionally replaced by F or Cl.
「經取代之矽基或芳基」較佳意謂經鹵素、-CN、R y、-OR y、-CO-R y、-CO-O-R y、-O-CO-R y或-O-CO-O-R y取代,其中R y表示H、具有1至12個C原子之直鏈、分支鏈或環狀烷基鏈。 “Substituted silyl or aryl” preferably means substituted by halogen, -CN, R y , -OR y , -CO-R y , -CO-OR y , -O-CO-R y or -O-CO-OR y , wherein R y represents H, a linear, branched or cyclic alkyl chain having 1 to 12 carbon atoms.
在上文及下文所展示之式中,經取代之伸苯基環 較佳為 , 其中L在每次出現時相同或不同地具有上文及下文所給出的含義中之一者,且較佳為F、Cl、CN、NO 2、CH 3、C 2H 5、C(CH 3) 3、CH(CH 3) 2、CH 2CH(CH 3)C 2H 5、OCH 3、OC 2H 5、COCH 3、COC 2H 5、COOCH 3、COOC 2H 5、CF 3、OCF 3、OCHF 2、OC 2F 5或P-Sp-,極佳為F、Cl、CN、CH 3、C 2H 5、OCH 3、COCH 3、OCF 3或P-Sp-,最佳為F、Cl、CH 3、OCH 3、COCH 3或OCF 3。 In the formulae shown above and below, the substituted phenylene ring Better , in which L, at each occurrence, identically or differently, has one of the meanings given above and below, and is preferably F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , C(CH 3 ) 3 , CH(CH 3 ) 2 , CH 2 CH(CH 3 )C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 or P-Sp-, very preferably F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 , OCF 3 or P-Sp-, most preferably F, Cl, CH 3 , OCH 3 , COCH 3 or OCF 3 .
「鹵素」表示F、Cl、Br或I,較佳為F或Cl,更佳為F。"Halogen" means F, Cl, Br or I, preferably F or Cl, more preferably F.
「可聚合的基團」(P)較佳選自含有C=C雙鍵或C≡C參鍵之基團,及適用於與開環聚合之基團,諸如氧呾(oxetane)或環氧基團。The "polymerizable group" (P) is preferably selected from groups containing a C=C double bond or a C≡C triple bond, and groups suitable for ring-opening polymerization, such as oxetane or epoxide groups.
較佳地,可聚合的基團(P)係選自由以下組成之群:CH 2=CW 1-COO-、CH 2=CW 1-CO-、 、CH 2=CW 2-(O) k3-、CW 1=CH-CO-(O) k3-、CW 1=CH-CO-NH-、CH 2=CW 1-CO-NH-、CH 3-CH=CH-O-、(CH 2=CH) 2CH-OCO-、(CH 2=CH-CH 2) 2CH-OCO-、(CH 2=CH) 2CH-O-、(CH 2=CH-CH 2) 2N-、(CH 2=CH-CH 2) 2N-CO-、CH 2=CW 1-CO-NH-、CH 2=CH-(COO) k1-Phe-(O) k2-、CH 2=CH-(CO) k1-Phe-(O) k2-、Phe-CH=CH-, 其中 W 1表示H、F、Cl、CN、CF 3、具有1至5個C原子之苯基或烷基,特定言之H、F、Cl或CH 3, W 2表示H或具有1至5個C原子之烷基,特定言之H、甲基、乙基或正丙基, W 3及W 4各自彼此獨立地表示H、Cl或具有1至5個C原子之烷基,Phe表示1,4-伸苯基,其視情況經一或多個如上文所定義但不同於P-Sp之基團L取代,較佳地,較佳取代基L為F、Cl、CN、NO 2、CH 3、C 2H 5、OCH 3、OC 2H 5、COCH 3、COC 2H 5、COOCH 3、COOC 2H 5、CF 3、OCF 3、OCHF 2、OC 2F 5以及苯基,且 k 1、k 2及k 3各自彼此獨立地表示0或1,k 3較佳表示1,且k 4為1至10之整數。 Preferably, the polymerizable group (P) is selected from the group consisting of: CH 2 =CW 1 -COO-, CH 2 =CW 1 -CO-, , CH 2 =CW 2 -(O) k3 -, CW 1 =CH-CO-(O) k3 -, CW 1 =CH-CO-NH-, CH 2 =CW 1 -CO-NH-, CH 3 -CH=CH-O-, (CH 2 =CH) 2 CH-OCO-, (CH 2 =CH-CH 2 ) 2 CH-OCO-, (CH 2 =CH) 2 CH-O-, (CH 2 =CH-CH 2 ) 2 N-, (CH 2 =CH-CH 2 ) 2 N-CO-, CH 2 =CW 1 -CO-NH-, CH 2 =CH-(COO) k1 -Phe-(O) k2 -, CH 2 =CH-(CO) k1 -Phe-(O) k2 -, Phe-CH=CH-, where W 1 represents H, F, Cl, CN, CF 3 , phenyl or alkyl having 1 to 5 C atoms, in particular H, F, Cl or CH 3 , W 2 represents H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl, W 3 and W 4 each independently represent H, Cl or alkyl having 1 to 5 C atoms, Phe represents 1,4-phenylene, which is optionally substituted by one or more groups L as defined above but different from P-Sp, preferably, preferred substituents L are F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 and phenyl, and k 1 , k 2 and k k 3 each independently represents 0 or 1, k 3 preferably represents 1, and k 4 is an integer from 1 to 10.
尤其較佳之可聚合的基團P為CH 2=CH-COO-、CH 2=C(CH 3)-COO-、CH 2=CF-COO-、CH 2=CH-、CH 2=CH-O-、(CH 2=CH) 2CH-OCO-、(CH 2=CH) 2CH-O-、 ,其中W 2表示H或具有1至5個C原子之烷基,特定言之H、甲基、乙基或正丙基。 Particularly preferred polymerizable groups P are CH 2 =CH-COO-, CH 2 =C(CH 3 )-COO-, CH 2 =CF-COO-, CH 2 =CH-, CH 2 =CH-O-, (CH 2 =CH) 2 CH-OCO-, (CH 2 =CH) 2 CH-O-, , wherein W 2 represents H or an alkyl group having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl.
更佳之可聚合的基團(P)為乙烯基氧基、丙烯酸酯、甲基丙烯酸酯、氟丙烯酸酯、氯丙烯酸酯、氧呾及環氧化物,最佳為丙烯酸酯或甲基丙烯酸酯,特定言之丙烯酸酯。More preferred polymerizable groups (P) are vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxycarbonyl, and epoxide, with acrylate or methacrylate being most preferred, particularly acrylate.
較佳地,所有多反應性可聚合的化合物及其子式均含有含兩個或更多個可聚合的基團P (多反應性可聚合的基團)之一或多個分支鏈基團,而非一或多個基團P-Sp-。Preferably, all polyreactive polymerizable compounds and subformulas thereof contain one or more branching groups containing two or more polymerizable groups P (polyreactive polymerizable groups) rather than one or more groups P-Sp-.
適合之此類型基團及含有該等基團之可聚合的化合物描述於例如US 7,060,200 B1或US 2006/0172090 A1中。Suitable groups of this type and polymerizable compounds containing these groups are described, for example, in US 7,060,200 B1 or US 2006/0172090 A1.
尤其較佳為選自下式之多反應性可聚合的基團: -X-alkyl-CHP x-CH 2-CH 2P yI*a -X-alkyl-C(CH 2P x)(CH 2P y)-CH 2P zI*b -X-alkyl-CHP xCHP y-CH 2P zI*c -X-alkyl-C(CH 2P x)(CH 2P y)-C aaH 2aa+1I*d -X-alkyl-CHP x-CH 2P yI*e -X-alkyl-CHP xP yI*f -X-alkyl-CP xP y-C aaH 2aa+1I*g -X-alkyl-C(CH 2P v)(CH 2P w)-CH 2OCH 2-C(CH 2P x)(CH 2Py)CH 2P zI*h -X-alkyl-CH((CH 2) aaP x)((CH 2) bbP y) I*i -X-alkyl-CHP xCHP y-C aaH 2aa+1I*k 其中 alkyl 表示單鍵或具有1至12個C原子之直鏈或分支鏈伸烷基,其中一或多個不相鄰的CH 2基團可以使得O及/或S原子彼此不直接連接之方式各自彼此獨立地經-C(R x)=C(R x)-、-C≡C-、-N(R x)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-置換,且其中另外,一或多個H原子可經F、Cl或CN置換,其中R x具有一種上文所提及之含義, aa及 bb各自彼此獨立地表示0、1、2、3、4、5或6, X 具有針對X'所指示之含義中之一者,且 P v至P z各自彼此獨立地具有上文針對P所指示之含義中之一者。 Particularly preferred are multi-reactive polymerizable groups selected from the following formulae: -X-alkyl-CHPx- CH2 - CH2Py I *a -X-alkyl-C( CH2Px ) ( CH2Py )-CH2Pz I *b -X-alkyl-CHPxCHPy - CH2Pz I * c -X - alkyl -C( CH2Px )(CH2Py) -CaaH2aa +1 I *d -X - alkyl - CHPx -CH2Py I*e -X-alkyl-CHPxPy I *f -X - alkyl - CPxPy -CaaH2aa+1 I*g -X-alkyl- C (CH2Pv ) ( CH2Pw ) -CH2OCH2 - C(CH2Px ) ( CH2Py ) CH2Pz I *h -X-alkyl-CH((CH 2 ) aa P x )((CH 2 ) bb P y ) I*i -X-alkyl-CHP x CHP y -C aa H 2aa+1 I*k wherein alkyl represents a single bond or a linear or branched alkyl group having 1 to 12 C atoms, wherein one or more non-adjacent CH 2 groups can each independently of one another be replaced by -C(R x )═C(R x )-, -C≡C-, -N(R x )-, -O-, -S-, -CO-, -CO- O- , -O-CO-, -O-CO-O- in such a way that the O and/or S atoms are not directly bonded to one another, and wherein in addition one or more H atoms can be replaced by F, Cl or CN, wherein R x has one of the meanings mentioned above, aa and bb each independently represent 0, 1, 2, 3, 4, 5 or 6, X has one of the meanings indicated for X′, and Pv to Pz each independently have one of the meanings indicated above for P.
較佳之間隔基團Sp係選自式Sp'-X',使得基團「P-Sp-」符合式「P-Sp'-X'-」,其中 Sp' 表示具有1至20個,較佳1至12個C原子之伸烷基,其視情況經F、Cl、Br、I或CN單取代或多取代,且其中另外,一或多個不相鄰的CH 2基團可以使得O及/或S原子彼此不直接連接之方式各自彼此獨立地經-O-、-S-、-NH-、-NR xx-、-SiR xxR yy-、-CO-、-COO-、-OCO-、-OCO-O-、-S-CO-、-CO-S-、-NR xx-CO-O-、-O-CO-NR 0xx-、-NR xx-CO-NR yy-、-CH=CH-或-C≡C-置換, X' 表示-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR xx-、-NR xx-CO-、-NR xx-CO-NR yy-、-OCH 2-、-CH 2O-、-SCH 2-、-CH 2S-、-CF 2O-、-OCF 2-、-CF 2S-、-SCF 2-、-CF 2CH 2-、-CH 2CF 2-、-CF 2CF 2-、-CH=N-、-N=CH-、-N=N-、-CH=CR xx-、-CY xx=CY xx-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-或單鍵, R xx及R yy各自彼此獨立地表示H或具有1至12個C原子之烷基,及 Y xx及Y yy各自彼此獨立地表示H、F、Cl或CN, X' 較佳為-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR xx-、-NR xx-CO-、-NR xx-CO-NR yy-或單鍵。 Preferred spacer groups Sp are selected from the formula Sp'-X', such that the group "P-Sp-" conforms to the formula "P-Sp'-X'-", wherein Sp' represents an alkylene group having 1 to 20, preferably 1 to 12, C atoms, which is optionally monosubstituted or polysubstituted with F, Cl, Br, I or CN, and wherein in addition, one or more non-adjacent CH2 groups may each be independently replaced by -O-, -S-, -NH-, -NRxx-, -SiRxxRyy- , -CO-, -COO-, -OCO-, -OCO - O-, -S - CO-, -CO-S-, -NRxx-CO-O-, -O-CO-NR0xx-, -NRxx -CO-NRyy-, -CH=CH- or -C≡C- in such a way that the O and /or S atoms are not directly connected to each other, and X' represents -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR xx -, -NR xx -CO-, -NR xx -CO-NR yy -, -OCH 2 -, -CH 2 O- , -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 -, -CH= N- , -N=CH-, -N=N-, -CH=CR xx -, -CY xx =CY xx -, -C≡C- , -CH=CH-COO-, -OCO-CH=CH-, or a single bond , R xx and R yy each independently represent H or an alkyl group having 1 to 12 C atoms, and Y xx and Y yy each independently represents H, F, Cl or CN, and X' is preferably -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR xx -, -NR xx -CO-, -NR xx -CO-NR yy -, or a single bond.
典型的間隔基團Sp'為例如-(CH 2) p1-、-(CH 2CH 2O) q1-CH 2CH 2-、-CH 2CH 2-S-CH 2CH 2-、-CH 2CH 2-NH-CH 2CH 2-或-(SiR xR xx-O) p1-, 其中p1為1至12之整數,q1為1至3之整數,且R xx及R yy具有上文所提及之含義。 Typical spacer groups Sp' are , for example, -( CH2 ) p1- , -( CH2CH2O ) q1 - CH2CH2- , -CH2CH2- S - CH2CH2- , -CH2CH2-NH-CH2CH2- , or - ( SiRxRxx - O ) p1- , wherein p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and Rxx and Ryy have the meanings mentioned above.
尤其較佳基團-X'-Sp'-為-(CH 2) p1-、-O-(CH 2) p1-、-OCO-(CH 2) p1-、-OCOO-(CH 2) p1-,其中p1為1至12之整數。 Particularly preferred groups -X'-Sp'- are -(CH 2 ) p1 -, -O-(CH 2 ) p1 -, -OCO-(CH 2 ) p1 -, and -OCOO-(CH 2 ) p1 -, wherein p1 is an integer from 1 to 12.
在各情況下,尤其較佳基團Sp'為例如直鏈、亞甲基、伸乙基、伸丙基、伸丁基、伸戊基、伸己基、伸庚基、伸辛基、伸壬基、伸癸基、伸十一烷基、伸十二烷基、伸十八烷基、伸乙基氧基伸乙基、亞甲基氧基伸丁基、伸乙基硫基伸乙基、伸乙基-N-甲基亞胺基伸乙基、1-甲基伸烷基、伸乙烯基、伸丙烯基及伸丁烯基。Particularly preferred radicals Sp' in each case are, for example, linear, methylene, ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene-N-methyliminoethylene, 1-methylalkylene, vinylene, propenylene and butenylene.
對於本發明, 表示反式-1,4-伸環己基,且 表示1,4-伸苯基。 For the present invention, represents trans-1,4-cyclohexylene, and represents 1,4-phenylene.
對於本發明,基團-COO-或-CO 2-表示式 之酯基,且基團-OCO-、-O 2C-或-OOC-表示式 之酯基。 For the present invention, the group -COO- or -CO 2 - is represented by Ester group, and the group -OCO-, -O 2 C- or -OOC- is represented by Ester group.
「聚合物網路」為其中所有聚合物鏈互連以藉由許多交聯形成單一肉眼可見實體的網路。A "polymer network" is a network in which all polymer chains are interconnected by numerous cross-links to form a single macroscopic entity.
聚合物網路可存在於以下類型中: - 接枝聚合物分子為分支鏈聚合物分子,其中一或多個側鏈在結構上或構型上與主鏈不同。 - 星型聚合物分子為分支鏈聚合物分子,其中單一分支點產生多個線形鏈或臂。若臂相同,則星型聚合物分子稱為規則的。若相鄰臂由不同重複子單元構成,則星型聚合物分子稱為多樣化的。 - 梳狀聚合物分子由具有兩個或更多個三路分支點之主鏈及線形側鏈組成。若臂相同,則梳狀聚合物分子稱為規則的。 - 刷狀聚合物分子由主鏈與線形、未分支側鏈組成,且其中分支點中之一或多者具有四路官能性或更大官能性。 Polymer networks can exist in the following types: - Graft polymer molecules are branched polymer molecules in which one or more side chains differ structurally or conformationally from the main chain. - Star polymer molecules are branched polymer molecules in which a single branch point gives rise to multiple linear chains or arms. If the arms are identical, the star polymer molecule is called regular. If adjacent arms are composed of different repeating subunits, the star polymer molecule is called diversified. - Comb polymer molecules consist of a main chain with two or more three-way branch points and linear side chains. If the arms are identical, the comb polymer molecule is called regular. - Brush polymer molecules consist of a main chain with linear, unbranched side chains, and one or more of the branch points has four-way functionality or greater.
貫穿本說明書之描述及申請專利範圍,字組「包含(comprise)」及「含有(contain)」以及該等字組之變化形式(例如,「包含(comprising)」及「包含(comprises)」)意謂「包括但不限於」,且不意欲(且不)排除其他組分。另一方面,字組「包含」亦涵蓋術語「由……組成」,但不限於該術語。Throughout this specification and the claims, the words "comprise" and "contain" and variations thereof (e.g., "comprising" and "comprises") mean "including but not limited to," and are not intended to (and do not) exclude other components. On the other hand, the word "comprising" also encompasses the term "consisting of," but is not limited to that term.
貫穿本說明書之描述及申請專利範圍,字組「可獲得的」及「所獲得的」以及該等字組之變化形式意謂「包括但不限於」,且不意欲(且不)排除其他組分。另一方面,字組「可獲得的」亦涵蓋術語「所獲得的」,但不限於該術語。Throughout the description and claims of this specification, the words "available" and "obtained" and variations thereof mean "including but not limited to," and are not intended to (and do not) exclude other components. On the other hand, the word "available" also encompasses the term "obtained," but is not limited to that term.
所有濃度均以重量百分比給出且係關於作為整體之各別混合物,所有溫度均以攝氏度給出且所有溫度差均以不同度數給出。All concentrations are given as percentages by weight and relate to the respective mixture as a whole, all temperatures are given in degrees Celsius and all temperature differences are given in degrees.
較佳之式I化合物係選自以下較佳實施例。Preferred compounds of formula I are selected from the following preferred examples.
在式I化合物中,基團N(R 13)(R 14)亦可較佳為胺。 In the compounds of formula I, the group N(R 13 )(R 14 ) may also preferably be an amine.
另一較佳的係式I化合物,其中
p 為2,
在本發明之一較佳實施例中,在式I化合物中,
在本申請案之一較佳實施例中,在式I化合物中, 表示選自下式之群的基團: 。 In one preferred embodiment of the present application, in the compound of formula I, represents a group selected from the group: .
在本申請案之一較佳實施例中,在式I化合物中, 表示選自下式之群的基團: 。 In one preferred embodiment of the present application, in the compound of formula I, represents a group selected from the group: .
在本申請案之一較佳實施例中,在式I化合物(其中p較佳表示1)中,
在本申請案之一較佳實施例中,在式I化合物中,基團 較佳表示選自下式之群的基團: 。 In one preferred embodiment of the present application, in the compound of formula I, the group Preferably, the group is selected from the group consisting of: .
在本申請案之另一較佳實施例(其可與上文所描述之彼等相同或不同)中,在式I化合物中, 較佳表示選自下式之群的基團: 。 In another preferred embodiment of the present application (which may be the same as or different from those described above), in the compound of formula I, Preferably, the group is selected from the group consisting of: .
在本發明之另一較佳實施例(其可與上文所描述之彼等相同或不同)中,在式I化合物中,基團
,
在每次出現時彼此獨立地表示
在本發明之一尤其較佳實施例中,在式I化合物中,所存在之全部基團 表示具有相同含義。 In a particularly preferred embodiment of the present invention, in the compound of formula I, all the groups present are Meanings have the same meaning.
在本發明之一較佳實施例中,根據本發明之介質在各情況下包含一或多種式I化合物,其選自以下式I-1至I-13之化合物之群,較佳選自式I-3、I-5、I-6、I-7、I-8、I-9、I-10、I-12及I-13之化合物之群,尤其較佳選自式I-6至I-9及極佳地式I-9之化合物之群, 。 In a preferred embodiment of the present invention, the medium according to the present invention in each case comprises one or more compounds of the formula I selected from the group of compounds of the following formulae I-1 to I-13, preferably from the group of compounds of the formulae I-3, I-5, I-6, I-7, I-8, I-9, I-10, I-12 and I-13, particularly preferably from the group of compounds of the formulae I-6 to I-9 and very preferably from the group of compounds of the formula I-9, .
在本發明之一甚至更佳實施例中,根據本發明之介質在各情況下包含一或多種式I化合物,其選自以下式I-1及/或I-3至I-7及/或I-8及/或I-9之化合物之群。In an even better embodiment of the invention, the medium according to the invention comprises in each case one or more compounds of formula I selected from the group of compounds of the following formulae I-1 and/or I-3 to I-7 and/or I-8 and/or I-9.
在本發明之一甚至更佳實施例中,根據本發明之介質在各情況下包含一或多種式I化合物,其選自以下式I-8及/或I-9之化合物之群。In an even more preferred embodiment of the invention, the medium according to the invention comprises in each case one or more compounds of the formula I selected from the group of compounds of the following formulae I-8 and/or I-9.
在本發明之另一較佳實施例中,根據本發明之介質在各情況下至少包含一或多種式I化合物,其中p表示1且n表示3、4、5或6,較佳4,且基團-Z 11-S 11-Z 12-表示ω-雙氧基伸烷基,亦即-O-S 11-O-,此等介質具有極佳穩定性。 In another preferred embodiment of the present invention, the medium according to the invention in each case comprises at least one or more compounds of the formula I, in which p is 1 and n is 3, 4, 5 or 6, preferably 4, and the group -Z 11 -S 11 -Z 12 - represents ω-bisoxyalkylene, i.e. -OS 11 -O-. Such mediators have excellent stability.
可有利地及較佳地根據美國申請案第15/883,976號中給出之揭示內容製備式I化合物。The compounds of formula I can advantageously and preferably be prepared according to the disclosure given in U.S. application Ser. No. 15/883,976.
較佳地,一或多種雙反應性或多反應性液晶原基化合物係選自式DRM P 1-Sp 1-MG-Sp 2-P 2DRM 其中 P 1及P 2彼此獨立地表示可聚合的基團, Sp 1及Sp 2彼此獨立地為間隔基團或單鍵,且 MG 為棒狀液晶原基基團,其較佳選自式MG -(A 1-Z 1) n-A 2- MG 其中 A 1及A 2在多次出現之情況下彼此獨立地表示芳族或脂環族基團,其視情況含有一或多個選自N、O及S之雜原子且視情況經L 1單取代或多取代, L 1為P-Sp-、F、Cl、Br、I、-CN、-NO 2、-NCO、-NCS、-OCN、-SCN、-C(=O)NR 00R 000、-C(=O)OR 00、-C(=O)R 00、-NR 00R 000、-OH、-SF 5、視情況經取代之矽基、具有1至12個,較佳1至6個C原子的芳基或雜芳基,及具有1至12個,較佳1至6個C原子之直鏈或分支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中一或多個H原子視情況經F或Cl置換, R 00及R 000彼此獨立地表示H或具有1至12個C原子之烷基, Z 1在多次出現之情況下彼此獨立地表示-O-、-S-、-CO-、-COO-、-OCO-、-S-CO-、-CO-S-、-O-COO-、-CO-NR 00-、-NR 00-CO-、-NR 00-CO-NR 000、-NR 00-CO-O-、-O-CO-NR 00-、-OCH 2-、-CH 2O-、-SCH 2-、-CH 2S-、-CF 2O-、-OCF 2-、-CF 2S-、-SCF 2-、-CH 2CH 2-、-(CH 2) n1、-CF 2CH 2-、-CH 2CF 2-、-CF 2CF 2-、-CH=N-、-N=CH-、-N=N-、-CH=CR 00-、-CY 1=CY 2-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-或單鍵, Y 1及Y 2彼此獨立地表示H、F、Cl或CN, n 為1、2、3或4,較佳為1或2,最佳為2, n1 為1至10之整數,較佳為1、2、3或4。 Preferably, one or more bireactive or polyreactive mesogen compounds are selected from the formula DRM P 1 -Sp 1 -MG-Sp 2 -P 2 DRM wherein P 1 and P 2 independently represent a polymerizable group, Sp 1 and Sp 2 independently represent a spacer group or a single bond, and MG is a rod-shaped mesogen group, which is preferably selected from the formula MG -(A 1 -Z 1 ) n -A 2 - MG wherein A 1 and A 2 , when occurring multiple times, independently represent an aromatic or alicyclic group, which optionally contains one or more heteroatoms selected from N, O and S and is optionally monosubstituted or polysubstituted by L 1 , L 1 is P-Sp-, F, Cl, Br, I, -CN, -NO 2 , -NCO, -NCS, -OCN, -SCN, -C(=O)NR 00 R 000 , -C(=O)OR 00 , -C(=O)R 00 , -NR 00 R 000 , -OH, -SF 5 , an optionally substituted silyl group, an aryl group or heteroaryl group having 1 to 12, preferably 1 to 6, C atoms, and a linear or branched alkyl group, alkoxy group, alkylcarbonyl group, alkoxycarbonyl group, alkylcarbonyloxy group or alkoxycarbonyloxy group having 1 to 12, preferably 1 to 6, C atoms, wherein one or more H atoms are optionally replaced by F or Cl, R 00 and R 000 independently represent H or an alkyl group having 1 to 12 C atoms, Z 1 In the case of multiple occurrences, it represents -O-, -S-, -CO-, -COO-, -OCO-, -S-CO-, -CO-S-, -O-COO-, -CO-NR 00 -, -NR 00 -CO-, -NR 00 -CO-NR 000 , -NR 00 -CO-O-, -O - CO-NR 00 -, -OCH 2 -, -CH 2 O-, -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CH 2 CH 2 -, -(CH 2 ) n1 , -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 - , -CH = N- , -N=CH-, -N=N-, -CH=CR 00 -, -CY 1 =CY 2 -, -C≡C-, -CH=CH-COO-, -OCO-CH=CH-, or a single bond; Y 1 and Y 2 independently represent H, F, Cl, or CN; n is 1, 2, 3, or 4, preferably 1 or 2, most preferably 2; and n1 is an integer from 1 to 10, preferably 1, 2, 3, or 4.
較佳基團A 1及A 2包括(但不限於)呋喃、吡咯、噻吩、㗁唑、噻唑、噻二唑、咪唑、伸苯基、伸環己基、伸雙環辛基、伸環己烯基、吡啶、嘧啶、吡𠯤、甘菊環(azulene)、茚烷、茀、萘、四氫萘、蒽、菲及二噻吩并噻吩,以上所有均未經取代或經1、2、3或4個如上文所定義之基團L取代。 Preferred groups A 1 and A 2 include, but are not limited to, furan, pyrrole, thiophene, oxazole, thiazole, thiadiazole, imidazole, phenylene, cyclohexylene, dicyclooctylene, cyclohexenylene, pyridine, pyrimidine, pyrrolidone, azulene, indane, fluorene, naphthalene, tetrahydronaphthalene, anthracene, phenanthrene, and dithienothiophene, all of which are unsubstituted or substituted with 1, 2, 3, or 4 groups L as defined above.
尤其較佳之基團A 1及A 2係選自1,4-伸苯基、吡啶-2,5-二基、嘧啶-2,5-二基、噻吩-2,5-二基、萘-2,6-二基、1,2,3,4-四氫-萘-2,6-二基、茚烷-2,5-二基、伸雙環辛基或1,4-伸環己基,其中一個或兩個不相鄰的CH 2基團視情況經O及/或S置換,其中此等基團未經取代或經1、2、3或4個如上所定義之基團L取代。 Particularly preferred groups A 1 and A 2 are selected from 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, thiophene-2,5-diyl, naphthalene-2,6-diyl, 1,2,3,4-tetrahydro-naphthalene-2,6-diyl, indane-2,5-diyl, bicyclooctyl or 1,4-cyclohexylene, wherein one or two non-adjacent CH 2 groups are optionally replaced by O and/or S, wherein these groups are unsubstituted or substituted by 1, 2, 3 or 4 groups L as defined above.
尤其較佳之基團Z 1在每次出現時彼此獨立地較佳選自-COO-、-OCO-、-CH 2CH 2-、-CF 2O-、-OCF 2-、-C≡C-、-CH=CH-、-OCO-CH=CH-、-CH=CH-COO-或單鍵。 Particularly preferred groups Z 1 are preferably independently selected at each occurrence from -COO-, -OCO-, -CH 2 CH 2 -, -CF 2 O-, -OCF 2 -, -C≡C-, -CH=CH-, -OCO-CH=CH-, -CH=CH-COO- or a single bond.
極佳的一或多種式DRM之雙反應性液晶原基化合物係選自下式: 其中 P 0在多次出現之情況下彼此獨立地為可聚合的基團,較佳為丙烯基、甲基丙烯基、氧呾、環氧基、乙烯基、庚二烯、乙烯基氧基、丙烯基醚或苯乙烯基, L 在每次出現時相同或不同地具有針對式DRM中之L 1所給出的含義中之一者,且在多次出現之情況下彼此獨立地較佳選自F、Cl、CN或具有1至5個C原子的視情況經鹵化之烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基, r 為0、1、2、3或4, x及y 彼此獨立地為0或1至12之相同或不同整數, z 各自且獨立地為0或1,其中若相鄰的x或y為0,則z為0。 The most preferred direactive mesogen compounds of the DRM type are selected from the following: wherein P0 is independently a polymerizable group in the case of multiple occurrences, preferably propenyl, methacryl, oxadiazol, epoxy, vinyl, heptadienyl, vinyloxy, propenyl ether or styryl, L has one of the meanings given for L1 in the formula DRM, the same or different on each occurrence, and is independently selected from F, Cl, CN or an optionally halogenated alkyl group having 1 to 5 C atoms, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy in the case of multiple occurrences, r is 0, 1, 2, 3 or 4, x and y are independently 0 or the same or different integers from 1 to 12, z is each and independently 0 or 1, wherein if adjacent x or y is 0, then z is 0.
尤其較佳為式DRMa1、DRMa2及DRMa3之化合物,特定言之式DRMa1之彼等化合物。Particularly preferred are compounds of formula DRMa1, DRMa2 and DRMa3, in particular those of formula DRMa1.
較佳地,可聚合的LC材料另外包含一或多種單反應性液晶原基化合物,其較佳選自式MRM, P 1-Sp 1-MG-R MRM 其中P 1、Sp 1及MG具有式DRM中所給出之含義, R 為F、Cl、Br、I、-CN、-NO 2、-NCO、-NCS、-OCN、-SCN、-C(=O)NR xR y、-C(=O)X、-C(=O)OR x、-C(=O)R y、-NR xR y、-OH、-SF 5、視情況經取代之矽基、具有1至12個,較佳1至6個C原子的直鏈或分支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中一或多個H原子視情況經F或Cl置換, X 為鹵素,較佳為F或Cl,及 R x及R y彼此獨立地為H或具有1至12個C原子之烷基。 Preferably, the polymerizable LC material further comprises one or more monoreactive mesogen compounds, preferably selected from the formula MRM, P1 - Sp1 -MG-RMRM wherein P1 , Sp1 and MG have the meanings given in formula DRM, R is F, Cl, Br, I, -CN, -NO2 , -NCO, -NCS, -OCN, -SCN, -C (=O) NRxRy , -C(=O)X, -C(=O) ORx , -C(=O) Ry , -NRxRy , -OH , -SF5 , optionally substituted silyl, linear or branched alkyl having 1 to 12, preferably 1 to 6, C atoms, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, wherein one or more H atoms are optionally replaced by F or Cl, X is halogen, preferably F or Cl, and R x and R y are independently H or alkyl having 1 to 12 C atoms.
較佳地,一或多種式MRM之單反應性液晶原基化合物係選自下式: 其中P 0、L、r、x、y及z為如式DRMa-1至式DRMe中所定義, R 0、R 01及R 02為具有1個或更多個,較佳1至15個C原子之烷基、烷氧基、硫烷基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,或表示Y 0, Y 0為F、Cl、CN、NO 2、OCH 3、OCN、SCN、SF 5,或具有1至4個C原子之單氟化、寡氟化或多氟化烷基或烷氧基, Z 0為-COO-、-OCO-、-CH 2CH 2-、-CF 2O-、-OCF 2-、-CH=CH-、-OCO-CH=CH-、-CH=CH-COO-或單鍵, A 0在多次出現之情況下彼此獨立地為未經取代或經1、2、3或4個基團L取代之1,4-伸苯基,或反式-1,4-伸環己基, u及v 彼此獨立地為0、1或2, w 為0或1, 且其中苯環及萘環可另外經一或多個相同或不同的基團L取代。 Preferably, one or more monoreactive mesogen compounds of formula MRM are selected from the following formulas: wherein P 0 , L, r, x, y and z are as defined in formulae DRMa-1 to DRMe, R 0 , R 01 and R 02 are alkyl, alkoxy, sulfanyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy groups having 1 or more, preferably 1 to 15, carbon atoms, or represent Y 0 , Y 0 is F, Cl, CN, NO 2 , OCH 3 , OCN, SCN, SF 5 , or a monofluorinated, oligofluorinated or polyfluorinated alkyl or alkoxy group having 1 to 4 carbon atoms, Z 0 is -COO-, -OCO-, -CH 2 CH 2 -, -CF 2 O-, -OCF 2 -, -CH=CH-, -OCO-CH=CH-, -CH=CH-COO- or a single bond, A 0, in the case of multiple occurrences, is independently 1,4-phenylene, which is unsubstituted or substituted with 1, 2, 3 or 4 groups L, or trans-1,4-cyclohexylene, u and v are independently 0, 1 or 2, w is 0 or 1, and the benzene ring and the naphthyl ring may be further substituted with one or more identical or different groups L.
更佳為式MRM1、MRM2、MRM3、MRM4、MRM5、MRM6、MRM7、MRM9及MRM10之化合物,尤其係式MRM1、MRM4、MRM6及MRM7之彼等化合物,且特定言之式MRM1及MRM7之彼等化合物。More preferred are compounds of the formulae MRM1, MRM2, MRM3, MRM4, MRM5, MRM6, MRM7, MRM9 and MRM10, especially those of the formulae MRM1, MRM4, MRM6 and MRM7, and particularly those of the formulae MRM1 and MRM7.
可以與熟習此項技術者已知且描述於有機化學之標準著作中(諸如在Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Thieme-Verlag, Stuttgart中)之製程類似之方式製備式DRM、式MRM及其子式之化合物。Compounds of formula DRM, formula MRM and subformulae thereof can be prepared in a manner analogous to the procedures known to those skilled in the art and described in standard texts of organic chemistry, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Thieme-Verlag, Stuttgart.
在一較佳實施例中,可聚合的液晶原基化合物在根據本發明之可聚合的液晶材料整體中之比例在30重量%至99重量%之範圍內,更佳在40重量%至97重量%之範圍內,且甚至更佳在50重量%至95重量%之範圍內。In a preferred embodiment, the proportion of the polymerizable liquid crystal primordial compound in the overall polymerizable liquid crystal material according to the present invention is in the range of 30 wt % to 99 wt %, more preferably in the range of 40 wt % to 97 wt %, and even more preferably in the range of 50 wt % to 95 wt %.
較佳地,該等單反應性、雙反應性或多反應性液晶化合物(較佳選自如上文及下文所給出的式DRM、MRM及/或ND之化合物)在根據本發明之可聚合的液晶材料整體中之比例較佳在30重量%至99.9重量%之範圍內,更佳在40重量%至99.9重量%之範圍內,且甚至更佳在50重量%至99.9重量%之範圍內。Preferably, the proportion of the monoreactive, bireactive or polyreactive liquid crystal compounds (preferably selected from the compounds of the formula DRM, MRM and/or ND as given above and below) in the overall polymerizable liquid crystal material according to the present invention is preferably in the range of 30 wt. % to 99.9 wt. %, more preferably in the range of 40 wt. % to 99.9 wt. %, and even more preferably in the range of 50 wt. % to 99.9 wt. %.
在一較佳實施例中,雙反應性或多反應性可聚合的液晶原基化合物在根據本發明之可聚合的液晶材料整體中之比例較佳在5重量%至99重量%之範圍內,更佳在10重量%至97重量%之範圍內,且甚至更佳在15重量%至95重量%之範圍內。In a preferred embodiment, the proportion of the bireactive or polyreactive polymerizable liquid crystal primordium compound in the overall polymerizable liquid crystal material according to the present invention is preferably in the range of 5 wt % to 99 wt %, more preferably in the range of 10 wt % to 97 wt %, and even more preferably in the range of 15 wt % to 95 wt %.
在另一較佳實施例中,單反應性可聚合的液晶原基化合物(若存在)在根據本發明之可聚合的液晶材料整體中之比例較佳在5重量%至80重量%之範圍內,更佳在10重量%至75重量%之範圍內,且甚至更佳在15重量%至70重量%之範圍內。In another preferred embodiment, the proportion of the monoreactive polymerizable mesogen compound (if present) in the overall polymerizable liquid crystal material according to the present invention is preferably in the range of 5 wt % to 80 wt %, more preferably in the range of 10 wt % to 75 wt %, and even more preferably in the range of 15 wt % to 70 wt %.
在另一較佳實施例中,多反應性可聚合的液晶原基化合物(若存在)在根據本發明之可聚合的液晶材料整體中之比例較佳在1重量%至30重量%之範圍內,更佳在2重量%至20重量%之範圍內,且甚至更佳在3重量%至10重量%之範圍內。In another preferred embodiment, the proportion of the multi-reactive polymerizable mesogen compound (if present) in the overall polymerizable liquid crystal material according to the present invention is preferably in the range of 1 wt % to 30 wt %, more preferably in the range of 2 wt % to 20 wt %, and even more preferably in the range of 3 wt % to 10 wt %.
在另一較佳實施例中,可聚合的LC材料不含具有超過兩個可聚合的基團之可聚合的液晶原基化合物。In another preferred embodiment, the polymerisable LC material does not contain a polymerisable mesogen compound having more than two polymerisable groups.
在另一較佳實施例中,可聚合的LC材料不含具有少於兩個可聚合的基團之可聚合的液晶原基化合物。In another preferred embodiment, the polymerisable LC material does not contain a polymerisable mesogen compound having less than two polymerisable groups.
在另一較佳實施例中,可聚合的LC材料為非對掌性材料,亦即,其不含任何對掌性可聚合的液晶原基化合物或其他對掌性化合物。In another preferred embodiment, the polymerizable LC material is a non-chiral material, that is, it does not contain any chiral polymerizable mesogen compound or other chiral compound.
在另一較佳實施例中,可聚合的LC材料包含一或多種較佳選自式MRM-1之單反應性液晶原基化合物、一或多種較佳選自式DRMa-1之雙反應性液晶原基化合物,及一或多種式I化合物。In another preferred embodiment, the polymerizable LC material comprises one or more monoreactive mesogen compounds preferably selected from formula MRM-1, one or more direactive mesogen compounds preferably selected from formula DRMa-1, and one or more compounds of formula I.
在另一較佳實施例中,可聚合的LC材料包含一或多種較佳選自式MRM-7之單反應性液晶原基化合物、一或多種較佳選自式DRMa-1之雙反應性液晶原基化合物,及一或多種式I化合物。In another preferred embodiment, the polymerizable LC material comprises one or more monoreactive mesogen compounds preferably selected from formula MRM-7, one or more direactive mesogen compounds preferably selected from formula DRMa-1, and one or more compounds of formula I.
在另一較佳實施例中,可聚合的LC材料包含至少兩種單反應性液晶原基化合物(較佳選自式MRM-1及/或MRM-7之化合物)、一或多種較佳選自式DRMa-1之雙反應性液晶原基化合物,及一或多種式I化合物。In another preferred embodiment, the polymerizable LC material comprises at least two monoreactive mesogen compounds (preferably selected from compounds of formula MRM-1 and/or MRM-7), one or more direactive mesogen compounds, preferably selected from formula DRMa-1, and one or more compounds of formula I.
在另一較佳實施例中,可聚合的LC材料包含至少兩種單反應性液晶原基化合物(較佳選自式MRM-1及/或MRM-7之化合物)、至少兩種雙反應性液晶原基化合物(較佳選自式DRMa-1化合物)及一或多種式I化合物。In another preferred embodiment, the polymerizable LC material comprises at least two monoreactive mesogen compounds (preferably selected from compounds of formula MRM-1 and/or MRM-7), at least two direactive mesogen compounds (preferably selected from compounds of formula DRMa-1) and one or more compounds of formula I.
在另一較佳實施例中,可聚合的LC材料包含至少兩種雙反應性液晶原基化合物(較佳選自式DRMa-1化合物)及一或多種式I化合物。In another preferred embodiment, the polymerizable LC material comprises at least two bireactive mesogen compounds (preferably selected from compounds of formula DRMa-1) and one or more compounds of formula I.
在另一較佳實施例中,尤其對於負光學分散應用,如上文所描述之可聚合的LC材料另外包含一或多種式ND化合物, 其中 U 1 、 2彼此獨立地選自: 包括其鏡像,其中該環U 1及該環U 2各自經由軸向鍵鍵結至基團-(B) q-,且此等環中之一個或兩個不相鄰的CH 2基團視情況經O及/或S置換,且該環U 1及該環U 2視情況經一或多個基團L取代, Q 1 、 2彼此獨立地為CH或SiH, Q 3為C或Si, B 在每次出現時彼此獨立地為-C≡C-、-CY 1=CY 2-或視情況經取代之芳族或雜芳族基團, Y 1 、 2彼此獨立地為H、F、Cl、CN或R 0, q 為1至10之整數,較佳為1、2、3、4、5、6或7, A 1-4彼此獨立地選自非芳族、芳族或雜芳族碳環基或雜環基,其視情況經一或多個基團R 5取代,且其中-(A 1-Z 1) m-U 1-(Z 2-A 2) n-及-(A 3-Z 3) o-U 2-(Z 4-A 4) p-中之每一者不含有比非芳族基更多的芳族基且較佳不含有超過一個芳族基, Z 1-4彼此獨立地為-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR 0-、-NR 0-CO-、-NR 0-CO-NR 00-、-OCH 2-、-CH 2O-、-SCH 2-、-CH 2S-、-CF 2O-、-OCF 2-、-CF 2S-、-SCF 2- 、-CH 2CH 2-、-(CH 2) 3-、-(CH 2) 4-、-CF 2CH 2-、-CH 2CF 2-、-CF 2CF 2-、-CH=CH-、-CY 1=CY 2-、-CH=N-、-N=CH-、-N=N-、-CH=CR 0-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-、CR 0R 00或單鍵, R 0及R 00彼此獨立地為H或具有1至12個C原子之烷基, m及n 彼此獨立地為0、1、2、3或4, o及p 彼此獨立地為0、1、2、3或4, R 1-5彼此獨立地為選自以下之相同或不同的基團:H、鹵素、-CN、-NC、-NCO、-NCS、-OCN、-SCN、-C(=O)NR 0R 00、-C(=O)R 0、-NH 2、-NR 0R 00、-SH、-SR 0、-SO 3H、-SO 2R 0、-OH、-NO 2、-CF 3、-SF 5、P-Sp-、視情況經取代之矽基或碳基或視情況經取代且視情況包含一或多個雜原子的具有1至40個C原子之烴基,或表示P或P-Sp-,或經P或P-Sp-取代,其中該等化合物包含表示P或P-Sp-或經P或P-Sp-取代之一或多個基團R 1-5, P 為可聚合的基團, Sp 為間隔基團或單鍵。 In another preferred embodiment, in particular for negative optical dispersion applications, the polymerizable LC material as described above additionally comprises one or more ND compounds of the formula Where U 1 and U 2 are independently selected from: Including mirror images thereof, wherein the ring U 1 and the ring U 2 are each bonded to the group -(B) q - via an axial bond, and one or two non-adjacent CH 2 groups in these rings are optionally replaced by O and/or S, and the ring U 1 and the ring U 2 are optionally substituted by one or more groups L, Q 1 and 2 are independently CH or SiH, Q 3 is C or Si, B is independently -C≡C-, -CY 1 =CY 2 - or an optionally substituted aromatic or heteroaromatic group at each occurrence, Y 1 and 2 are independently H, F, Cl, CN or R 0 , q is an integer from 1 to 10, preferably 1, 2, 3, 4, 5, 6 or 7, A 1-4 are independently selected from non-aromatic, aromatic or heteroaromatic carbocyclic or heterocyclic groups, which are optionally substituted by one or more groups R 5 , and each of -(A 1 -Z 1 ) m -U 1 -(Z 2 -A 2 ) n - and -(A 3 -Z 3 ) o -U 2 -(Z 4 -A 4 ) p - does not contain more aromatic groups than non-aromatic groups and preferably does not contain more than one aromatic group, and Z 1-4 are independently -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR 0 -, -NR 0 -CO-, -NR 0 -CO-NR 00 - , -OCH 2 -, -CH 2 O-, -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 - , -CH 2 CH 2 -, -(CH 2 ) 3 -, -(CH 2 ) 4 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 - , -CH=CH-, -CY 1 =CY 2 -, -CH=N-, -N=CH-, -N=N- , -CH=CR 0 -, -C≡C-, -CH=CH-COO-, -OCO-CH=CH-, CR 0 R 00 or a single bond, R 0 and R 00 are independently H or an alkyl group having 1 to 12 C atoms, m and n are independently 0, 1, 2, 3 or 4, o and p are independently 0, 1, 2, 3 or 4, R 1-5 are independently the same or different groups selected from the following: H, halogen, -CN, -NC, -NCO, -NCS, -OCN, -SCN, -C(=O)NR 0 R 00 , -C(=O)R 0 , -NH 2 , -NR 0 R 00 , -SH, -SR 0 , -SO 3 H, -SO 2 R 0 , -OH, -NO 2 , -CF 3 , -SF 5 , P-Sp-, an optionally substituted silyl group or carbon group, or an optionally substituted alkyl group having 1 to 40 C atoms which optionally contains one or more heteroatoms, or represents P or P-Sp-, or is substituted with P or P-Sp-, wherein the compounds contain one or more groups R 1-5 representing P or P-Sp- or substituted with P or P-Sp-, P is a polymerizable group, and Sp is a spacer group or a single bond.
較佳地,形成式ND中之橋連基團B之亞基較佳選自具有120°或更大,較佳在180°範圍內的鍵結角之基團。極佳為-C≡C-基團或以對位連接至其鄰近基團之二價芳族基,如1,4-伸苯基、萘-2,6-二基、茚烷-2,6-二基或噻吩并[3,2-b]噻吩-2,5-二基。Preferably, the subunit forming the bridging group B in formula ND is selected from groups having a bonding angle of 120° or greater, preferably within the range of 180°. Most preferably, it is a -C≡C- group or a divalent aromatic group linked to its neighboring group at the para position, such as 1,4-phenylene, naphthalene-2,6-diyl, indane-2,6-diyl, or thieno[3,2-b]thiophene-2,5-diyl.
其他可能的亞基包括-CH=CH-、-CY 1=CY 2-、-CH=N-、-N=CH-、-N=N-及-CH=CR 0-,其中Y 1、Y 2、R 0具有上文所給出之含義。 Other possible subunits include -CH=CH-, -CY 1 =CY 2 -, -CH=N-, -N=CH-, -N=N- and -CH=CR 0 -, wherein Y 1 , Y 2 and R 0 have the meanings given above.
較佳地,橋連基團或式ND中之-(B) q-包含一或多個選自由以下組成之群的基團:-C≡C-、視情況經取代之1,4-伸苯基及視情況經取代之9H-茀-2,7-二基。亞基或式ND中之B較佳選自由以下組成之群:-C≡C-、視情況經取代之1,4-伸苯基及視情況經取代之9H-茀-2,7-二基,其中在茀基中,9位之H原子視情況經碳基或烴基置換。 Preferably, the bridging group or -(B) q- in Formula ND comprises one or more groups selected from the group consisting of -C≡C-, optionally substituted 1,4-phenylene, and optionally substituted 9H-fluorene-2,7-diyl. The subunit or B in Formula ND is preferably selected from the group consisting of -C≡C-, optionally substituted 1,4-phenylene, and optionally substituted 9H-fluorene-2,7-diyl, wherein the H atom at position 9 in the fluorene group is optionally replaced by a carbonyl or alkyl group.
極佳地,橋聯基團或式ND中之-(B) q-係選自-C≡C-、-C≡C-C≡C-、-C≡C-C≡C-C≡C-、-C≡C-C≡C-C≡C-C≡C-、 其中r為0、1、2、3或4,且L具有如下文所描述之含義。 Most preferably, the bridging group or -(B) q - in formula ND is selected from -C≡C-, -C≡CC≡C-, -C≡CC≡CC≡C-, -C≡CC≡CC≡C-, wherein r is 0, 1, 2, 3 or 4, and L has the meaning described below.
較佳地,橋聯基團所連接之液晶原基團的非芳族環(如式ND中之U 1及U 2)較佳選自 ,其中R 5如式ND中所定義。 Preferably, the non-aromatic ring of the mesogen group to which the bridging group is connected (such as U 1 and U 2 in formula ND) is preferably selected from , wherein R 5 is as defined in Formula ND.
較佳地,式ND中之芳族基A 1-4可為單核,亦即僅具有一個芳環(如苯基或伸苯基);或多核,亦即具有兩個或更多個稠合環(如萘基或伸萘基)。尤其較佳為亦可包含稠合環且視情況經取代的具有至多25個C原子之單環、雙環或三環芳族或雜芳族基團。 Preferably, the aromatic groups A 1-4 in formula ND are mononuclear, i.e., have only one aromatic ring (e.g., phenyl or phenylene), or polynuclear, i.e., have two or more fused rings (e.g., naphthyl or naphthylene). Particularly preferred are monocyclic, bicyclic, or tricyclic aromatic or heteroaromatic groups having up to 25 carbon atoms, which may also contain fused rings and are optionally substituted.
較佳地,式ND化合物中之非芳族碳環及雜環A 1-4包括飽和(亦稱作「完全飽和」)的彼等環,亦即其確實僅含有由單鍵連接之C原子或雜原子;及不飽和(亦稱作「部分飽和」)的彼等環,亦即其亦包含由雙鍵連接之C原子或雜原子。非芳族環亦可包含一或多個較佳選自Si、O、N及S之雜原子。 Preferably, the non-aromatic carbocyclic and heterocyclic rings A 1-4 in the compounds of formula ND include those that are saturated (also referred to as "fully saturated"), i.e., they contain only carbon atoms or heteroatoms linked by single bonds; and those that are unsaturated (also referred to as "partially saturated"), i.e., they also contain carbon atoms or heteroatoms linked by double bonds. Non-aromatic rings may also contain one or more heteroatoms, preferably selected from Si, O, N, and S.
較佳地,非芳族環及芳族環或式ND中之A 1-4係選自反式-1,4-伸環己基及視情況經一或多個基團L取代之1,4-伸苯基。 Preferably, the non-aromatic ring and the aromatic ring or A 1-4 in formula ND are selected from trans-1,4-cyclohexylene and 1,4-phenylene optionally substituted with one or more groups L.
極佳為式ND化合物,其中m及p為1且n及o為1或2。更佳為式ND化合物,其中m及p為1或2且n及o為0。更佳為其中m、n、o及p為2之化合物。Very preferred are compounds of formula ND, wherein m and p are 1 and n and o are 1 or 2. More preferred are compounds of formula ND, wherein m and p are 1 or 2 and n and o are 0. Even more preferred are compounds wherein m, n, o and p are 2.
在式ND化合物中,連接液晶原基基團中之芳族及非芳族環狀基團的鍵聯基團或Z 1-4較佳選自-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR 0-、-NR 0-CO-、-NR 0-CO-NR 0-、-OCH 2-、-CH 2O-、-SCH 2-、-CH 2S-、-CF 2O-、-OCF 2-、-CF 2S-、-SCF 2-、-CH 2CH 2-、-(CH 2) 3-、-(CH 2) 4-、-CF 2CH 2-、-CH 2CF 2-、-CF 2CF 2-、-CH=CH-、-CY 1=CY 2-、-CH=N-、-N=CH-、-N=N-、-CH=CR 0-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-、CR 0R 00或單鍵,極佳選自-COO-、-OCO-及單鍵。 In the compound of formula ND, the linking group connecting the aromatic and non-aromatic cyclic groups in the mesogen group or Z 1-4 is preferably selected from -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR 0 -, -NR 0 -CO-, -NR 0 -CO-NR 0 -, -OCH 2 -, -CH 2 O-, -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CH 2 CH 2 -, -(CH 2 ) 3 -, -(CH 2 ) 4 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 -, -CH=CH-, -CY 1 =CY 2 -, -CH=N-, -N=CH-, -N=N-, -CH=CR 0 -, -C≡C-, -CH=CH-COO-, -OCO-CH=CH-, CR 0 R 00 or a single bond, preferably selected from -COO-, -OCO- and a single bond.
較佳地,在式ND化合物中,環上之取代基(諸如L)較佳選自P-Sp-、F、Cl、Br、I、-CN、-NO 2、-NCO、-NCS、-OCN、-SCN、-C(=O)NR 0R 00、-C(=O)X、-C(=O)OR 0、-C(=O)R 0、-NR 0R 00、-OH、-SF 5、視情況經取代之矽基、具有1至12個,較佳1至6個C原子的芳基或雜芳基,及具有1至12個,較佳1至6個C原子之直鏈或分支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中一或多個H原子視情況經F或Cl置換,其中R 0及R 00如式ND中所定義且X為鹵素。 Preferably, in the compound of formula ND, the substituents on the ring (such as L) are preferably selected from P-Sp-, F, Cl, Br, I, -CN, -NO2 , -NCO, -NCS, -OCN, -SCN , -C(=O) NR0R00 , -C(=O)X, -C(=O) OR0 , -C(=O )R0, -NR0R00 , -OH , -SF5 , an optionally substituted silyl group, an aryl group or heteroaryl group having 1 to 12, preferably 1 to 6, C atoms, and a straight or branched alkyl group, alkoxy group, alkylcarbonyl group, alkoxycarbonyl group, alkylcarbonyloxy group or alkoxycarbonyloxy group having 1 to 12, preferably 1 to 6, C atoms, wherein one or more H atoms are optionally replaced by F or Cl, wherein R 0 and R 00 are as defined in formula ND and X is a halogen.
較佳地,式ND化合物包含經兩個或更多個可聚合的基團P或P-Sp- (多官能性可聚合的基團)取代之一或多個端基(如R 1-4)或取代基(如R 5)。此類型之適合多官能性可聚合的基團揭示於例如US 7,060,200 B1或US 2006/0172090 A1中。 Preferably, the compound of formula ND comprises one or more terminal groups (e.g., R 1-4 ) or substituents (e.g., R 5 ) substituted with two or more polymerizable groups P or P-Sp- (multifunctional polymerizable groups). Suitable multifunctional polymerizable groups of this type are disclosed, for example, in US 7,060,200 B1 or US 2006/0172090 A1.
極佳之式ND化合物為以下子式之彼等化合物: 其中R 1-5、A 1-4、Z 1-4、B、m、n、o、p及q具有上文所給出之含義中之一者。 Very preferred compounds of formula ND are those of the following sub-formula: wherein R 1-5 , A 1-4 , Z 1-4 , B, m, n, o, p and q have one of the meanings given above.
尤其較佳為以下子式之化合物: 其中Z具有上文所給出之Z 1的含義中之一者,R具有不同於P-Sp-的如上文所給出之R 1的含義中之一者,且P、Sp、L及r如上文所定義,且液晶原基基團中之苯環視情況經一或多個如上文所定義之基團L取代。 Particularly preferred are compounds of the following sub-formula: wherein Z has one of the meanings given above for Z 1 , R has one of the meanings given above for R 1 different from P-Sp-, and P, Sp, L and r are as defined above, and the benzene ring in the mesogen group is optionally substituted by one or more groups L as defined above.
此外,較佳為可聚合的液晶介質,其中式ND化合物係選自式ND 25或式ND 26之化合物的群,特定言之其中Z表示-COO-,r在每次出現時為0,且P、Sp如上文所定義。Furthermore, preferred are polymerizable liquid crystal media wherein the compound of formula ND is selected from the group of compounds of formula ND 25 or ND 26, in particular wherein Z represents -COO-, r is 0 at each occurrence, and P, Sp are as defined above.
此等較佳化合物中之P-Sp-較佳為P-Sp'-X',其中X'較佳為-O-、-COO-或-OCOO-。In these preferred compounds, P-Sp- is preferably P-Sp'-X', wherein X' is preferably -O-, -COO- or -OCOO-.
式ND、其子式之化合物及用於該等化合物合成之適合方法揭示於WO 2008/119427 A1中。Compounds of formula ND, its subformulae and suitable methods for their synthesis are disclosed in WO 2008/119427 A1.
式ND化合物在可聚合的LC材料中之量較佳為0%至50%,極佳為0%至40%。The amount of the compound of formula ND in the polymerizable LC material is preferably from 0% to 50%, very preferably from 0% to 40%.
在另一較佳實施例中,可聚合的LC材料視情況包含一或多種選自由以下組成之群的添加劑:其他聚合引發劑、抗氧化劑、界面活性劑、穩定劑、催化劑、敏化劑、抑制劑、鏈轉移劑、共反應單體、反應性減黏劑(reactive thinner)、表面活性化合物、潤滑劑、潤濕劑、分散劑、疏水劑、黏著劑、流動改良劑、除氣劑或消泡劑、脫氣劑、稀釋劑、反應性稀釋劑、助劑、著色劑、染料、顏料及奈米粒子。In another preferred embodiment, the polymerizable LC material optionally comprises one or more additives selected from the group consisting of other polymerization initiators, antioxidants, surfactants, stabilizers, catalysts, sensitizers, inhibitors, chain transfer agents, co-reactive monomers, reactive thinners, surface-active compounds, lubricants, wetting agents, dispersants, hydrophobic agents, tackifiers, flow improvers, deaerators or defoamers, degassing agents, diluents, reactive diluents, auxiliary agents, colorants, dyes, pigments, and nanoparticles.
在另一較佳實施例中,可聚合的LC材料視情況包含一或多種選自可聚合的非液晶原基化合物之添加劑(反應性減黏劑)。此等添加劑在可聚合的LC材料中之量較佳為0%至30%,極佳為0%至25%。In another preferred embodiment, the polymerizable LC material optionally contains one or more additives selected from polymerizable non-mesogenic compounds (reactive viscosity reducing agents). The amount of such additives in the polymerizable LC material is preferably 0% to 30%, and most preferably 0% to 25%.
所使用的反應性減黏劑不僅為實際意義上稱為反應性減黏劑之物質,且亦為上文已經提及之含有一或多個互補反應單元或可聚合的基團P (例如,羥基、硫醇基或胺基)的助劑化合物,與液晶化合物之可聚合單元的反應可經由該等物質進行。The reactive detackifier used is not only a substance that is actually called a reactive detackifier, but also the auxiliary compound mentioned above containing one or more complementary reactive units or polymerizable groups P (for example, hydroxyl groups, thiol groups or amine groups). The reaction with the polymerizable units of the liquid crystal compound can be carried out via these substances.
通常能夠進行光聚合之物質包括例如含有至少一種烯烴雙鍵的單官能、雙官能及多官能化合物。其實例為羧酸(例如,月桂酸、肉豆蔻酸、棕櫚酸及硬脂酸)之乙烯酯及二羧酸(例如,丁二酸、己二酸)之乙烯酯;單官能醇(例如,月桂醇、肉豆蔻醇、棕櫚醇及硬脂醇)之烯丙基醚及乙烯醚以及甲基丙烯酸酯及丙烯酸酯;以及雙官能醇(例如,乙二醇及1,4-丁二醇)之二烯丙基醚及二乙烯基醚。Typical photopolymerizable substances include monofunctional, difunctional, and polyfunctional compounds containing at least one olefinic double bond. Examples include vinyl esters of carboxylic acids (e.g., lauric acid, myristic acid, palmitic acid, and stearic acid) and vinyl esters of dicarboxylic acids (e.g., succinic acid and adipic acid); allyl and vinyl ethers, as well as methacrylates and acrylates, of monofunctional alcohols (e.g., lauryl alcohol, myristyl alcohol, palmitic acid, and stearyl alcohol); and diallyl and divinyl ethers of difunctional alcohols (e.g., ethylene glycol and 1,4-butanediol).
同樣適合的係例如多官能醇之甲基丙烯酸酯及丙烯酸酯,特定言之除羥基以外不含其他官能基或至多含有醚基的彼等。此類醇之實例為雙官能醇,諸如乙二醇、丙二醇及其更加高度縮合之代表(例如,二乙二醇、三乙二醇、二丙二醇、三丙二醇等)、丁二醇、戊二醇、己二醇、新戊二醇、烷氧基化酚類化合物(諸如乙氧基化雙酚及丙氧基化雙酚)、環己烷二甲醇;三官能醇及多官能醇,諸如甘油、三羥甲基丙烷、丁三醇、三羥甲基乙烷、新戊四醇、二(三羥甲基丙烷)、二新戊四醇、山梨糖醇、甘露醇及對應烷氧基化醇,特定言之乙氧基化醇及丙氧基化醇。Also suitable are, for example, methacrylates and acrylates of polyfunctional alcohols, in particular those which, in addition to hydroxyl groups, do not contain any other functional groups or at most contain ether groups. Examples of such alcohols are difunctional alcohols such as ethylene glycol, propylene glycol and their more highly condensed representatives (e.g., diethylene glycol, triethylene glycol, dipropylene glycol, tripropylene glycol, etc.), butanediol, pentanediol, hexanediol, neopentyl glycol, alkoxylated phenolic compounds (e.g., ethoxylated and propoxylated bisphenols), cyclohexanedimethanol; trifunctional and polyfunctional alcohols such as glycerol, trihydroxymethylpropane, butanetriol, trihydroxymethylethane, neopentyletrol, ditrihydroxymethylpropane, dipentatriol, sorbitol, mannitol and the corresponding alkoxylated alcohols, in particular ethoxylated and propoxylated alcohols.
其他適合之反應性減黏劑為聚酯(甲基)丙烯酸酯,其為聚酯醇之(甲基)丙烯酸酯。Other suitable reactive detackifiers are polyester (meth)acrylates, which are (meth)acrylates of polyester alcohols.
適合聚酯醇之實例為可藉由使用多元醇(較佳二醇)酯化多羧酸(較佳二羧酸)而製備之彼等聚酯醇。用於此類含羥基聚酯之起始物質為熟習此項技術者所已知。可採用之二羧酸為丁二酸、戊二酸、己二酸、癸二酸、鄰苯二甲酸及其異構體及氫化產物,及該等酸之可酯化及可轉酯化衍生物,例如酸酐及二烷基酯。適合之多元醇為上述醇,較佳為乙二醇、1,2-丙二醇及1,3-丙二醇、1,4-丁二醇、1,6-己二醇、新戊二醇、環己烷二甲醇及乙二醇及丙二醇類型之聚二醇。Examples of suitable polyesterols are those that can be prepared by esterifying polycarboxylic acids (preferably dicarboxylic acids) with polyols (preferably diols). Starting materials for such hydroxyl-containing polyesters are known to those skilled in the art. Suitable dicarboxylic acids include succinic acid, glutaric acid, adipic acid, sebacic acid, phthalic acid, their isomers, and hydrogenated products, as well as their esterifiable and transesterifiable derivatives, such as anhydrides and dialkyl esters. Suitable polyols are the alcohols listed above, preferably ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,4-butanediol, 1,6-hexanediol, neopentyl glycol, cyclohexanedimethanol, and polyglycols of the ethylene glycol and propylene glycol types.
此外,適合之反應性減黏劑為1,4-二乙烯苯、三聚氰酸三烯丙酯、下式之三環癸烯醇之丙烯酸酯 , 其亦稱為丙烯酸二氫二環戊二烯酯,及丙烯酸、甲基丙烯酸及氰基丙烯酸之烯丙酯。 In addition, suitable reactive viscosity reducers are 1,4-divinylbenzene, triallyl cyanurate, and the acrylate of tricyclodecenol of the following formula: , which is also known as dihydrodicyclopentadienyl acrylate, and allyl esters of acrylic acid, methacrylic acid, and cyanoacrylate.
關於藉助於實例提及之反應性減黏劑,特定言之且鑒於上述較佳組合物而使用含有光可聚合的基團之彼等。With regard to the reactive viscosity reducers mentioned in the examples, in particular and in view of the preferred compositions described above, those containing photopolymerizable groups are used.
此基團包括例如二元醇及多元醇,例如乙二醇、丙二醇及其更加高度縮合之代表(例如,二乙二醇、三乙二醇、二丙二醇、三丙二醇等)、丁二醇、戊二醇、己二醇、新戊二醇、環己烷二甲醇、甘油、三羥甲基丙烷、丁三醇、三羥甲基乙烷、新戊四醇、二(三羥甲基丙烷)、二新戊四醇、山梨糖醇、甘露醇及對應烷氧基化醇,特定言之乙氧基化醇及丙氧基化醇。This group includes, for example, diols and polyols, such as ethylene glycol, propylene glycol and their more highly condensed representatives (e.g., diethylene glycol, triethylene glycol, dipropylene glycol, tripropylene glycol, etc.), butanediol, pentanediol, hexanediol, neopentyl glycol, cyclohexanedimethanol, glycerol, trihydroxymethylpropane, butanetriol, trihydroxymethylethane, pentaerythritol, di(trihydroxymethylpropane), dipentaerythritol, sorbitol, mannitol and the corresponding alkoxylated alcohols, in particular ethoxylated and propoxylated alcohols.
該基團另外亦包括例如烷氧基化酚類化合物,例如乙氧基化雙酚及丙氧基化雙酚。This group further includes, for example, alkoxylated phenolic compounds, such as ethoxylated bisphenols and propoxylated bisphenols.
此等反應性減黏劑可另外為例如環氧化物或胺基甲酸酯(甲基)丙烯酸酯。Such reactive detackifiers may additionally be, for example, epoxides or urethane (meth)acrylates.
環氧化物(甲基)丙烯酸酯為(例如)如可藉由環氧化烯烴或聚縮水甘油醚或二縮水甘油醚(諸如雙酚A二縮水甘油醚)與(甲基)丙烯酸之反應(為熟習此項技術者所已知)所獲得的彼等。Epoxide (meth)acrylates are, for example, those obtainable by reaction of epoxides or polyglycidyl ethers or diglycidyl ethers, such as bisphenol A diglycidyl ether, with (meth)acrylic acid, as is known to those skilled in the art.
特定言之,胺基甲酸酯(甲基)丙烯酸酯為(甲基)丙烯酸羥基烷基酯與聚異氰酸酯或二異氰酸酯之反應(同樣為熟習此項技術者所已知)的產物。Specifically, urethane (meth)acrylates are the products of the reaction of hydroxyalkyl (meth)acrylates with polyisocyanates or diisocyanates (also known to those skilled in the art).
此類環氧化物及胺基甲酸酯(甲基)丙烯酸酯包括於上文作為「混合形式」列出之化合物中。Such epoxides and urethane (meth)acrylates are included in the compounds listed above as "mixed forms".
若使用反應性減黏劑,則必須以一定方式使其量及特性與各別條件匹配,該方式使得一方面達成令人滿意的所需效果(例如,根據本發明之組合物的所需色彩),但另一方面不過度損害液晶組合物之相行為。可例如使用對應反應性減黏劑來製備低交聯(高交聯)液晶組合物,該等反應性減黏劑每分子具有相對較低(較高)數目之反應單元。If reactive deviscosifiers are used, their amount and properties must be adapted to the respective conditions in such a way that, on the one hand, the desired effect is achieved (e.g., the desired color of the composition according to the invention), but on the other hand, the phase behavior of the liquid crystal composition is not excessively impaired. For example, low-crosslinked (highly crosslinked) liquid crystal compositions can be prepared using corresponding reactive deviscosifiers that have a relatively low (high) number of reactive units per molecule.
稀釋劑之群組包括例如: C1-C4醇,例如甲醇、乙醇、正丙醇、異丙醇、丁醇、異丁醇、二級丁醇;及特定言之C5-C12醇,正戊醇、正己醇、正庚醇、正辛醇、正壬醇、正癸醇、正十一醇及正十二醇,及其異構體;二醇,例如1,2-乙二醇、1,2-丙二醇及1,3-丙二醇、1,2-丁二醇、2,3-丁二醇及1,4-丁二醇、二乙二醇及三乙二醇以及二丙二醇及三丙二醇;醚,例如甲基三級丁基醚、1,2-乙二醇單甲醚及二甲醚、1,2-乙二醇單乙醚及二乙醚、3-甲氧基丙醇、3-異丙氧基丙醇、四氫呋喃及二㗁烷;酮,例如丙酮、甲基乙基酮、甲基異丁基酮及二丙酮醇(4-羥基-4-甲基-2-戊酮);C1-C5烷基酯,例如乙酸甲酯、乙酸乙酯、乙酸丙酯、乙酸丁酯及乙酸戊酯;脂族烴及芳族烴,例如戊烷、己烷、庚烷、辛烷、異辛烷、石油醚、甲苯、二甲苯、乙苯、四氫萘、十氫萘、二甲基萘、白色石油腦(white spirit);Shellsol®及Solvesso®礦物油,例如汽油、煤油、柴油及加熱油;以及天然油,例如橄欖油、大豆油、菜籽油、亞麻籽油及葵花籽油。 The group of diluents includes, for example: C1-C4 alcohols, such as methanol, ethanol, n-propanol, isopropanol, butanol, isobutanol, dibutanol; and specifically C5-C12 alcohols, n-pentanol, n-hexanol, n-heptanol, n-octanol, n-nonanol, n-decanol, n-undecanol, and n-dodecanol, and their isomers; diols, such as 1,2-ethanediol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butanediol, 2,3-butanediol, 1,4-butanediol, diethylene glycol, triethylene glycol, and dipropylene glycol and tripropylene glycol; ethers, such as methyl tert-butyl ether, 1,2-ethanediol monomethyl ether, and Dimethyl ether, 1,2-ethylene glycol monoethyl ether and diethyl ether, 3-methoxypropanol, 3-isopropoxypropanol, tetrahydrofuran, and dioxane; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, and diacetone alcohol (4-hydroxy-4-methyl-2-pentanone); C1-C5 alkyl esters such as methyl acetate, ethyl acetate, propyl acetate, butyl acetate, and amyl acetate; aliphatic and aromatic hydrocarbons such as pentane, hexane, heptane, octane, isooctane, petroleum ether, toluene, xylene, ethylbenzene, tetrahydronaphthalene, decahydronaphthalene, dimethylnaphthalene, and white spirit; Shellsol® and Solvesso® mineral oils such as gasoline, kerosene, diesel, and heating oil; and natural oils such as olive oil, soybean oil, rapeseed oil, linseed oil, and sunflower oil.
當然亦有可能在根據本發明之組合物中使用此等稀釋劑之混合物。It is of course also possible to use mixtures of these diluents in the compositions according to the invention.
只要存在至少部分互混性,則此等稀釋劑亦可與水混合。此處適合之稀釋劑之實例為C1-C4醇,例如甲醇、乙醇、正丙醇、異丙醇、丁醇、異丁醇及二級丁醇;二醇,例如1,2-乙二醇、1,2-丙二醇及1,3-丙二醇、1,2-丁二醇、2,3-丁二醇及1,4-丁二醇、二乙二醇及三乙二醇以及二丙二醇及三丙二醇;醚,例如四氫呋喃及二㗁烷;酮,例如丙酮、甲基乙基酮及二丙酮醇(4-羥基-4-甲基-2-戊酮);以及C1-C4烷基酯,例如乙酸甲酯、乙酸乙酯、乙酸丙酯及乙酸丁酯。These diluents can also be mixed with water as long as there is at least partial miscibility. Examples of suitable diluents here are C1-C4 alcohols, such as methanol, ethanol, n-propanol, isopropanol, butanol, isobutanol and dibutanol; diols, such as 1,2-ethanediol, 1,2-propylene glycol and 1,3-propylene glycol, 1,2-butanediol, 2,3-butanediol and 1,4-butanediol, diethylene glycol and triethylene glycol, as well as dipropylene glycol and tripropylene glycol; ethers, such as tetrahydrofuran and dioxane; ketones, such as acetone, methyl ethyl ketone and diacetone alcohol (4-hydroxy-4-methyl-2-pentanone); and C1-C4 alkyl esters, such as methyl acetate, ethyl acetate, propyl acetate and butyl acetate.
按可聚合的LC材料之總重量計,視情況以約0重量%至10.0重量%、較佳約0重量%至5.0重量%之比例採用稀釋劑。The diluent is optionally used in a proportion of about 0 wt% to 10.0 wt%, preferably about 0 wt% to 5.0 wt%, based on the total weight of the polymerizable LC material.
消泡劑及脫氣劑(c1))、潤滑劑及流動助劑(c2))、熱固化助劑或輻射固化助劑(c3))、基板潤濕助劑(c4))、潤濕助劑及分散助劑(c5))、疏水劑(c6))、黏著促進劑(c7))及用於促進抗刮擦性之助劑(c8))在其作用時彼此不能嚴格定界。Defoamers and degassing agents (c1)), lubricants and flow aids (c2)), heat curing aids or radiation curing aids (c3)), substrate wetting aids (c4)), wetting aids and dispersing aids (c5)), hydrophobic agents (c6)), adhesion promoters (c7)), and agents for promoting anti-scratch properties (c8)) cannot be strictly defined as one another in terms of their effects.
舉例而言,潤滑劑及流動助劑通常亦充當消泡劑及/或脫氣劑及/或充當用於改善抗刮擦性之助劑。輻射固化助劑亦可充當潤滑劑及流動助劑及/或脫氣劑及/或充當基板潤濕助劑。在個別情況下,此等助劑中之一些亦可滿足黏著促進劑(c8))之功能。For example, lubricants and flow aids often also function as defoamers and/or deaerators and/or as agents for improving scratch resistance. Radiation curing aids can also function as lubricants, flow aids, deaerators, and/or substrate wetting agents. In individual cases, some of these agents can also fulfill the function of adhesion promoters (c8).
對應於上述情況,因此可將某一添加劑分類於下文所描述之多個群組c1)至c8)中。Corresponding to the above situation, a certain additive can be classified into the multiple groups c1) to c8) described below.
群組c1)中之消泡劑包括無矽聚合物及含矽聚合物。含矽聚合物為例如未經修飾或經修飾之聚二烷基矽氧烷;或包含聚二烷基矽氧烷及聚醚單元之分支鏈共聚物、梳狀或嵌段共聚物,後者可獲自環氧乙烷或環氧丙烷。The defoaming agents in group c1) include silicone-free polymers and silicone-containing polymers. Silicon-containing polymers are, for example, unmodified or modified polydialkylsiloxanes, or branched chain copolymers, comb copolymers, or block copolymers comprising polydialkylsiloxanes and polyether units, the latter being obtainable from ethylene oxide or propylene oxide.
群組c1)中之脫氣劑包括例如有機聚合物,例如聚醚及聚丙烯酸酯、二烷基聚矽氧烷(特定言之二甲基聚矽氧烷);經有機修飾之聚矽氧烷,例如經芳烷基修飾之聚矽氧烷及氟聚矽氧。Degassing agents in group c1) include, for example, organic polymers such as polyethers and polyacrylates, dialkylpolysiloxanes (particularly dimethylpolysiloxanes); organically modified polysiloxanes such as aralkyl-modified polysiloxanes and fluoropolysiloxanes.
消泡劑之作用基本上係基於防止發泡體形成或毀壞已經形成之發泡體。消泡劑基本上藉由促進精細劃分之氣體或氣泡的聚結以在待脫氣之介質(例如,根據本發明之組合物)中產生較大氣泡且因此加速氣體(空氣)之逸出而起作用。由於消泡劑亦可頻繁地用作脫氣劑,且反之亦然,因此此等添加劑已一起包括於群組c1)下。The action of defoamers is essentially based on preventing the formation of foam or destroying already formed foam. Defoamers essentially work by promoting the coalescence of finely divided gases or bubbles to produce larger bubbles in the medium to be deaerated (e.g., the composition according to the invention) and thus accelerating the escape of the gas (air). Since defoamers can also frequently be used as deaerators, and vice versa, these additives are included together under group c1).
此類助劑例如可商購自Tego,如TEGO® Foamex 800、TEGO® Foamex 805、TEGO® Foamex 810、TEGO® Foamex 815、TEGO® Foamex 825、TEGO® Foamex 835、TEGO® Foamex 840、TEGO® Foamex 842、TEGO® Foamex 1435、TEGO® Foamex 1488、TEGO® Foamex 1495、TEGO® Foamex 3062、TEGO® Foamex 7447、TEGO® Foamex 8020、Tego® Foamex N、TEGO® Foamex K 3、TEGO® Antifoam 2-18、TEGO® Antifoam 2-18、TEGO® Antifoam 2-57、TEGO® Antifoam 2-80、TEGO® Antifoam 2-82、TEGO® Antifoam 2-89、TEGO® Antifoam 2-92、TEGO® Antifoam 14、TEGO® Antifoam 28、TEGO® Antifoam 81、TEGO® Antifoam D 90、TEGO® Antifoam 93、TEGO® Antifoam 200、TEGO® Antifoam 201、TEGO® Antifoam 202、TEGO® Antifoam 793、TEGO® Antifoam 1488、TEGO® Antifoam 3062、TEGOPREN® 5803、TEGOPREN® 5852、TEGOPREN® 5863、TEGOPREN® 7008、TEGO® Antifoam 1-60、TEGO® Antifoam 1-62、TEGO® Antifoam 1-85、TEGO® Antifoam 2-67、TEGO® Antifoam WM 20、TEGO® Antifoam 50、TEGO® Antifoam 105、TEGO® Antifoam 730、TEGO® Antifoam MR 1015、TEGO® Antifoam MR 1016、TEGO® Antifoam 1435、TEGO® Antifoam N、TEGO® Antifoam KS 6、TEGO® Antifoam KS 10、TEGO® Antifoam KS 53、TEGO® Antifoam KS 95、TEGO® Antifoam KS 100、TEGO® Antifoam KE 600、TEGO® Antifoam KS 911、TEGO® Antifoam MR 1000、TEGO® Antifoam KS 1100、Tego® Airex 900、Tego® Airex 910、Tego® Airex 931、Tego® Airex 935、Tego® Airex 936、Tego® Airex 960、Tego® Airex 970、Tego® Airex 980及Tego® Airex 985,且商購自BYK,如BYK®-011、BYK®-019、BYK®-020、BYK®-021、BYK®-022、BYK®-023、BYK®-024、BYK®-025、BYK®-027、BYK®-031、BYK®-032、BYK®-033、BYK®-034、BYK®-035、BYK®-036、BYK®-037、BYK®-045、BYK®-051、BYK®-052、BYK®-053、BYK®-055、BYK®-057、BYK®-065、BYK®-066、BYK®-070、BYK®-080、BYK®-088、BYK®-141及BYK®-A 530。Such additives are commercially available, for example, from Tego, such as TEGO® Foamex 800, TEGO® Foamex 805, TEGO® Foamex 810, TEGO® Foamex 815, TEGO® Foamex 825, TEGO® Foamex 835, TEGO® Foamex 840, TEGO® Foamex 842, TEGO® Foamex 1435, TEGO® Foamex 1488, TEGO® Foamex 1495, TEGO® Foamex 3062, TEGO® Foamex 7447, TEGO® Foamex 8020, Tego® Foamex N, TEGO® Foamex K 3, TEGO® Antifoam 2-18, TEGO® Antifoam 2-18, TEGO® Antifoam 2-57, TEGO® Antifoam 2-80、TEGO® Antifoam 2-82, TEGO® Antifoam 2-89, TEGO® Antifoam 2-92, TEGO® Antifoam 14, TEGO® Antifoam 28, TEGO® Antifoam 81, TEGO® Antifoam D 90, TEGO® Antifoam 93, TEGO® Antifoam 200, TEGO® Antifoam 201, TEGO® Antifoam 202. TEGO® Antifoam 793, TEGO® Antifoam 1488, TEGO® Antifoam 3062, TEGOPREN® 5803, TEGOPREN® 5852, TEGOPREN® 5863, TEGOPREN® 7008, TEGO® Antifoam 1-60, TEGO® Antifoam 1-62, TEGO® Antifoam 1-85, TEGO® Antifoam 2-67, TEGO® Antifoam WM 20, TEGO® Antifoam 50, TEGO® Antifoam 105, TEGO® Antifoam 730, TEGO® Antifoam MR 1015, TEGO® Antifoam MR 1016, TEGO® Antifoam 1435, TEGO® Antifoam N, TEGO® Antifoam KS 6, TEGO® Antifoam KS 10. TEGO® Antifoam KS 53, TEGO® Antifoam KS 95, TEGO® Antifoam KS 100, TEGO® Antifoam KE 600, TEGO® Antifoam KS 911, TEGO® Antifoam MR 1000, TEGO® Antifoam KS 1100, Tego® Airex 900, Tego® Airex 910, Tego® Airex 931, Tego® Airex 935, Tego® Airex 936, Tego® Airex 960, Tego® Airex 970, Tego® Airex 980 and Tego® Airex 985, and are commercially available from BYK, such as BYK®-011, BYK®-019, BYK®-020, BYK®-021, BYK®-022, BYK®-023, BYK®-024, BYK®-025, BYK®-027, BYK®-031, BYK®-032, BYK®-033, BYK®-034, BYK®- 035, BYK®-036, BYK®-037, BYK®-045, BYK®-051, BYK®-052, BYK®-053, BYK®-055, B YK®-057, BYK®-065, BYK®-066, BYK®-070, BYK®-080, BYK®-088, BYK®-141 and BYK®-A 530.
按可聚合的LC材料之總重量計,視情況以約0重量%至3.0重量%、較佳約0重量%至2.0重量%之比例採用群組c1)中之助劑。The auxiliary agents from group c1) are optionally used in a proportion of about 0% to 3.0% by weight, preferably about 0% to 2.0% by weight, based on the total weight of the polymerizable LC material.
在群組c2)中,潤滑劑及流動助劑通常包括無矽聚合物,以及含矽聚合物,例如聚丙烯酸酯或改質劑、低分子量聚二烷基矽氧烷。改質在於一些烷基經廣泛多個有機基團置換。此等有機基團為例如聚醚、聚酯或甚至長鏈(氟化)烷基,前者使用最頻繁。In group c2), lubricants and flow aids typically include silicone-free polymers and silicone-containing polymers such as polyacrylates or, as modified, low-molecular-weight polydialkylsiloxanes. These modifications involve the replacement of some alkyl groups with a wide variety of organic groups, such as polyethers, polyesters, or even long-chain (fluorinated) alkyl groups, with the former being the most commonly used.
經對應改質之聚矽氧烷中之聚醚基團通常由環氧乙烷及/或環氧丙烷單元構建。大體而言,此等環氧烷單元在經改質聚矽氧烷中之比例愈高,所得產物親水性愈大。The polyether groups in the corresponding modified polysiloxanes are typically constructed from ethylene oxide and/or propylene oxide units. Generally speaking, the higher the proportion of these ethylene oxide units in the modified polysiloxane, the more hydrophilic the resulting product.
此類助劑例如可商購自Tego,如TEGO® Glide 100、TEGO® Glide ZG 400、TEGO® Glide 406、TEGO® Glide 410、TEGO® Glide 411、TEGO® Glide 415、TEGO® Glide 420、TEGO® Glide 435、TEGO® Glide 440、TEGO® Glide 450、TEGO® Glide A 115、TEGO® Glide B 1484 (亦可用作消泡劑及脫氣劑)、TEGO® Flow ATF、TEGO® Flow 300、TEGO® Flow 460、TEGO® Flow 425及TEGO® Flow ZFS 460。適合之可輻射固化潤滑劑及流動助劑(其亦可用於改善抗刮擦性)為同樣可獲自TEGO的產品TEGO® Rad 2100、TEGO® Rad 2200、TEGO® Rad 2500、TEGO® Rad 2600及TEGO® Rad 2700。Such additives are commercially available, for example, from Tego, such as TEGO® Glide 100, TEGO® Glide ZG 400, TEGO® Glide 406, TEGO® Glide 410, TEGO® Glide 411, TEGO® Glide 415, TEGO® Glide 420, TEGO® Glide 435, TEGO® Glide 440, TEGO® Glide 450, TEGO® Glide A 115, TEGO® Glide B 1484 (which can also be used as a defoamer and deaerator), TEGO® Flow ATF, TEGO® Flow 300, TEGO® Flow 460, TEGO® Flow 425 and TEGO® Flow ZFS 460. Suitable radiation-curable lubricants and flow aids (which can also be used to improve scratch resistance) are the products TEGO® Rad 2100, TEGO® Rad 2200, TEGO® Rad 2500, TEGO® Rad 2600 and TEGO® Rad 2700, also available from TEGO.
此類助劑亦可例如購自BYK,如BYK®-300、BYK®-306、BYK®-307、BYK®-310、BYK®-320、BYK®-333、BYK®-341、Byk® 354、Byk®361、Byk®361N、BYK®388。Such additives are also commercially available from BYK, for example, BYK®-300, BYK®-306, BYK®-307, BYK®-310, BYK®-320, BYK®-333, BYK®-341, Byk® 354, Byk® 361, Byk® 361N, BYK® 388.
此類助劑亦可例如購自3M,如FC4430®。Such additives are also available from 3M, for example, as FC4430®.
此類助劑亦可例如購自Cytonix,如FluorN®561或FluorN®562。Such adjuvants are also available commercially, for example, from Cytonix, such as FluorN® 561 or FluorN® 562.
此類助劑亦可例如購自Merck KGaA,如Tivida® FL 2300及Tivida® FL 2500。Such additives are also commercially available, for example, from Merck KGaA as Tivida® FL 2300 and Tivida® FL 2500.
按可聚合的LC材料之總重量計,視情況以約0重量%至3.0重量%、較佳約0重量%至2.0重量%之比例採用群組c2)中之助劑。The auxiliary agents from group c2) are optionally used in a proportion of about 0% to 3.0% by weight, preferably about 0% to 2.0% by weight, based on the total weight of the polymerizable LC material.
在群組c3)中,輻射固化助劑特定言之包括具有末端雙鍵之聚矽氧烷,該等末端雙鍵為例如丙烯基之組分。此類助劑可藉由光化或(例如)電子輻射交聯。此等助劑通常將多個特性組合在一起。在未交聯狀態中,其可充當消泡劑、脫氣劑、潤滑劑及流動助劑及/或基板潤濕助劑,而在交聯狀態中,其特定言之增加例如可使用根據本發明之組合物產生之塗層或膜的抗刮擦性。例如彼等塗層或膜之光澤特性的精確改良被認為基本上歸因於如消泡劑、脫氣劑及/或潤滑劑及流動助劑(在未交聯狀態下)之此等助劑的作用。In group c3), radiation-curing additives include, in particular, polysiloxanes having terminal double bonds, such as acrylic groups. These additives can be crosslinked actinically or, for example, by electron beam irradiation. These additives often combine several properties. In the uncrosslinked state, they can act as defoamers, degassing agents, lubricants, flow aids, and/or substrate wetting agents. In the crosslinked state, they can, in particular, increase the scratch resistance of coatings or films produced using the compositions according to the invention. For example, the precise improvement of the gloss properties of such coatings or films is believed to be essentially due to the action of additives such as defoamers, deaerators and/or lubricants and flow aids (in the uncrosslinked state).
適合的輻射固化助劑之實例為可購自TEGO之產品TEGO® Rad 2100、TEGO® Rad 2200、TEGO® Rad 2500、TEGO® Rad 2600及TEGO® Rad 2700,及可購自BYK之產品BYK®-371。Examples of suitable radiation curing aids are the products TEGO® Rad 2100, TEGO® Rad 2200, TEGO® Rad 2500, TEGO® Rad 2600 and TEGO® Rad 2700 available from TEGO, and the product BYK®-371 available from BYK.
群組c3)中之熱固化助劑含有例如能夠與(例如)結合劑之異氰酸酯基反應之一級OH基團。The heat-curing auxiliaries in group c3) contain, for example, primary OH groups which are capable of reacting with, for example, isocyanate groups of the binding agent.
可使用之熱固化助劑的實例為可購自BYK之產品BYK®-370、BYK®-373及BYK®-375。Examples of thermal curing aids that can be used are the products BYK®-370, BYK®-373 and BYK®-375 available from BYK.
按可聚合的LC材料之總重量計,視情況以約0重量%至5.0重量%、較佳約0重量%至3.0重量%之比例採用群組c3)中之助劑。The auxiliary agents from group c3) are optionally used in a proportion of about 0% to 5.0% by weight, preferably about 0% to 3.0% by weight, based on the total weight of the polymerizable LC material.
群組c4)中之基板潤濕助劑特定言之用於增加例如藉由印刷油墨或塗層組合物(例如,根據本發明之組合物)印刷或塗佈之基板的可濕性。此類印刷油墨或塗層組合物之潤滑及流動行為的一般附帶改良對已加工(例如,交聯)印刷或塗佈之外觀具有影響。The substrate wetting additives of group c4) are used in particular to increase the wettability of substrates printed or coated, for example, with printing inks or coating compositions (e.g., compositions according to the present invention). The generally accompanying improvement in the lubrication and flow behavior of such printing inks or coating compositions has an impact on the appearance of the processed (e.g., cross-linked) print or coating.
廣泛多種此類助劑例如可商購自Tego,如TEGO® Wet KL 245、TEGO® Wet 250、TEGO® Wet 260及TEGO® Wet ZFS 453,且商購自BYK,如BYK®-306、BYK®-307、BYK®-310、BYK®-333、BYK®-344、BYK®-345、BYK®-346及Byk®-348。A wide variety of such additives is commercially available, for example, from Tego, such as TEGO® Wet KL 245, TEGO® Wet 250, TEGO® Wet 260 and TEGO® Wet ZFS 453, and from BYK, such as BYK®-306, BYK®-307, BYK®-310, BYK®-333, BYK®-344, BYK®-345, BYK®-346 and Byk®-348.
按液晶組合物之總重量計,視情況以約0重量%至3.0重量%、較佳約0重量%至1.5重量%之比例採用群組c4)中之助劑。The auxiliary agent in group c4) is optionally used in a proportion of about 0 wt % to 3.0 wt %, preferably about 0 wt % to 1.5 wt %, based on the total weight of the liquid crystal composition.
特定言之,群組c5)中之潤濕助劑及分散助劑用於防止顏料之溢流及浮動以及沈降,且因此視需要,特定言之適用於經著色之組合物。In particular, the wetting and dispersing aids of group c5) serve to prevent overflow and flotation of the pigments as well as sedimentation and are therefore, if desired, suitable in particular for pigmented compositions.
此等助劑基本上經由含有此等添加劑之顏料粒子之靜電斥力及/或位阻使顏料分散液穩定,其中在後一種情況中,助劑與環境介質(例如,結合劑)之相互作用起主要作用。These additives stabilize the pigment dispersion essentially by electrostatic repulsion and/or steric hindrance of the pigment particles containing these additives, wherein in the latter case the interaction of the additive with the surrounding medium (e.g., binder) plays a major role.
由於例如在印刷油墨及塗料之技術領域中使用此類潤濕助劑及分散助劑係慣例,因此若使用該等助劑,則選擇此類型之適合助劑通常不會給熟習此項技術者帶來任何困難。Since the use of such wetting and dispersing additives is customary, for example in the technical field of printing inks and coatings, the selection of suitable additives of this type, if used, generally does not present any difficulties to those skilled in the art.
此類潤濕助劑及分散助劑例如可商購自Tego,如TEGO® Dispers 610、TEGO® Dispers 610 S、TEGO® Dispers 630、TEGO® Dispers 700、TEGO® Dispers 705、TEGO® Dispers 710、TEGO® Dispers 720 W、TEGO® Dispers 725 W、TEGO® Dispers 730 W、TEGO® Dispers 735 W及TEGO® Dispers 740 W,且商購自BYK,如Disperbyk®、Disperbyk®-107、Disperbyk®-108、Disperbyk®-110、Disperbyk®-111、Disperbyk®-115、Disperbyk®-130、Disperbyk®-160、Disperbyk®-161、Disperbyk®-162、Disperbyk®-163、Disperbyk®-164、Disperbyk®-165、Disperbyk®-166、Disperbyk®-167、Disperbyk®-170、Disperbyk®-174、Disperbyk®-180、Disperbyk®-181、Disperbyk®-182、Disperbyk®-183、Disperbyk®-184、Disperbyk®-185、Disperbyk®-190、Anti-Terra®-U、Anti-Terra®-U 80、Anti-Terra®-P、Anti-Terra®-203、Anti-Terra®-204、Anti-Terra®-206、BYK®-151、BYK®-154、BYK®-155、BYK®-P 104 S、BYK®-P 105、Lactimon®、Lactimon®-WS及Bykumen®。Such wetting and dispersing aids are commercially available from Tego, for example, as TEGO® Dispers 610, TEGO® Dispers 610 S, TEGO® Dispers 630, TEGO® Dispers 700, TEGO® Dispers 705, TEGO® Dispers 710, TEGO® Dispers 720 W, TEGO® Dispers 725 W, TEGO® Dispers 730 W, TEGO® Dispers 735 W and TEGO® Dispers 740 W, and commercially available from BYK, such as Disperbyk®, Disperbyk®-107, Disperbyk®-108, Disperbyk®-110, Disperbyk®-111, Disperbyk®-115, D isperbyk®-130, Disperbyk®-160, Disperbyk®-161, Disperbyk®-162, Disperbyk®-163, Disperbyk®-164, Disperbyk® -165, Disperbyk®-166, Disperbyk®-167, Disperbyk®-170, Disperbyk®-174, Disperbyk®-180, Disperbyk®-181, Dis perbyk®-182, Disperbyk®-183, Disperbyk®-184, Disperbyk®-185, Disperbyk®-190, Anti-Terra®-U, Anti-Terra®-U 80. Anti-Terra®-P, Anti-Terra®-203, Anti-Terra®-204, Anti-Terra®-206, BYK®-151, BYK®-154, BYK®-155, BYK®-P 104 S, BYK®-P 105, Lactimon®, Lactimon®-WS and Bykumen®.
所使用之群組c5)中之助劑的量係基於助劑之平均分子量。在任何情況下,初步實驗因此係合理的,但此僅可藉由熟習此項技術者實現。The amount of the auxiliary agent from group c5) used is based on the average molecular weight of the auxiliary agent. In any case, preliminary experiments are therefore advisable, but can only be carried out by those skilled in the art.
群組c6)中之疏水劑可用以向例如使用根據本發明之組合物產生之印刷物或塗層給予防水特性。此防止或至少極大地抑制因水吸收所致之泡脹且因此防止例如此類印刷物或塗層之光學特性中之變化。另外,當將組合物例如用作平版印刷中之印刷油墨時,可藉此防止或至少極大地減少水吸收。The hydrophobic agents in group c6) can be used to impart water-repellent properties to printed materials or coatings produced, for example, using the compositions according to the invention. This prevents or at least significantly suppresses swelling due to water absorption and thus prevents, for example, changes in the optical properties of such printed materials or coatings. Furthermore, when the compositions are used, for example, as printing inks in lithographic printing, water absorption can be prevented or at least significantly reduced.
此類疏水劑例如可商購自Tego,如Tego® Phobe WF、Tego® Phobe 1000、Tego® Phobe 1000 S、Tego® Phobe 1010、Tego® Phobe 1030、Tego® Phobe 1010、Tego® Phobe 1010、Tego® Phobe 1030、Tego® Phobe 1040、Tego® Phobe 1050、Tego® Phobe 1200、Tego® Phobe 1300、Tego® Phobe 1310及Tego® Phobe 1400。Such hydrophobic agents are, for example, commercially available from Tego as Tego® Phobe WF, Tego® Phobe 1000, Tego® Phobe 1000 S, Tego® Phobe 1010, Tego® Phobe 1030, Tego® Phobe 1010, Tego® Phobe 1010, Tego® Phobe 1030, Tego® Phobe 1040, Tego® Phobe 1050, Tego® Phobe 1200, Tego® Phobe 1300, Tego® Phobe 1310 and Tego® Phobe 1400.
按可聚合的LC材料之總重量計,視情況以約0重量%至5.0重量%、較佳約0重量%至3.0重量%之比例採用群組c6)中之助劑。The auxiliary agents from group c6) are optionally used in a proportion of about 0% to 5.0% by weight, preferably about 0% to 3.0% by weight, based on the total weight of the polymerizable LC material.
來自群組c7)之其他黏著促進劑用於改良接觸之兩個界面的黏著力。自此直接顯而易見,基本上唯一有效的黏著促進劑部分為位於一個界面或另一界面或兩個界面之黏著促進劑。若例如需要將液體或糊狀印刷油墨、塗層組合物或塗料塗覆至固體基板,則此通常意謂必須將黏著促進劑直接添加至固體基板,或必須用黏著促進劑預處理該基板(亦稱為上底漆),亦即為此基板提供經改質之化學及/或物理表面特性。Other adhesion promoters from group c7) are used to improve the adhesion of two contacting interfaces. It is immediately apparent that essentially the only effective adhesion promoter fraction is that which is located at one or the other or both interfaces. If, for example, a liquid or pasty printing ink, coating composition, or paint is to be applied to a solid substrate, this generally means that the adhesion promoter must be added directly to the solid substrate or that the substrate must be pretreated (also known as primed) with the adhesion promoter, i.e., provided with modified chemical and/or physical surface properties.
若預先已用底塗劑對基板上底漆,則此意謂接觸之界面一方面為底塗劑之界面,且另一方面為印刷油墨或塗層組合物或塗料之界面。在此情況下,不僅基板與底塗劑之間而且基板與印刷油墨或塗層組合物或塗料之間的黏著特性在基板上之整個多層結構之黏著中起作用。If the substrate has been primed with a primer beforehand, this means that the interfaces that come into contact are those of the primer on the one hand and the printing ink or coating composition or paint on the other. In this case, the adhesion properties not only between the substrate and the primer, but also between the substrate and the printing ink or coating composition or paint, play a role in the adhesion of the entire multi-layer structure on the substrate.
可提及之在更廣意義上的黏著促進劑亦為已列於群組c4)下的基板潤濕助劑,但此等助劑通常不具有相同黏著促進能力。Mention may also be made of adhesion promoters in a broader sense, which are already listed under group c4) as substrate wetting agents, but these generally do not have the same adhesion promoting capabilities.
鑒於基板及預期例如用於該等基板之印刷或塗佈之印刷油墨、塗層組合物及塗料的廣泛變化之物理及化學性質,黏著促進劑系統之多樣性並不出人意料。The diversity of adhesion promoter systems is not surprising given the wide variety of physical and chemical properties of substrates and of the printing inks, coating compositions and coatings that are intended, for example, to be used for printing or coating on these substrates.
基於矽烷之黏著促進劑為例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基甲基二乙氧基矽烷、N-胺基乙基-3-胺基丙基三甲氧基矽烷、N-胺基乙基-3-胺基丙基甲基二甲氧基矽烷、N-甲基-3-胺基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-縮水甘油基氧基丙基三甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-氯丙基三甲氧基矽烷及乙烯基三甲氧基矽烷。此等及其他矽烷例如以商品名DYNASILAN®可商購自Hüls。Silane-based adhesion promoters include, for example, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropylmethyldiethoxysilane, N-aminoethyl-3-aminopropyltrimethoxysilane, N-aminoethyl-3-aminopropylmethyldimethoxysilane, N-methyl-3-aminopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, 3-methacryloyloxypropyltrimethoxysilane, 3-glycidyloxypropyltrimethoxysilane, 3-butylpropyltrimethoxysilane, 3-chloropropyltrimethoxysilane, and vinyltrimethoxysilane. These and other silanes are commercially available, for example, from Hüls under the trade name DYNASILAN®.
通常應使用來自此類添加劑之製造商的對應技術資訊,或熟習此項技術者可經由對應初步實驗以簡單方式獲得此資訊。Corresponding technical information from the manufacturers of such additives should usually be used, or this information can be easily obtained by a person skilled in the art through corresponding preliminary experiments.
然而,若將此等添加劑作為來自群組c7)之助劑添加至根據本發明之可聚合的LC材料中,則按可聚合的LC材料之總重量計,其比例視情況對應於約0重量%至5.0重量%。此等濃度資料僅用作指導,此係因為添加劑之量及屬性(identity)在各個別情況下係藉由基板及印刷/塗層組合物之性質而測定的。針對此情況,對應技術資訊通常可購自此類添加劑之製造商,或可由熟習此項技術者經由對應初步實驗以簡單方式來測定。However, if these additives are added as auxiliary agents from group c7) to the polymerizable LC material according to the present invention, their proportions, based on the total weight of the polymerizable LC material, may correspond to approximately 0% to 5.0% by weight. These concentrations are provided as a guide only, as the amount and identity of the additives will depend on the properties of the substrate and the printed/coated composition in each individual case. Corresponding technical information is generally available from the manufacturers of these additives or can be easily determined by those skilled in the art through preliminary experiments.
群組c8)中之用於改善抗刮擦性的助劑包括例如上述產品TEGO® Rad 2100、TEGO® Rad 2200、TEGO® Rad 2500、TEGO® Rad 2600及TEGO® Rad 2700,其可購自Tego。Additives from group c8) for improving scratch resistance include, for example, the above-mentioned products TEGO® Rad 2100, TEGO® Rad 2200, TEGO® Rad 2500, TEGO® Rad 2600 and TEGO® Rad 2700, which are commercially available from Tego.
對於此等助劑,針對群組c3)給出之量資料同樣適合,亦即按液晶組合物之重量計,視情況以約0重量%至5.0重量%、較佳約0重量%至3.0重量%之比例採用此等添加劑。For these additives, the amounts given for group c3) are also applicable, that is, these additives are used in a proportion of about 0 wt % to 5.0 wt %, preferably about 0 wt % to 3.0 wt %, based on the weight of the liquid crystal composition.
可提及之其他光穩定劑、熱穩定劑及/或氧化穩定劑的實例係如下: 烷基化單酚,諸如2,6-二三級丁基-4-甲基苯酚、2-三級丁基-4,6-二甲基苯酚、2,6-二三級丁基-4-乙基苯酚、2,6-二三級丁基-4-正丁基苯酚、2,6-二三級丁基-4-異丁基苯酚、2,6-二環戊基-4-甲基苯酚、2-(α-甲基環己基)-4,6-二甲基苯酚、2,6-二(十八烷基)-4-甲基苯酚、2,4,6-三環己基苯酚、2,6-二三級丁基-4-甲氧基甲基苯酚;具有直鏈或分支鏈側鏈之壬酚,例如2,6-二壬基-4-甲基苯酚、2,4-二甲基-6-(1'-甲基十一碳-1'-基)苯酚、2,4-二甲基-6-(1'-甲基十七碳-1'-基)苯酚、2,4-二甲基-6-(1'-甲基十三碳-1'-基)苯酚及此等化合物之混合物;烷基硫基甲基酚,諸如2,4-二辛基硫基甲基-6-三級丁基苯酚、2,4-二辛基硫基甲基-6-甲基苯酚、2,4-二辛基硫基甲基-6-乙基苯酚及2,6-二(十二烷基)硫基甲基-4-壬基苯酚, 對苯二酚及烷基化對苯二酚,諸如2,6-二三級丁基-4-甲氧基苯酚、2,5-二三級丁基對苯二酚、2,5-二三級戊基對苯二酚、2,6-二苯基-4-十八烷氧基苯酚、2,6-二三級丁基對苯二酚、2,5-二三級丁基-4-羥基苯甲醚、3,5-二三級丁基-4-羥基苯甲醚、硬脂酸3,5-二三級丁基-4-羥基苯酯及雙(3,5-二三級丁基-4-羥苯基)己二酸酯, 生育酚,諸如α-生育酚、β-生育酚、γ-生育酚、δ-生育酚及此等化合物之混合物;及生育酚衍生物,諸如乙酸生育酚酯、琥珀酸生育酚酯、菸鹼酸生育酚酯及聚氧乙烯琥珀酸生育酚酯(「生育酚琥珀酸酯(tocofersolate)」), 羥基化二苯基硫醚,諸如2,2'-硫基雙(6-三級丁基-4-甲基苯酚)、2,2'-硫基雙(4-辛基苯酚)、4,4'-硫基雙(6-三級丁基-3-甲基苯酚)、4,4'-硫基雙(6-三級丁基-2-甲基苯酚)、4,4'-硫基雙(3,6-二二級戊基苯酚)及4,4'-雙(2,6-二甲基-4-羥苯基)二硫化物, 伸烷基雙酚,諸如2,2′-亞甲基雙(6-三級丁基-4-甲基苯酚)、2,2′-亞甲基雙(6-三級丁基-4-乙基苯酚)、2,2′-亞甲基雙[4-甲基-6-(α-甲基環己基)苯酚]、2,2′-亞甲基雙(4-甲基-6-環己基苯酚)、2,2′-亞甲基雙(6-壬基-4-甲基苯酚)、2,2′-亞甲基雙(4,6-二三級丁基苯酚)、2,2-伸乙基雙(4,6-二三級丁基苯酚)、2,2′-伸乙基雙(6-三級丁基-4-異丁基苯酚)、2,2′-亞甲基雙[6-(α-甲基苯甲基)-4-壬基苯酚]、2,2′-亞甲基雙[6-(α,α-二甲基苯甲基)-4-壬基苯酚]、4,4′-亞甲基雙(2,6-二三級丁基苯酚)、4,4′-亞甲基雙(6-三級丁基-2-甲基苯酚)、1,1-雙(5-三級丁基-4-羥基-2-甲基苯基)丁烷、2,6-雙(3-三級丁基-5-甲基-2-羥基苯甲基)-4-甲基苯酚、1,1,3-參(5-三級丁基-4-羥基-2-甲基苯基)丁烷、1,1-雙(5-三級丁基-4-羥基-2-甲基苯基)-3-正十二基-巰基丁烷、乙二醇雙[3,3-雙(3′-三級丁基-4′-羥苯基)丁酸酯]、雙(3-三級丁基-4-羥基-5-甲基苯基)二環戊二烯、雙[2-(3′-三級丁基-2′-羥基-5′-甲基苯甲基)-6-三級丁基-4-甲基苯基]對苯二甲酸酯、1,1-雙(3,5-二甲基-2-羥苯基)丁烷、2,2-雙(3,5-二三級丁基-4-羥苯基)丙烷、2,2-雙(5-三級丁基-4-羥基-2-甲基苯基)-4-正十二基-巰基丁烷及1,1,5,5-肆(5-三級丁基-4-羥基-2-甲基苯基)戊烷, O-苯甲基、N-苯甲基及S-苯甲基化合物,諸如3,5,3′,5′-四三級丁基-4,4′-二羥基二苯甲基醚、4-羥基-3,5-二甲基苯甲基巰基乙酸十八酯、4-羥基-3,5-二三級丁基苯甲基巰基乙酸十三酯、參(3,5-二三級丁基-4-羥基苯甲基)胺、雙(4-三級丁基-3-羥基-2,6-二甲基苯甲基)二硫對苯二甲酸酯、雙(3,5-二三級丁基-4-羥基苯甲基)硫化物及異辛基-3,5-二三級丁基-4-羥基苯甲基巰基乙酸酯, 芳族羥基苯甲基化合物,諸如1,3,5-參(3,5-二三級丁基-4-羥基苯甲基)-2,4,6-三甲基-苯、1,4-雙(3,5-二三級丁基-4-羥基苯甲基)-2,3,5,6-四甲基-苯及2,4,6-參(3,5-二三級丁基-4-羥基苯甲基)苯酚, 三𠯤化合物,諸如2,4-雙(辛基巰基)-6-(3,5-二三級丁基-4-羥基苯胺基)-1,3,5-三𠯤、2-辛基巰基-4,6-雙(3,5-二三級丁基-4-羥基苯胺基)-1,3,5-三𠯤、2-辛基巰基-4,6-雙(3,5-二三級丁基-4-羥基苯氧基)-1,3,5-三𠯤、2,4,6-參(3,5-二三級丁基-4-羥基苯氧基)-1,2,3-三𠯤、1,3,5-參(3,5-二三級丁基-4-羥基苯甲基)異氰尿酸酯、1,3,5-參(4-三級丁基-3-羥基-2,6-二甲基苯甲基)異氰尿酸酯、2,4,6-參(3,5-二三級丁基-4-羥基苯乙基)-1,3,5-三𠯤、1,3,5-參-(3,5-二三級丁基-4-羥基苯丙醯基)六氫-1,3,5-三𠯤、1,3,5-參(3,5-二環己基-4-羥基苯甲基)異氰尿酸酯及1,3,5-參(2-羥乙基)異氰尿酸酯, 苯甲基膦酸酯,諸如2,5-二三級丁基-4-羥基苯甲基膦酸二甲酯、3,5-二三級丁基-4-羥基苯甲基膦酸二乙酯、3,5-二三級丁基-4-羥基苯甲基膦酸二(十八烷基酯)及5-三級丁基-4-羥基-3-甲基苯甲基膦酸二(十八烷基酯), 醯胺基苯酚,諸如4-羥基月桂醯苯胺、4-羥基硬脂醯苯胺及N-(3,5-二三級丁基-4-羥苯基)胺基甲酸辛酯, 丙酸酯及乙酸酯,例如一元醇或多元醇之丙酸酯及乙酸酯,該等一元醇或多元醇諸如甲醇、乙醇、正辛醇、異辛醇、十八醇、1,6-己二醇、1,9-壬二醇、乙二醇、1,2-丙二醇、新戊二醇、硫代二乙二醇、二乙二醇、三乙二醇、新戊四醇、參(羥乙基)異氰尿酸酯、N,N'-雙(羥乙基)草醯胺、3-硫雜十一醇、3-硫雜十五醇、三甲基己二醇、三羥甲基丙烷及4-羥甲基-1-磷雜-2,6,7-三氧雜雙環[2.2.2]-辛烷, 基於胺衍生物之丙醯胺,諸如N,N'-雙(3,5-二三級丁基-4-羥基苯丙醯基)己二胺、N,N'-雙(3,5-二三級丁基-4-羥基苯丙醯基)三亞甲基二胺及N,N'-雙(3,5-二三級丁基-4-羥基苯丙醯基)肼, 抗壞血酸(維生素C)及抗壞血酸衍生物,諸如抗壞血酸棕櫚酸酯、抗壞血酸月桂酸酯及抗壞血酸硬脂酸酯,以及硫酸抗壞血酸酯及磷酸抗壞血酸酯, 基於胺化合物之抗氧化劑,諸如N,N′-二異丙基-對苯二胺、N,N′-二二級丁基-對苯二胺、N,N′-雙(1,4-二甲基戊基)-對苯二胺、N,N′-雙(1-乙基-3-甲基戊基)-對苯二胺、N,N′-雙(1-甲基庚基)-對苯二胺、N,N′-二環己基-對苯二胺、N,N′-二苯基-對苯二胺、N,N′-雙(2-萘基)-對苯二胺、N-異丙基-N′-苯基-對苯二胺、N-(1,3-二甲基丁基)-N′-苯基-對苯二胺、N-(1-甲基庚基)-N′-苯基-對苯二胺、N-環己基-N′-苯基-對苯二胺、4-(對甲苯胺磺醯基)二苯胺、N,N′-二甲基-N,N′-二二級丁基-對苯二胺、二苯胺、N-烯丙基二苯胺、4-異丙氧基二苯胺、N-苯基-1-萘胺、N-(4-三級辛基苯基)-1-萘胺、N-苯基-2-萘胺、辛基取代的二苯胺(諸如p,p'-二三級辛基二苯胺)、4-正丁胺基苯酚、4-丁醯基胺基苯酚、4-壬醯基胺基苯酚、4-十二醯基胺基苯酚、4-十八醯基胺基苯酚、雙(4-甲氧基苯基)胺、2,6-二三級丁基-4-二甲胺基甲基苯酚、2,4-二胺基二苯基甲烷、4,4′-二胺基二苯基甲烷、N,N,N′,N′-四甲基-4,4′-二胺基二苯基甲烷、1,2-雙[(2-甲基苯基)胺基]乙烷、1,2-雙(苯胺基)丙烷、(鄰甲苯基)二胍、雙[4-(1′,3′-二甲基丁基)苯基]胺、三級辛基取代的N-苯基-1-萘胺、單烷基化及二烷基化三級丁基/三級辛基二苯胺之混合物、單烷基化及二烷基化壬基二苯胺之混合物、單烷基化及二烷基化十二烷基二苯胺之混合物、單烷基化及二烷基化異丙基/異己基二苯胺之混合物、單烷基化及二烷基化三級丁基二苯胺之混合物、2,3-二氫-3,3-二甲基-4H-1,4-苯并噻𠯤、啡噻𠯤、單烷基化及二烷基化三級丁基/三級辛基啡噻𠯤之混合物、單烷基化及二烷基化三級辛基啡噻𠯤之混合物、N-烯丙基啡噻𠯤、N,N,N′,N′-四苯基-1,4-二胺基丁-2-烯、N,N-雙(2,2,6,6-四甲基哌啶-4-基)己二胺、雙(2,2,6,6-四甲基哌啶-4-基)癸二酸酯、2,2,6,6-四甲基哌啶-4-酮及2,2,6,6-四甲基哌啶-4-醇, 膦、亞磷酸酯及亞膦酸二酯,諸如三苯基膦亞磷酸三苯酯、亞磷酸二苯基烷基酯、亞磷酸苯基二烷基酯、參(壬基苯基)亞磷酸酯、亞磷酸三(十二)酯、亞磷酸三(十八)酯、二硬脂醯基新戊四醇二亞磷酸酯、參(2,4-二三級丁基苯基)亞磷酸酯、二異癸基新戊四醇二亞磷酸酯、雙(2,4-二三級丁基苯基)新戊四醇二亞磷酸酯、雙(2,6-二三級丁基-4-甲基苯基)新戊四醇二亞磷酸酯、二異癸氧基新戊四醇二亞磷酸酯、雙(2,4-二三級丁基-6-甲基苯基)新戊四醇二亞磷酸酯、雙(2,4,6-參(三級丁基苯基))新戊四醇二亞磷酸酯、三硬脂醯基山梨糖醇三亞磷酸酯、肆(2,4-二三級丁基苯基)4,4′-聯伸二苯二亞磷酸酯、6-異辛氧基-2,4,8,10-四三級丁基-12H-二苯并[d,g]-1,3,2-二氧雜膦、6-氟-2,4,8,10-四三級丁基-12-甲基-二苯并[d,g]-1,3,2-二氧雜膦、亞磷酸雙(2,4-二三級丁基-6-甲基苯基)甲酯及亞磷酸雙(2,4-二三級丁基-6-甲基苯基)乙酯, 2-(2'-羥苯基)苯并三唑,諸如2-(2'-羥基-5'-甲基苯基)苯并三唑、2-(3',5'-二三級丁基-2'-羥苯基)苯并三唑、2-(5'-三級丁基-2'-羥苯基)苯并三唑、2-(2'-羥基-5'-(1,1,3,3-四甲基丁基)苯基)苯并三唑、2-(3',5'-二三級丁基-2'-羥苯基)-5-氯苯并三唑、2-(3'-三級丁基-2'-羥基-5'-甲基苯基)-5-氯苯并三唑、2-(3'-二級丁基-5'-三級丁基-2'-羥苯基)苯并三唑、2-(2'-羥基-4′-辛氧基苯基)苯并三唑、2-(3',5'-二三級戊基-2'-羥苯基)苯并三唑、2-(3,5'-雙-(α,α-二甲基苯甲基)-2'-羥苯基)苯并三唑;2-(3'-三級丁基-2'-羥基-5'-(2-辛氧基羰基乙基)苯基)-5-氯苯并三唑、2-(3'-三級丁基-5'-[2-(2-乙基己氧基)羰基乙基]-2'-羥苯基)-5-氯苯并三唑、2-(3'-三級丁基-2'-羥基-5'-(2-甲氧基羰基乙基)苯基)-5-氯苯并三唑、2-(3'-三級丁基-2'-羥基-5'-(2-甲氧基羰基乙基)苯基)苯并三唑、2-(3'-三級丁基-2'-羥基-5'-(2-辛氧基羰基乙基)苯基)苯并三唑、2-(3'-三級丁基-5'-[2-(2-乙基己氧基)羰基乙基]-2'-羥苯基)苯并三唑、2-(3'-十二烷基-2'-羥基-5'-甲基苯基)苯并三唑及2-(3'-三級丁基-2'-羥基-5'-(2-異辛氧基羰乙基)苯基苯并三唑之混合物、2,2'-亞甲基雙[4-(1,1,3,3-四甲基丁基)-6-苯并三唑-2-基苯酚];2-[3'-三級丁基-5'-(2-甲氧基羰基乙基)-2'-羥苯基]-2H-苯并三唑與聚乙二醇300完全酯化的產物; 含硫過氧化物清除劑及含硫抗氧化劑,諸如3,3′-硫二丙酸之酯,例如十二烷基酯、十八烷基酯、十四烷基酯及十三烷基酯、巰基苯并咪唑及2-巰基苯并咪唑之鋅鹽、二硫代胺基甲酸二丁基鋅、二(十八烷基)二硫化物及新戊四醇肆(β-十二烷基巰基)丙酸酯, 2-羥基二苯甲酮,諸如4-羥基、4-甲氧基、4-辛氧基、4-癸氧基、4-十二烷氧基、4-苯甲氧基、4,2′,4′-三羥基及2′-羥基-4,4′-二甲氧基衍生物, 未經取代及經取代的苯甲酸之酯,諸如水楊酸4-三級丁基苯酯、水楊酸苯酯、水楊酸辛基苯酯、二苯甲醯基間苯二酚、雙(4-三級丁基苯甲醯基)間苯二酚、苯甲醯基間苯二酚、3,5-二三級丁基-4-羥基苯甲酸2,4-二三級丁基苯酯、十六基-3,5-二三級丁基-4-羥基苯甲酸酯、十八基-3,5-二三級丁基-4-羥基苯甲酸酯及2-甲基-4,6-二三級丁基苯基-3,5-二三級丁基-4-羥基苯甲酸酯, 丙烯酸酯,諸如α-氰基-β,β-二苯基丙烯酸乙酯、α-氰基-β,β-二苯基丙烯酸異辛酯、α-甲氧基羰基肉桂酸甲酯、α-氰基-β-甲基-對甲氧基肉桂酸甲酯、丁基-α-氰基-β-甲基-對甲氧基肉桂酸酯及甲基-α-甲氧羰基-對甲氧基肉桂酸酯;位阻胺,諸如雙(2,2,6,6-四甲基哌啶-4-基)癸二酸酯、雙(2,2,6,6-四甲基哌啶-4-基)丁二酸酯、雙(1,2,2,6,6-五甲基哌啶-4-基)癸二酸酯、雙(1-辛氧基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯、雙(1,2,2,6,6-五甲基哌啶-4-基)-正丁基-3,5-二三級丁基-4-羥基苯甲基丙二酸酯、1-(2-羥乙基)-2,2,6,6-四甲基-4-羥基哌啶及丁二酸之縮合產物、N,N′-雙(2,2,6,6-四甲基哌啶-4-基)己二胺及4-三級辛基胺基-2,6-二氯-1,3,5-三𠯤之縮合產物、參(2,2,6,6-四甲基哌啶-4-基)氮基三乙酸酯、肆(2,2,6,6-四甲基哌啶-4-基)1,2,3,4-丁烷四羧酸酯、1,1′-(1,2-伸乙基)雙(3,3,5,5-四甲基哌𠯤酮)、4-苯甲醯基-2,2,6,6-四甲基哌啶、4-十八烷氧基(stearyloxy)-2,2,6,6-四甲基哌啶、雙(1,2,2,6,6-五甲基哌啶-4-基)2-正丁基-2-(2-羥基-3,5-二三級丁基苯甲基)丙二酸酯、3-正辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮、雙(1-辛氧基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯、雙(1-辛氧基-2,2,6,6-四甲基哌啶-4-基)丁二酸酯、N,N′-雙(2,2,6,6-四甲基哌啶-4-基)己二胺及4-𠰌啉基-2,6-二氯-1,3,5-三𠯤之縮合產物、2-氯-4,6-雙(4-正丁胺基-2,2,6,6-四甲基哌啶-4-基)-1,3,5-三𠯤及1,2-雙(3-胺基丙胺基)乙烷之縮合產物、2-氯-4,6-二(4-正丁胺基-1,2,2,6,6-五甲基哌啶-4-基)-1,3,5-三𠯤及1,2-雙(3-胺基丙胺基)乙烷之縮合產物、8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]-癸烷-2,4-二酮、3-十二烷基-1-(2,2,6,6-四甲基哌啶-4-基)吡咯啶-2,5-二酮、3-十二烷基-1-(1,2,2,6,6-五甲基哌啶-4-基)吡咯啶-2,5-二酮、4-十六烷氧基-2,2,6,6-四甲基哌啶及4-十八烷氧基-2,2,6,6-四甲基哌啶之混合物、N,N′-雙(2,2,6,6-四甲基哌啶-4-基)己二胺及4-環己基胺基-2,6-二氯-1,3,5-三𠯤之縮合產物、1,2-雙(3-胺基丙胺基)乙烷及2,4,6-三氯-1,3,5-三𠯤之縮合產物、4-丁胺基-2,2,6,6-四甲基哌啶、N-(2,2,6,6-四甲基哌啶-4-基)-正十二烷基丁二醯亞胺、N-(1,2,2,6,6-五甲基哌啶-4-基)-正十二烷基丁二醯亞胺、2-十一烷基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基-螺[4.5]-癸烷、7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺-[4.5]癸烷及表氯醇的縮合產物、4-胺基-2,2,6,6-四甲基哌啶與四羥甲基乙炔二脲及聚(甲氧基丙基-3-氧基)-[4(2,2,6,6-四甲基)哌啶基]-矽氧烷之縮合產物, 草醯胺,諸如4,4′-二辛氧基草醯替苯胺、2,2′-二乙氧基草醯替苯胺、2,2′-二辛氧基-5,5′-二三級丁草醯替苯胺、2,2′-二(十二烷氧基)-5,5′-二三級丁草醯替苯胺、2-乙氧基-2'-乙基草醯替苯胺、N,N′-雙(3-二甲胺基丙基)草醯胺、2-乙氧基-5-三級丁基-2'-乙草醯替苯胺及其與2-乙氧基-2'-乙基-5,4′-二三級丁草醯替苯胺之混合物,及鄰甲氧基二取代之草醯替苯胺、對甲氧基二取代之草醯替苯胺的混合物以及鄰乙氧基二取代之草醯替苯胺及對乙氧基二取代之草醯替苯胺的混合物,及 2-(2-羥苯基)-1,3,5-三𠯤,諸如2,4,6-參-(2-羥基-4-辛氧基苯基)-1,3,5-三𠯤、2-(2-羥基-4-辛氧基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-(2,4-二羥基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2,4-雙(2-羥基-4-丙氧基苯基)-6-(2,4-二甲基苯基)-1,3,5-三𠯤、2-(2-羥基-4-辛氧基苯基)-4,6-雙(4-甲基苯基)-1,3,5-三𠯤、2-(2-羥基-4-十二烷氧基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-(2-羥基-4-十三烷氧基苯基)-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-[2-羥基-4-(2-羥基-3-丁氧基丙氧基)苯基]-4,6-雙(2,4-二甲基)-1,3,5-三𠯤、2-[2-羥基-4-(2-羥基-3-辛氧基丙氧基)苯基]-4,6-雙(2,4-二甲基)-1,3,5-三𠯤、2-[4-(十二烷氧基/十三烷氧基-2-羥基丙氧基)-2-羥苯基]-4,6-雙(2,4-二甲基苯基)-1,3,5-三𠯤、2-[2-羥基-4-(2-羥基-3-十二烷氧基丙氧基)苯基]-4,6-雙-(2,4-二甲基苯基)-1,3,5-三𠯤、2-(2-羥基-4-己氧基苯基)-4,6-二苯基-1,3,5-三𠯤、2-(2-羥基-4-甲氧基苯基)-4,6-二苯基-1,3,5-三𠯤、2,4,6-參[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-1,3,5-三𠯤及2-(2-羥苯基)-4-(4-甲氧基苯基)-6-苯基-1,3,5-三𠯤。 Examples of other light stabilizers, heat stabilizers and/or oxidation stabilizers that may be mentioned are: Alkylated monophenols, such as 2,6-di-tert-butyl-4-methylphenol, 2-tert-butyl-4,6-dimethylphenol, 2,6-di-tert-butyl-4-ethylphenol, 2,6-di-tert-butyl-4-n-butylphenol, 2,6-di-tert-butyl-4-isobutylphenol, 2,6-dicyclopentyl-4-methylphenol, 2-(α-methylcyclohexyl)-4,6-dimethylphenol, 2,6-dioctadecyl-4-methylphenol, 2,4,6-tricyclohexylphenol, 2,6-di-tert-butyl-4-methoxymethylphenol; nonylphenols with linear or branched side chains, such as 2,6-dinonyl-4-methylphenol, 2,4-dimethyl-6-(1'-methylundec-1'-yl)phenol, 2,4-dimethyl-6-(1'-methylheptadecan-1'-yl)phenol, 2,4-dimethyl-6-(1'-methyltridecan-1'-yl)phenol and mixtures of these compounds; alkylthiomethylphenols, such as 2,4-dioctylthiomethyl-6-tert-butylphenol, 2,4-dioctylthiomethyl-6-methylphenol, 2,4-dioctylthiomethyl-6-ethylphenol and 2,6-didodecylthiomethyl-4-nonylphenol, Hydroquinone and alkylated hydroquinones, such as 2,6-di-tert-butyl-4-methoxyphenol, 2,5-di-tert-butylhydroquinone, 2,5-di-tert-pentylhydroquinone, 2,6-diphenyl-4-octadecyloxyphenol, 2,6-di-tert-butylhydroquinone, 2,5-di-tert-butyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxyanisole, 3,5-di-tert-butyl-4-hydroxyphenyl stearate, and bis(3,5-di-tert-butyl-4-hydroxyphenyl) adipate. Tocopherols, such as α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol and mixtures of these compounds; and tocopherol derivatives, such as tocopheryl acetate, tocopheryl succinate, tocopheryl nicotinate and polyoxyethylene tocopheryl succinate ("tocofersolate"), Hydroxylated diphenyl sulfides, such as 2,2'-thiobis(6-tert-butyl-4-methylphenol), 2,2'-thiobis(4-octylphenol), 4,4'-thiobis(6-tert-butyl-3-methylphenol), 4,4'-thiobis(6-tert-butyl-2-methylphenol), 4,4'-thiobis(3,6-dipentylphenol) and 4,4'-bis(2,6-dimethyl-4-hydroxyphenyl) disulfide, Alkylene bisphenols, such as 2,2′-methylenebis(6-tert-butyl-4-methylphenol), 2,2′-methylenebis(6-tert-butyl-4-ethylphenol), 2,2′-methylenebis[4-methyl-6-(α-methylcyclohexyl)phenol], 2,2′-methylenebis(4-methyl-6-cyclohexylphenol), 2,2′-methylenebis(6-nonyl-4-methylphenol), 2,2′-methylenebis(4,6-di-tert-butylphenol), 2,2-ethylenebis(4 ,6-di- and tri-butylphenol), 2,2′-ethylidenebis(6-tert-butyl-4-isobutylphenol), 2,2′-methylenebis[6-(α-methylbenzyl)-4-nonylphenol], 2,2′-methylenebis[6-(α,α-dimethylbenzyl)-4-nonylphenol], 4,4′-methylenebis(2,6-di- and tri-butylphenol), 4,4′-methylenebis(6-tert-butyl-2-methylphenol), 1,1-bis(5-tert-butyl-4-hydroxy-2- methylphenyl)butane, 2,6-bis(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol, 1,1,3-tris(5-tert-butyl-4-hydroxy-2-methylphenyl)butane, 1,1-bis(5-tert-butyl-4-hydroxy-2-methylphenyl)-3-n-dodecyl-butylbutane, ethylene glycol bis[3,3-bis(3′-tert-butyl-4′-hydroxyphenyl)butyrate], bis(3-tert-butyl-4-hydroxy-5-methylphenyl)dicyclopentadiene, Bis[2-(3′-tert-butyl-2′-hydroxy-5′-methylbenzyl)-6-tert-butyl-4-methylphenyl] terephthalate, 1,1-bis(3,5-dimethyl-2-hydroxyphenyl)butane, 2,2-bis(3,5-di-tert-butyl-4-hydroxyphenyl)propane, 2,2-bis(5-tert-butyl-4-hydroxy-2-methylphenyl)-4-n-dodecyl-butylbutane, and 1,1,5,5-tetrakis(5-tert-butyl-4-hydroxy-2-methylphenyl)pentane. O-Benzyl, N-Benzyl and S-Benzyl compounds, such as 3,5,3′,5′-tetrabutyl-4,4′-dihydroxybenzhydryl ether, 4-hydroxy-3,5-dimethylbenzyl alkyl octadecyl acetate, 4-hydroxy-3,5-di-tert-butylbenzyl alkyl tridecyl acetate, tris(3,5-di-tert-butyl-4-hydroxybenzyl)amine, bis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) dithioterephthalate, bis(3,5-di-tert-butyl-4-hydroxybenzyl) sulfide and isooctyl-3,5-di-tert-butyl-4-hydroxybenzyl alkyl acetate. Aromatic hydroxybenzyl compounds, such as 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene, 1,4-bis(3,5-di-tert-butyl-4-hydroxybenzyl)-2,3,5,6-tetramethylbenzene and 2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)phenol, Trihydroxide compounds, such as 2,4-bis(octylbutyl)-6-(3,5-di-tert-butyl-4-hydroxyanilino)-1,3,5-trihydroxide, 2-octylbutyl-4,6-bis(3,5-di-tert-butyl-4-hydroxyanilino)-1,3,5-trihydroxide, 2-octylbutyl-4,6-bis(3,5-di-tert-butyl-4-hydroxyphenoxy)-1,3,5-trihydroxide, 2,4,6-tris(3,5-di-tert-butyl-4-hydroxyphenoxy)-1,2,3-trisoxide, 1,3,5-tris(3,5-di-tert-butyl- tributyl-4-hydroxyphenylpropionyl) hexahydro-1,3,5-tris(3,5-di- and tri-butyl-4-hydroxyphenylpropionyl) isocyanurate, 1,3,5-tris(3,5-di- and tri-butyl-4-hydroxyphenylpropionyl) isocyanurate, and 1,3,5-tris(2-hydroxyethyl) isocyanurate. Benzylphosphonates, such as dimethyl 2,5-di-tert-butyl-4-hydroxybenzylphosphonate, diethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, distearyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, and distearyl 5-tert-butyl-4-hydroxy-3-methylbenzylphosphonate; Aminophenols, such as 4-hydroxylaurylanilide, 4-hydroxystearylanilide, and octyl N-(3,5-di-tert-butyl-4-hydroxyphenyl)carbamate; Propionates and acetates, for example, propionates and acetates of monohydric or polyhydric alcohols such as methanol, ethanol, n-octanol, isooctanol, octadecanol, 1,6-hexanediol, 1,9-nonanediol, ethylene glycol, 1,2-propylene glycol, neopentyl glycol, thiodiethylene glycol, diethylene glycol, triethylene glycol, pentaerythritol, tris(hydroxyethyl)isocyanurate, N,N'-bis(hydroxyethyl)oxalamide, 3-thiaundecanol, 3-thiapentadecanol, trimethylhexanediol, trihydroxymethylpropane and 4-hydroxymethyl-1-phospha-2,6,7-trioxabicyclo[2.2.2]-octane, Amine-based propionamides, such as N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hexanediamine, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)trimethylenediamine, and N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hydrazine; Ascorbic acid (vitamin C) and ascorbic acid derivatives, such as ascorbyl palmitate, ascorbyl laurate, and ascorbyl stearate, as well as ascorbyl sulfate and ascorbyl phosphate; Antioxidants based on amine compounds, such as N,N′-diisopropyl-p-phenylenediamine, N,N′-dibutyl-p-phenylenediamine, N,N′-bis(1,4-dimethylpentyl)-p-phenylenediamine, N,N′-bis(1-ethyl-3-methylpentyl)-p-phenylenediamine, N,N′-bis(1-methylheptyl)-p-phenylenediamine, N,N′-dicyclohexyl-p-phenylenediamine, N,N′-diphenyl-p-phenylenediamine, N,N′-bis(2-naphthyl)-p-phenylenediamine, N-isopropyl-N′-phenyl-p-phenylenediamine, N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine, N-(1-methylheptyl)-N′-phenyl-p-phenylenediamine, N -Cyclohexyl-N'-phenyl-p-phenylenediamine, 4-(p-toluidinesulfonyl)diphenylamine, N,N'-dimethyl-N,N'-di-butyl-p-phenylenediamine, diphenylamine, N-allyldiphenylamine, 4-isopropoxydiphenylamine, N-phenyl-1-naphthylamine, N-(4-tert-octylphenyl)-1-naphthylamine, N-phenyl-2-naphthylamine, octyl-substituted diphenylamines (such as p,p'-di-tert-octyldiphenylamine), 4-n-butylaminophenol, 4-butyrylaminophenol, 4-nonylaminophenol, 4-dodecylaminophenol, 4-octadecylaminophenol, bis(4-methoxyphenyl)amine, 2,6-di-tert-butyl-4-dimethylaminomethylphenol , 2,4-diaminodiphenylmethane, 4,4′-diaminodiphenylmethane, N,N,N′,N′-tetramethyl-4,4′-diaminodiphenylmethane, 1,2-bis[(2-methylphenyl)amino]ethane, 1,2-bis(anilino)propane, (o-tolyl)biguanidine, bis[4-(1′,3′-dimethylbutyl)phenyl]amine, tertiary octyl-substituted N-phenyl-1-naphthylamine, mixture of mono- and di-alkylated tertiary butyl/tertiary octyl diphenylamine, mixture of mono- and di-alkylated nonyl diphenylamine, mixture of mono- and di-alkylated dodecyl diphenylamine, mixture of mono- and di-alkylated isopropyl/isohexyl diphenylamine , a mixture of mono- and di-alkylated tertiary butyldiphenylamine, 2,3-dihydro-3,3-dimethyl-4H-1,4-benzothiol, thiophenethiophene, a mixture of mono- and di-alkylated tertiary butyl/tertiary octylthiophenethiophene, a mixture of mono- and di-alkylated tertiary octylthiophenethiophene, N-allylthiophenethiophene, N,N,N′,N′-tetraphenyl-1,4-diaminobut-2-ene, N,N-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexanediamine, bis(2,2,6,6-tetramethylpiperidin-4-yl)sebacate, 2,2,6,6-tetramethylpiperidin-4-one and 2,2,6,6-tetramethylpiperidin-4-ol, Phosphine, phosphite and phosphite diesters, such as triphenylphosphine triphenyl phosphite, diphenyl alkyl phosphite, phenyl dialkyl phosphite, tris(nonylphenyl) phosphite, tris(dodecyl) phosphite, tris(octadecyl) phosphite, distearyl neopentyl acetate diphosphite, tris(2,4-di-tert-butylphenyl) phosphite, diisodecyl neopentyl acetate diphosphite, bis(2,4-di-tert-butylphenyl) neopentyl acetate diphosphite, bis(2,6-di-tert-butyl-4-methylphenyl) neopentyl acetate diphosphite, diisodecyl neopentyl acetate diphosphite, bis(2,4-di-tert-butyl-6-methylphenyl) neopentyl acetate diphosphite, Phosphites, bis(2,4,6-tris(tert-butylphenyl))pentylethoxyl diphosphite, tristearyl sorbitol triphosphite, tetrakis(2,4-di-tert-butylphenyl)4,4′-diphenyl diphosphite, 6-isooctyloxy-2,4,8,10-tetra-tert-butyl-12H-dibenzo[d,g]-1,3,2-dioxophosphine, 6-fluoro-2,4,8,10-tetra-tert-butyl-12-methyl-dibenzo[d,g]-1,3,2-dioxophosphine, bis(2,4-di-tert-butyl-6-methylphenyl)methyl phosphite, and bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphite, 2-(2'-Hydroxyphenyl)benzotriazole, such as 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)benzotriazole, 2-(5'-tert-butyl-2'-hydroxyphenyl)benzotriazole, 2-(2'-hydroxy-5'-(1,1,3,3-tetramethylbutyl)phenyl)benzotriazole, 2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-methylphenyl)-5- Chlorobenzotriazole, 2-(3'-dibutyl-5'-tert-butyl-2'-hydroxyphenyl)benzotriazole, 2-(2'-hydroxy-4'-octyloxyphenyl)benzotriazole, 2-(3',5'-di-tert-pentyl-2'-hydroxyphenyl)benzotriazole, 2-(3,5'-bis-(α,α-dimethylbenzyl)-2'-hydroxyphenyl)benzotriazole; 2-(3'-tert-butyl-2'-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)-5-chlorobenzotriazole, 2-(3'-tert-butyl-5'-[2-( 2-(3'-tert-butyl-2'-hydroxy-5'-(2-methoxycarbonylethyl)phenyl)benzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-(2-methoxycarbonylethyl)phenyl)benzotriazole, 2-(3'-tert-butyl-2'-hydroxy-5'-(2-octyloxycarbonylethyl)phenyl)benzotriazole, 2-(3'-tert-butyl-5'-[2-(2-ethylhexyloxy)carbonylethyl]- A mixture of 2-(3'-dodecyl-2'-hydroxy-5'-methylphenyl)benzotriazole, 2-(3'-t-butyl-2'-hydroxy-5'-(2-isooctyloxycarbonylethyl)phenylbenzotriazole, 2,2'-methylenebis[4-(1,1,3,3-tetramethylbutyl)-6-benzotriazol-2-ylphenol]; and a fully esterified product of 2-[3'-t-butyl-5'-(2-methoxycarbonylethyl)-2'-hydroxyphenyl]-2H-benzotriazole and polyethylene glycol 300. Sulfur peroxide scavengers and sulfur antioxidants, such as esters of 3,3′-thiodipropionic acid, such as the dodecyl, octadecyl, tetradecyl, and tridecyl esters, zinc salts of alkylbenzimidazole and 2-alkylbenzimidazole, dibutylzinc dithiocarbamate, dioctadecyl disulfide, and pentaerythritol tetrakis(β-dodecylalkyl)propionate; 2-Hydroxybenzophenones, such as the 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy, 4-dodecyloxy, 4-benzyloxy, 4,2′,4′-trihydroxy, and 2′-hydroxy-4,4′-dimethoxy derivatives; Unsubstituted and substituted benzoic acid esters, such as 4-tert-butylphenyl salicylate, phenyl salicylate, octylphenyl salicylate, dibenzoylresorcinol, bis(4-tert-butylbenzoyl)resorcinol, benzoylresorcinol, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate, hexadecyl-3,5-di-tert-butyl-4-hydroxybenzoate, octadecyl-3,5-di-tert-butyl-4-hydroxybenzoate, and 2-methyl-4,6-di-tert-butylphenyl-3,5-di-tert-butyl-4-hydroxybenzoate. Acrylates, such as ethyl α-cyano-β,β-diphenylacrylate, isooctyl α-cyano-β,β-diphenylacrylate, methyl α-methoxycarbonylcinnamate, methyl α-cyano-β-methyl-p-methoxycinnamate, butyl-α-cyano-β-methyl-p-methoxycinnamate, and methyl-α-methoxycarbonyl-p-methoxycinnamate; hindered amines, such as bis(2,2,6,6-tetramethylpiperidin-4-yl)sebacate, bis(2,2,6,6-tetramethylpiperidin-4-yl)succinate, bis(1 ,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-n-butyl-3,5-di-tert-butyl-4-hydroxybenzylmalonate, condensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexanediamine and 4-tert-octylamine condensation products of 2,6-dichloro-1,3,5-triazolidine, tris(2,2,6,6-tetramethylpiperidin-4-yl)nitrilotriacetate, tetrakis(2,2,6,6-tetramethylpiperidin-4-yl)1,2,3,4-butanetetracarboxylate, 1,1′-(1,2-ethylidene)bis(3,3,5,5-tetramethylpiperidinone), 4-benzoyl-2,2,6,6-tetramethylpiperidine, 4-octadecyloxy-2,2,6,6-tetramethylpiperidine, bis(1,2 ,2,6,6-pentamethylpiperidin-4-yl) 2-n-butyl-2-(2-hydroxy-3,5-di-tert-butylbenzyl) malonate, 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione, bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) succinate, N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl) ) hexanediamine and 4-oxo-2,6-dichloro-1,3,5-trioxane condensation product, 2-chloro-4,6-bis(4-n-butylamino-2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-trioxane and 1,2-bis(3-aminopropylamino)ethane condensation product, 2-chloro-4,6-bis(4-n-butylamino-1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-trioxane and 1,2-bis(3-aminopropylamino)ethane condensation product, 8-acetyl-3-decyl Dialkyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]-decane-2,4-dione, 3-dodecyl-1-(2,2,6,6-tetramethylpiperidin-4-yl)pyrrolidine-2,5-dione, 3-dodecyl-1-(1,2,2,6,6-pentamethylpiperidin-4-yl)pyrrolidine-2,5-dione, a mixture of 4-hexadecyloxy-2,2,6,6-tetramethylpiperidine and 4-octadecyloxy-2,2,6,6-tetramethylpiperidine, N,N′-bis(2 ,2,6,6-tetramethylpiperidin-4-yl)hexanediamine and 4-cyclohexylamino-2,6-dichloro-1,3,5-tris(II) condensation product, 1,2-bis(3-aminopropylamino)ethane and 2,4,6-trichloro-1,3,5-tris(II) condensation product, 4-butylamino-2,2,6,6-tetramethylpiperidine, N-(2,2,6,6-tetramethylpiperidin-4-yl)-n-dodecylsuccinimide, N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-n-dodecylsuccinimide , 2-undecyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxo-spiro[4.5]-decane, condensation products of 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza-4-oxo-spiro[4.5]decane and epichlorohydrin, condensation products of 4-amino-2,2,6,6-tetramethylpiperidine, tetrahydroxymethylacetylene diurea and poly(methoxypropyl-3-oxy)-[4(2,2,6,6-tetramethyl)piperidinyl]-siloxane, Oxalic acid amides, such as 4,4′-dioctyloxyoxalanilide, 2,2′-diethoxyoxalanilide, 2,2′-dioctyloxy-5,5′-di- and tertiary-butyridine, 2,2′-di(dodecyloxy)-5,5′-di- and tertiary-butyridine, 2-ethoxy-2'-ethyloxalanilide, N,N′-bis(3-dimethylaminopropyl)oxalyl Amine, 2-ethoxy-5-tert-butyl-2'-acetophenidine and its mixture with 2-ethoxy-2'-ethyl-5,4'-di-tert-butyloxalylaniline, a mixture of o-methoxy-disubstituted oxalylaniline and p-methoxy-disubstituted oxalylaniline, and a mixture of o-ethoxy-disubstituted oxalylaniline and p-ethoxy-disubstituted oxalylaniline, and 2-(2-hydroxyphenyl)-1,3,5-trisinium, such as 2,4,6-trisinium-(2-hydroxy-4-octyloxyphenyl)-1,3,5-trisinium, 2-(2-hydroxy-4-octyloxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-trisinium, 2-(2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-trisinium, 2,4-bis(2-hydroxy-4-propoxyphenyl)-6-(2,4-dimethylphenyl)- 1,3,5-trisinium, 2-(2-hydroxy-4-octyloxyphenyl)-4,6-bis(4-methylphenyl)-1,3,5-trisinium, 2-(2-hydroxy-4-dodecyloxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-trisinium, 2-(2-hydroxy-4-tridecyloxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-trisinium, 2-[2-hydroxy-4-(2-hydroxy-3-butoxypropoxy)phenyl]-4, 6-bis(2,4-dimethyl)-1,3,5-trisinium, 2-[2-hydroxy-4-(2-hydroxy-3-octyloxypropoxy)phenyl]-4,6-bis(2,4-dimethyl)-1,3,5-trisinium, 2-[4-(dodecyloxy/tridecyloxy-2-hydroxypropoxy)-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-trisinium, 2-[2-hydroxy-4-(2-hydroxy-3-dodecyloxypropoxy)phenyl]-4,6- Bis-(2,4-dimethylphenyl)-1,3,5-trisinium, 2-(2-hydroxy-4-hexyloxyphenyl)-4,6-diphenyl-1,3,5-trisinium, 2-(2-hydroxy-4-methoxyphenyl)-4,6-diphenyl-1,3,5-trisinium, 2,4,6-tris[2-hydroxy-4-(3-butoxy-2-hydroxypropoxy)phenyl]-1,3,5-trisinium, and 2-(2-hydroxyphenyl)-4-(4-methoxyphenyl)-6-phenyl-1,3,5-trisinium.
在另一較佳實施例中,可聚合的LC材料包含一或多種特定抗氧化劑添加劑,其較佳選自Irganox®系列,例如可商購自Ciba, Switzerland之抗氧化劑Irganox®1076及Irganox®1010。In another preferred embodiment, the polymerizable LC material comprises one or more specific antioxidant additives, which are preferably selected from the Irganox® range, such as the antioxidants Irganox® 1076 and Irganox® 1010 commercially available from Ciba, Switzerland.
在另一較佳實施例中,可聚合的LC材料包含一或多種、更佳兩種或更多種光引發劑之組合,該等光引發劑例如選自可商購的Irgacure®或Darocure® (Ciba AG)系列,特定言之Irgacure 127、Irgacure 184、Irgacure 369、Irgacure 651、Irgacure 817、Irgacure 907、Irgacure 1300、Irgacure、Irgacure 2022、Irgacure 2100、Irgacure 2959或Darcure TPO,進一步選自可商購的OXE02 (Ciba AG)、NCI 930、N1919T (Adeka)、SPI-03或SPI-04 (Samyang)。In another preferred embodiment, the polymerizable LC material comprises a combination of one or more, more preferably two or more photoinitiators, selected, for example, from the commercially available Irgacure® or Darocure® (Ciba AG) series, in particular Irgacure 127, Irgacure 184, Irgacure 369, Irgacure 651, Irgacure 817, Irgacure 907, Irgacure 1300, Irgacure, Irgacure 2022, Irgacure 2100, Irgacure 2959 or Darcure TPO, further selected from the commercially available OXE02 (Ciba AG), NCI 930, N1919T (Adeka), SPI-03 or SPI-04. (Samyang).
聚合引發劑整體在可聚合的LC材料中之濃度較佳為0.5至10%,極佳為0.8至8%,更佳為1至6%。The overall concentration of the polymerization initiator in the polymerizable LC material is preferably 0.5 to 10%, very preferably 0.8 to 8%, and more preferably 1 to 6%.
較佳地,除一或多種式I化合物以外,可聚合的LC材料包含: a) 一或多種雙反應性或多反應性可聚合的液晶原基化合物, b) 視情況選用之一或多種單反應性可聚合的液晶原基化合物, c) 視情況選用之一或多種抗氧化添加劑, d) 視情況選用之一或多種黏著促進劑, e) 視情況選用之一或多種界面活性劑, f) 視情況選用之一或多種單反應性、雙反應性或多反應性可聚合的非液晶原基化合物, g) 視情況選用之一或多種染料,其在用於引發光聚合之波長下顯示吸收最大值, h) 視情況選用之一或多種鏈轉移劑, i) 視情況選用之一或多種其他穩定劑, j) 視情況選用之一或多種潤滑劑及流動助劑,及 k) 視情況選用之一或多種稀釋劑, l) 視情況選用之非可聚合向列組分。 Preferably, the polymerizable LC material comprises, in addition to one or more compounds of formula I: a) one or more direactive or polyreactive polymerizable mesogenic compounds, b) optionally one or more monoreactive polymerizable mesogenic compounds, c) optionally one or more antioxidant additives, d) optionally one or more adhesion promoters, e) optionally one or more surfactants, f) optionally one or more monoreactive, direactive or polyreactive polymerizable non-mesogenic compounds, g) optionally one or more dyes which exhibit an absorption maximum at the wavelength used to initiate photopolymerization, h) Optionally, one or more chain transfer agents, i) Optionally, one or more other stabilizers, j) Optionally, one or more lubricants and flow aids, and k) Optionally, one or more diluents, l) Optionally, a non-polymerizable nematic component.
更佳地,可聚合的LC材料包含: a) 一或多種式I化合物, b) 一或多種、較佳兩種或更多種雙反應性可聚合的液晶原基化合物,(若存在)其量較佳為10重量%至90重量%、極佳15重量%至75重量%,較佳選自式DRMa-1化合物, c) 視情況選用之一或多種、較佳兩種或更多種單反應性可聚合的液晶原基化合物,其量較佳為10重量%至95重量%、極佳25%至85%,較佳選自式MRM-1及/或MRM-7之化合物, d) 視情況選用之一或多種式ND化合物,其量較佳為0至50%、極佳0至40%, e) 視情況選用之一或多種抗氧化添加劑,其較佳選自未經取代及經苯甲酸取代之酯,特定言之Irganox®1076,且若存在,則其量較佳為0.01重量%至2重量%、極佳0.05重量%至1重量%, f) 視情況選用之一或多種潤滑劑及流動助劑,其較佳選自BYK®388、FC 4430及/或Fluor N 562,且若存在,則其量較佳為0.1重量%至5重量%、極佳0.2重量%至3重量%,及 g) 視情況選用之一或多種稀釋劑,其較佳選自正十二醇,若存在,則其量較佳為0.1重量%至5重量%、極佳0.2重量%至3重量%。 More preferably, the polymerizable LC material comprises: a) one or more compounds of formula I, b) one or more, preferably two or more, direactive polymerizable mesogen compounds, if present, preferably in an amount of 10% to 90% by weight, very preferably 15% to 75% by weight, preferably selected from compounds of formula DRMa-1, c) optionally one or more, preferably two or more, monoreactive polymerizable mesogen compounds, preferably in an amount of 10% to 95% by weight, very preferably 25% to 85%, preferably selected from compounds of formula MRM-1 and/or MRM-7, d) optionally one or more compounds of formula ND, preferably in an amount of 0 to 50%, very preferably 0 to 40%, e) Optionally, one or more antioxidant additives, preferably selected from unsubstituted and substituted benzoic acid esters, in particular Irganox® 1076, and if present, preferably in an amount of 0.01 to 2 wt%, particularly 0.05 to 1 wt%, f) Optionally, one or more lubricants and flow aids, preferably selected from BYK® 388, FC 4430 and/or Fluor N 562, and if present, preferably in an amount of 0.1 to 5 wt%, particularly 0.2 to 3 wt%, and g) One or more diluents are optionally used, preferably selected from n-dodecanol. If present, the amount is preferably 0.1 wt% to 5 wt%, and most preferably 0.2 wt% to 3 wt%.
本發明進一步係關於一種製備聚合物膜之方法,其藉由以下進行 - 將如上文及下文所描述之可聚合的LC材料的層提供於基板上, - 藉由光聚合使可聚合的LC材料之可聚合組分聚合,且 - 視情況自基板移除經聚合之LC材料,及/或視情況將其提供於另一基板上。 The present invention further relates to a method for preparing a polymer film by: - providing a layer of a polymerizable LC material as described above and below on a substrate, - polymerizing a polymerizable component of the polymerizable LC material by photopolymerization, and - optionally removing the polymerized LC material from the substrate and/or optionally providing it on another substrate.
亦有可能將可聚合的LC材料溶解於適合溶劑中。It is also possible to dissolve the polymerizable LC material in a suitable solvent.
在另一較佳實施例中,可聚合的LC材料包含一或多種溶劑,其較佳選自有機溶劑。溶劑較佳選自酮,諸如丙酮、甲基乙基酮、甲基丙基酮、甲基異丁基酮或環己酮;乙酸酯,諸如乙酸甲酯、乙酸乙酯或乙酸丁酯或乙醯乙酸甲酯;醇,諸如甲醇、乙醇或異丙醇;芳族溶劑,諸如甲苯或二甲苯;脂環烴,諸如環戊烷或環己烷;鹵化烴,諸如二氯甲烷或三氯甲烷;二醇或其酯,諸如PGMEA (丙基二醇單甲醚乙酸酯)、γ-丁內酯。亦有可能使用以上溶劑之二元、三元或更高混合物。In another preferred embodiment, the polymerizable LC material comprises one or more solvents, preferably selected from organic solvents. The solvent is preferably selected from ketones such as acetone, methyl ethyl ketone, methyl propyl ketone, methyl isobutyl ketone, or cyclohexanone; acetates such as methyl acetate, ethyl acetate, butyl acetate, or methyl acetylacetate; alcohols such as methanol, ethanol, or isopropanol; aromatic solvents such as toluene or xylene; alicyclic hydrocarbons such as cyclopentane or cyclohexane; hydrocarbon halides such as dichloromethane or trichloromethane; and glycols or their esters such as PGMEA (propyl glycol monomethyl ether acetate) and γ-butyrolactone. It is also possible to use binary, ternary, or higher-order mixtures of the above solvents.
在可聚合的LC材料含有一或多種溶劑之情況下,溶劑中之所有固體(包括RM)之總濃度較佳為10%至60%。In case the polymerisable LC material contains one or more solvents, the total concentration of all solids (including RMs) in the solvents is preferably from 10% to 60%.
隨後例如藉由旋塗、印刷或其他已知技術將此溶液塗佈或印刷至基板上,且在聚合之前使溶劑蒸發掉。在大多數情況下,適合於加熱混合物以便有助於溶劑蒸發。The solution is then applied or printed onto a substrate, for example, by spin coating, printing or other known techniques, and the solvent is evaporated before polymerization. In most cases, it is appropriate to heat the mixture to assist in evaporation of the solvent.
可藉由如旋塗、棒塗或刮塗之習知塗佈技術將可聚合的LC材料塗覆至基板上。亦可藉由專家所已知之習知印刷技術,如(例如)網版印刷、平版印刷、卷軸至卷軸印刷、印字機印刷、凹版印刷、輪轉式凹版印刷、彈性凸版印刷、凹紋印刷、移印、熱封印刷、噴墨印刷或藉助於印模或印刷板之印刷來將其塗覆至基板上。The polymerizable LC material can be applied to the substrate by conventional coating techniques such as spin coating, rod coating, or doctor blade coating. It can also be applied to the substrate by conventional printing techniques known to experts, such as, for example, screen printing, lithographic printing, reel-to-reel printing, printer printing, gravure printing, rotogravure printing, flexographic printing, intaglio printing, pad printing, heat seal printing, inkjet printing, or printing with the aid of a stamp or printing plate.
適合的基板材料及基板為專家所已知且描述於文獻中,例如用於光學膜行業之習知基板,諸如玻璃或塑膠。用於聚合之尤其適合且較佳的基板為聚酯,諸如聚對苯二甲酸乙二酯(PET)或聚萘二甲酸乙二酯(PEN)、聚乙烯醇(PVA)、聚碳酸酯(PC)、三乙醯纖維素(TAC)或環烯烴聚合物(COP),或通常已知的濾色器材料,特定言之三乙醯纖維素(TAC)、環烯烴聚合物(COP)或通常已知的濾色器材料。Suitable substrate materials and substrates are known to experts and described in the literature, for example, substrates known from the optical film industry, such as glass or plastic. Particularly suitable and preferred substrates for polymerization are polyesters, such as polyethylene terephthalate (PET) or polyethylene naphthalate (PEN), polyvinyl alcohol (PVA), polycarbonate (PC), triacetyl cellulose (TAC) or cycloolefin polymers (COP), or generally known color filter materials, in particular triacetyl cellulose (TAC), cycloolefin polymers (COP) or generally known color filter materials.
可聚合的LC材料較佳展現遍及整個層之均勻配向。較佳地,可聚合的LC材料展現均勻平面配向或均勻垂直配向。The polymerizable LC material preferably exhibits uniform alignment throughout the entire layer. Preferably, the polymerizable LC material exhibits uniform planar alignment or uniform homeotropic alignment.
Friedel-Creagh-Kmetz定律可用於藉由比較RM層與基板之表面能來預測混合物是否將採用平面配向或垂直配向: 若γ RM>γ s,則反應性液晶原基化合物將顯示垂直配向,若γ RM<γ s,則反應性液晶原基化合物將顯示均勻配向。 The Friedel-Creagh-Kmetz law can be used to predict whether the mixture will adopt planar or homeotropic alignment by comparing the surface energies of the RM layer and the substrate: if γ RM > γ s , the reactive mesogen compound will exhibit homeotropic alignment; if γ RM < γ s , the reactive mesogen compound will exhibit homogeneous alignment.
當基板之表面能相對較低時,反應性液晶原基之間的分子間力比遍及RM基板界面之力更強。因此,反應性液晶原基垂直於基板配向(垂直配向)以便使分子間力最大化。When the surface energy of the substrate is relatively low, the intermolecular forces between the reactive mesogens are stronger than the forces across the RM-substrate interface. Therefore, the reactive mesogens align perpendicular to the substrate (homeotropic alignment) to maximize the intermolecular forces.
亦可藉由使用兩親媒性材料達成垂直配向;可直接將其添加至可聚合的LC材料,或可用呈垂直配向層形式之此等材料處理基板。將兩親媒性材料之極性頭化學鍵結至基板,且烴尾點垂直於基板。兩親媒性材料與RM之間的分子間相互作用促進垂直配向。常用之兩親媒性界面活性劑描述於上文中。Homeotropic alignment can also be achieved by using amphiphilic materials; these can be added directly to the polymerizable LC material, or the substrate can be treated with these materials in the form of a homeotropic alignment layer. The polar head of the amphiphilic material is chemically bonded to the substrate, with the carbon tail oriented perpendicular to the substrate. Intermolecular interactions between the amphiphilic material and the RM promote homeotropic alignment. Commonly used amphiphilic surfactants are described above.
用於促進垂直配向之另一方法為將電暈放電處理應用於塑膠基板,從而在基板表面上產生醇官能基或酮官能基。此等極性基團可與存在於RM或界面活性劑中之極性基團相互作用以促進垂直配向。Another method for promoting vertical alignment is to apply a corona discharge treatment to the plastic substrate, thereby generating alcohol or ketone functional groups on the substrate surface. These polar groups can interact with polar groups present in RMs or surfactants to promote vertical alignment.
當基板之表面張力大於RM之表面張力時,跨越界面之力佔優勢。若反應性液晶原基平行於基板配向,則界面能量降至最低,因此RM之長軸可與基板相互作用。可促進平面配向的一種方式係藉由用聚醯亞胺層塗佈基板且隨後用天鵝絨布料摩擦配向層。When the surface tension of the substrate is greater than that of the RM, the forces across the interface dominate. If the reactive mesogens are aligned parallel to the substrate, the interfacial energy is minimized, allowing the long axis of the RM to interact with the substrate. One way to promote planar alignment is by coating the substrate with a polyimide layer and then rubbing the alignment layer with velvet fabric.
其他適合之平面配向層為此項技術中已知的,如(例如)由光配向製備之經摩擦的聚醯亞胺或配向層,如US 5,602,661、US 5,389,698或US 6,717,644中所描述。Other suitable planar alignment layers are known in the art, such as, for example, rubbed polyimides or alignment layers prepared by photoalignment, as described in US 5,602,661, US 5,389,698 or US 6,717,644.
大體而言,例如由I. Sage在「Thermotropic Liquid Crystals」, G. W. Gray編, John Wiley & Sons, 1987, 第75-77頁中;及由T. Uchida及H. Seki在「Liquid Crystals - Applications and Uses Vol. 3」, B. Bahadur編, World Scientific Publishing, Singapore 1992, 第1-63頁中給出配向技術之評述。由J. Cognard, Mol. Cryst. Liq. Cryst. 78, 增刊1 (1981), 第1-77頁給出配向材料及配向技術之另一評述。In general, alignment techniques are reviewed, for example, in I. Sage, "Thermotropic Liquid Crystals," edited by G. W. Gray, John Wiley & Sons, 1987, pp. 75-77; and in T. Uchida and H. Seki, "Liquid Crystals - Applications and Uses Vol. 3," edited by B. Bahadur, World Scientific Publishing, Singapore 1992, pp. 1-63. Another review of alignment materials and techniques is provided by J. Cognard, Mol. Cryst. Liq. Cryst. 78, Supplement 1 (1981), pp. 1-77.
為了產生根據本發明之聚合物膜,可聚合的LC材料中之可聚合的化合物係藉由原位光聚合而聚合或交聯(在一種化合物含有兩個或更多個可聚合的基團之情況下)。To produce the polymer film according to the invention, the polymerisable compounds in the polymerisable LC material are polymerised or cross-linked (in the case of a compound containing two or more polymerisable groups) by in situ photopolymerisation.
可在一個步驟中進行光聚合。亦有可能在第二步驟中使未在第一步驟中反應之化合物光聚合或交聯(「最終固化」)。Photopolymerization can be carried out in one step. It is also possible to photopolymerize or crosslink the compounds that did not react in the first step in a second step ("final curing").
在一較佳製備方法中,將可聚合的LC材料塗佈至基板上且隨後例如藉由曝露於光化輻射來光聚合,如例如WO 01/20394、GB 2,315,072或WO 98/04651中所描述。In a preferred preparation method, a polymerisable LC material is coated onto a substrate and subsequently photopolymerised, for example by exposure to actinic radiation, as described in, for example, WO 01/20394, GB 2,315,072 or WO 98/04651.
LC材料之光聚合較佳藉由將其曝露於光化輻射來達成。光化輻射意謂用如UV光、IR光或可見光之光照射,用X射線或γ射線照射,或用諸如離子或電子之高能粒子照射。較佳地,聚合係藉由光照射,特定言之用UV光進行。作為光化輻射之光源,例如可使用單個UV燈或一組UV燈。當使用高功率燈時,可減少固化時間。用於輻射之另一可能光源為雷射,如(例如) UV雷射、IR雷射或可見光雷射。Photopolymerization of the LC material is preferably achieved by exposing it to actinic radiation. Actinic radiation means irradiation with light such as UV light, IR light, or visible light, irradiation with X-rays or gamma rays, or irradiation with high-energy particles such as ions or electrons. Preferably, polymerization is carried out by irradiation with light, in particular with UV light. As a light source for actinic radiation, for example, a single UV lamp or a system of UV lamps can be used. When using high-power lamps, the curing time can be reduced. Another possible light source for irradiation is a laser, such as, for example, a UV laser, an IR laser, or a visible laser.
固化時間尤其視可聚合的LC材料之反應性、經塗佈層之厚度、聚合引發劑之類型及UV燈之功率而定。固化時間較佳≤ 5分鐘,極佳≤ 3分鐘,最佳≤ 1分鐘。對於大批量生產,≤30秒之短固化時間係較佳的。Curing time depends, among other things, on the reactivity of the polymerizable LC material, the thickness of the coated layer, the type of polymerization initiator, and the power of the UV lamp. Curing times are preferably ≤ 5 minutes, very preferably ≤ 3 minutes, and optimally ≤ 1 minute. For high-volume production, a short curing time of ≤ 30 seconds is preferred.
適合之UV輻射功率較佳在5至200 mWcm-2範圍內,更佳在50至175 mWcm -2範圍內,且最佳在100至150 mWcm -2範圍內。 Suitable UV radiation power is preferably in the range of 5 to 200 mWcm-2, more preferably in the range of 50 to 175 mWcm -2 , and most preferably in the range of 100 to 150 mWcm -2 .
與所施加之UV輻射相關且隨時間而變化,適合之UV劑量較佳在25至7200 mJcm -2範圍內,更佳在500至7200 mJcm -2範圍內,且最佳在3000至7200 mJcm -2範圍內。 Depending on the applied UV radiation and varying over time, the suitable UV dose is preferably in the range of 25 to 7200 mJcm -2 , more preferably in the range of 500 to 7200 mJcm -2 , and most preferably in the range of 3000 to 7200 mJcm -2 .
光聚合較佳在惰性氣體氛圍下、較佳在經加熱之氮氣氛圍中執行,且亦有可能在空氣中發生聚合。Photopolymerization is preferably carried out in an inert gas atmosphere, preferably in a heated nitrogen atmosphere, but polymerization in air is also possible.
光聚合較佳在1至70℃、更佳5至50℃、甚至更佳15至30℃之溫度下執行。The photopolymerization is preferably carried out at a temperature of 1 to 70°C, more preferably 5 to 50°C, even more preferably 15 to 30°C.
根據本發明之經聚合的LC膜對塑膠基板,特定言之對TAC、COP及濾色器具有良好黏著性。因此,其可用作後續LC層之黏著劑或基底塗層,否則後續LC層將不會良好地黏附至基板。The polymerized LC film according to the present invention has good adhesion to plastic substrates, in particular to TAC, COP, and color filters. Therefore, it can be used as an adhesive or base coating for subsequent LC layers that would otherwise not adhere well to the substrate.
根據本發明之經聚合的LC膜之較佳厚度係藉由膜或最終產品的所需光學特性判定。舉例而言,若經聚合的LC膜並不主要充當光學層,而是例如充當黏著層、配向層或保護層,則其厚度較佳不超過1 μm,特定言之不超過0.5 μm,極佳不超過0.2 μm。The preferred thickness of the polymerized LC film according to the present invention is determined by the desired optical properties of the film or final product. For example, if the polymerized LC film does not primarily serve as an optical layer, but rather serves as an adhesive layer, alignment layer, or protective layer, its thickness is preferably no more than 1 μm, particularly no more than 0.5 μm, and most preferably no more than 0.2 μm.
舉例而言,本發明之均勻垂直或平面配向的聚合物膜可用作例如LCD中之延遲膜或補償膜,以在較大視角下改善對比度及亮度且降低色度。其可在LCD中之可切換液晶單元外部,或在基板(通常玻璃基板)之間使用,從而形成可切換液晶單元且含有可切換液晶介質(在單元應用中)。For example, the polymer films of the present invention with uniform homeotropic or planar alignment can be used as retardation films or compensation films in LCDs, for example, to improve contrast and brightness at wide viewing angles and reduce chromaticity. They can be used outside of a switchable liquid crystal cell in an LCD, or between substrates (typically glass substrates) to form a switchable liquid crystal cell containing a switchable liquid crystal medium (in cell applications).
對於聚合物膜之光學應用,其厚度較佳為0.5至10 μm,極佳為0.5至5 μm,特定言之0.5至3 μm。For optical applications of polymer films, the thickness is preferably 0.5 to 10 μm, most preferably 0.5 to 5 μm, and particularly 0.5 to 3 μm.
隨入射光束之波長(λ)而變的聚合物膜之光學延遲(δ(λ))由以下方程式(7)給出: δ(λ)=(2πΔn∙d)/λ (7) 其中(Δn)為膜之雙折射率,(d)為膜之厚度且λ為入射光束之波長。 The optical delay (δ(λ)) of the polymer film as a function of the wavelength (λ) of the incident light beam is given by the following equation (7): δ(λ)=(2πΔn∙d)/λ (7) where (Δn) is the birefringence of the film, (d) is the thickness of the film and λ is the wavelength of the incident light beam.
根據Snellius定律,隨入射光束之方向而變的雙折射率定義為 Δn = sinΘ/sinΨ (8) 其中sinΘ為光軸在膜中之入射角或傾斜角,且sinΨ為對應反射角。 According to Snellius's law, the birefringence as a function of the direction of the incident light beam is defined as: Δn = sinΘ/sinΨ (8) where sinΘ is the angle of incidence or tilt of the optical axis in the film, and sinΨ is the corresponding reflection angle.
基於此等定律,雙折射率及相應地光學延遲視膜之厚度及光軸在膜中之傾斜角而定(參見貝雷克氏補償器(Berek's compensator))。因此,熟習專家意識到,不同光學遲延或不同雙折射率可藉由調節液晶分子在聚合物膜中之定向而誘發。Based on these laws, the birefringence and, accordingly, the optical retardation depend on the film thickness and the tilt angle of the optical axis in the film (see Berek's compensator). Therefore, skilled experts recognize that different optical retardations or different birefringence can be induced by adjusting the orientation of the liquid crystal molecules in the polymer film.
根據本發明之聚合物膜的雙折射率(Δn)較佳在0.01至0.30之範圍內,更佳在0.01至0.25之範圍內,且甚至更佳在0.01至0.16之範圍內。The birefringence (Δn) of the polymer film according to the present invention is preferably in the range of 0.01 to 0.30, more preferably in the range of 0.01 to 0.25, and even more preferably in the range of 0.01 to 0.16.
隨根據本發明之聚合物膜的厚度而變之光學延遲小於200 nm,較佳小於180 nm且甚至更佳小於150 nm。The optical retardation as a function of the thickness of the polymer film according to the invention is less than 200 nm, preferably less than 180 nm and even better less than 150 nm.
本發明之聚合物膜亦可用作用於其他液晶或RM材料之配向膜。舉例而言,其可用於LCD以誘發或改良可切換液晶介質之配向,或對塗佈於其上之可聚合的LC材料之後續層進行配向。以此方式,可製備經聚合的LC膜之堆疊。The polymer films of the present invention can also be used as alignment films for other liquid crystal or liquid crystal materials. For example, they can be used in LCDs to induce or modify the alignment of switchable liquid crystal media, or to align subsequent layers of polymerizable LC materials coated thereon. In this way, stacks of polymerized LC films can be prepared.
總體而言,根據本發明之經聚合的LC膜及可聚合的LC材料適用於光學組件,如偏光器、補償器、配向層、液晶顯示器或投影系統中之圓形偏光器或濾色器、裝飾影像,以製備液晶或效應顏料,且尤其適用於具有空間上變化之反射色彩的反射膜,例如作為用於裝飾、資訊儲存或安全用途(諸如不可偽造文件,如身分證或信用卡、鈔票等)之多色影像。In general, the polymerized LC films and polymerizable LC materials according to the present invention are suitable for use in optical components such as polarizers, compensators, alignment layers, circular polarizers or color filters in liquid crystal displays or projection systems, decorative images, for preparing liquid crystals or effect pigments, and are particularly suitable for use in reflective films with spatially varying reflective colors, such as multicolor images for decoration, information storage, or security purposes (e.g., unforgeable documents such as ID cards, credit cards, banknotes, etc.).
根據本發明之經聚合的LC膜可用於透射或反射型顯示器。其可用於習知的OLED顯示器或LCD,特定言之DAP (配向相變形)或VA (豎直配向型)模式之LCD,如(例如) ECB (電控雙折射率)、CSH (彩色超垂直)、VAN或VAC (豎直配向向列型或膽固醇型)顯示器、MVA (多域豎直配向型)或PVA (圖案化豎直配向型)顯示器;用於彎曲模式顯示器或混合類型顯示器,如(例如) OCB (光學補償彎曲型單元或光學補償雙折射率)、R-OCB (反射OCB)、HAN (混合配向向列型)或pi單元(π單元)顯示器;此外用於TN (扭轉向列)、HTN (高度扭轉向列)或STN (超扭轉向列)模式之顯示器;用於AMD-TN (主動矩陣驅動TN)顯示器;或用於IPS (共平面切換型)模式之顯示器(其亦稱為『超TFT』顯示器)。尤其較佳為VA、MVA、PVA、OCB及pi單元顯示器。The polymerized LC film according to the invention can be used in transmissive or reflective displays. They can be used in conventional OLED displays or LCDs, in particular LCDs in DAP (alignment phase change) or VA (vertical alignment) mode, such as, for example, ECB (electrically controlled birefringence), CSH (color super vertical), VAN or VAC (vertical alignment nematic or cholesteric) displays, MVA (multi-domain vertical alignment) or PVA (patterned vertical alignment) displays; in bend mode displays or hybrid type displays, such as, for example, OCB (optically compensated bend cell or optically compensated birefringence), R-OCB (reflective OCB), HAN (hybrid alignment nematic) or pi cell (π cell) displays; and in TN (twisted nematic), HTN (highly twisted nematic) or STN displays. Displays using TFT-LCD (Super Twisted Nematic) mode; displays using AMD-TN (Active Matrix Driven TN) mode; or displays using IPS (In-Plane Switching) mode (also known as "Super TFT" displays). Particularly preferred are VA, MVA, PVA, OCB, and pi cell displays.
根據本發明之可聚合的LC材料及聚合物膜尤其適用於3D顯示器,如EP 0 829 744、EP 0 887 666 A2、EP 0 887 692、US 6,046,849、US 6,437,915及「Proceedings of the SID 20 thInternational Display Research Conference, 2000」第280頁中所描述。包含根據本發明之聚合物膜的此類型之3D顯示器為本發明之另一目標。 The polymerizable LC materials and polymer films according to the present invention are particularly suitable for use in 3D displays, as described in EP 0 829 744, EP 0 887 666 A2, EP 0 887 692, US Pat. No. 6,046,849, US Pat. No. 6,437,915, and in "Proceedings of the SID 20th International Display Research Conference, 2000," page 280. A 3D display of this type comprising the polymer film according to the present invention is another object of the present invention.
藉由特定參考較佳實施例在上文及下文描述本發明。應理解,在不脫離本發明之精神及範疇之情況下,其中可作出各種變化及修改。The present invention is described above and below with specific reference to preferred embodiments thereof. It should be understood that various changes and modifications can be made therein without departing from the spirit and scope of the present invention.
上文及下文所提及之許多化合物或其混合物為可商購的。如文獻中(例如,在諸如Houben-Weyl, Methoden der Organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart之標準著作中)所描述,所有此等化合物為已知的或可藉由本身已知之方法製備,確切言之在已知及適用於該等反應之反應條件下製備。亦可在此使用本身已知但未在此提及之變化形式。Many of the compounds mentioned above and below, or mixtures thereof, are commercially available. All of these compounds are known or can be prepared by methods known per se, specifically under reaction conditions known and suitable for these reactions, as described in the literature (e.g., in standard works such as Houben-Weyl, Methoden der Organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart). Variants known per se but not mentioned here may also be used.
應瞭解,可對本發明之前述實施例作出變化,但其仍屬於本發明之範疇內。除非另外陳述,否則用於相同、等效或類似目的之替代性特徵可替換本說明書中所揭示之各特徵。因此,除非另外陳述,否則所揭示之各特徵僅為一系列通用等效或類似特徵之一個實例。It should be understood that variations can be made to the embodiments described above and still fall within the scope of the present invention. Unless otherwise stated, alternative features serving the same, equivalent, or similar purpose may be substituted for each feature disclosed herein. Therefore, unless otherwise stated, each feature disclosed is merely one example of a generic series of equivalent or similar features.
除此類特徵及/或步驟中之至少一些彼此排他的組合外,本說明書中所揭示之所有特徵可以任何組合形式組合。特定言之,本發明之較佳特徵適用於本發明之所有態樣,且可以任何組合形式使用。同樣,可分別(不以組合形式)使用以非必需組合形式描述之特徵。Except for at least some mutually exclusive combinations of such features and/or steps, all features disclosed in this specification may be combined in any combination. In particular, preferred features of the present invention apply to all aspects of the present invention and may be used in any combination. Similarly, features described in non-essential combinations may be used separately (not in combination).
應瞭解,上文所描述之許多特徵,特定言之較佳實施例其本身為發明性的,且不僅僅作為本發明之實施例的一部分。除目前所主張之任何發明以外或替代目前所主張之任何發明,可為此等特徵尋求獨立保護。It will be appreciated that many of the features described above, particularly the preferred embodiments, are inventive in their own right and not merely as part of embodiments of the present invention. Independent protection may be sought for these features in addition to or in lieu of any presently claimed invention.
現將參考以下實施例更詳細地描述本發明,該等實施例僅為說明性的且不限制本發明之範疇。The present invention will now be described in more detail with reference to the following examples, which are merely illustrative and do not limit the scope of the present invention.
實例 通用程序使混合物在甲苯/環己酮(7/3)中溶解至30%固體。用Mayer Bar 7號將溶液棒塗於塗佈有光配向層(HSPA-156,Nissan)之TAC基板上。在60℃下將膜退火120秒,且使用Fusion輸送器,H形燈泡(95%功率,10 m/min,約400 mJ/cm 2,UV B)在N2氛圍下固化。 Example General Procedure : The mixture was dissolved in toluene/cyclohexanone (7/3) to 30% solids. The solution was bar-coated onto a TAC substrate coated with a photoalignment layer (HSPA-156, Nissan) using a Mayer Bar No. 7. The film was annealed at 60°C for 120 seconds and cured in an N2 atmosphere using a Fusion conveyor and H-shaped bulb (95% power, 10 m/min, approximately 400 mJ/ cm2 , UV B).
將膜層壓至壓敏黏著劑且保留開放表面,因此整個膜堆疊為玻璃/聚合物膜/壓敏黏著劑且使膜經受耐久性實驗。The film layers were pressed onto the pressure-sensitive adhesive leaving the surface open so that the entire film stack was glass/polymer film/pressure-sensitive adhesive and subjected to durability testing.
為了根據UV應力量測固化膜之延遲及分散的差值,使用Axoscan橢圓偏光計以測定初始延遲及分散。接著在63℃下用Suntest XLS+ (430 W/m 2)使膜加壓202 h。在測試之後,再次測定延遲概況及分散。藉由在UV測試之前及之後的R in及/或分散(R 450/ 550)之差值來定量耐久性。 To measure the difference in retardation and dispersion of the cured film based on UV stress, an Axoscan ellipsoidal polarimeter was used to measure initial retardation and dispersion. The film was then stressed at 63°C for 202 hours using a Suntest XLS+ (430 W/ m² ). After testing, the retardation profile and dispersion were measured again. Durability was quantified by the difference in R in and/or dispersion (R 450 / 550 ) before and after UV testing.
實例 1製備以下混合物M1:
化合物SPI-03 (Samyng Corp.)、Tinuvin 970 (BASF)、LA-F70 (Adeka)、NCI-930 (Adeka)、BYK-310 (BYK)及Irganox 1076 (BASF)可商購自指定供應商。Compounds SPI-03 (Samyng Corp.), Tinuvin 970 (BASF), LA-F70 (Adeka), NCI-930 (Adeka), BYK-310 (BYK), and Irganox 1076 (BASF) are commercially available from the designated suppliers.
如上文所描述溶解、塗佈及固化M1,且在日光測試之前後測定分散且定量為其差值ΔR
(450/550)(以[%]計)。
比較實例 1製備以下混合物CM1:
如上文所描述溶解、塗佈及固化CM1,且在日光測試之前後測定分散且定量為其差值ΔR
(450/550)(以[%]計)。
如自實例1與比較實例1之間的比較可見,光學分散之耐久性藉由在反應性液晶原基混合物中使用式I化合物而顯著改善。As can be seen from a comparison between Example 1 and Comparative Example 1, the durability of the optical dispersion is significantly improved by using the compound of Formula I in the reactive mesogen mixture.
Claims (13)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20172539 | 2020-04-30 | ||
| EP20172539.7 | 2020-04-30 | ||
| EP20181692 | 2020-06-23 | ||
| EP20181692.3 | 2020-06-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202200630A TW202200630A (en) | 2022-01-01 |
| TWI893109B true TWI893109B (en) | 2025-08-11 |
Family
ID=75674858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110115201A TWI893109B (en) | 2020-04-30 | 2021-04-27 | Polymerizable liquid crystal material and polymerized liquid crystal film |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TWI893109B (en) |
| WO (1) | WO2021219765A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202003809A (en) * | 2018-05-30 | 2020-01-16 | 德商馬克專利公司 | Compounds and liquid-crystalline medium |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0525477B1 (en) | 1991-07-26 | 1998-09-16 | Rolic AG | Oriented photopolymers and process of preparing same |
| US6160597A (en) | 1993-02-17 | 2000-12-12 | Rolic Ag | Optical component and method of manufacture |
| EP0611981B1 (en) | 1993-02-17 | 1997-06-11 | F. Hoffmann-La Roche Ag | Optical device |
| DE69739229D1 (en) | 1996-03-19 | 2009-03-12 | Merck Patent Gmbh | Reflective polarizer, liquid crystal display device and material composition equipped therewith |
| TW373100B (en) | 1996-07-01 | 1999-11-01 | Merck Patent Gmbh | Compensation film and liquid crystal display device containing the same |
| GB2315072B (en) | 1996-07-04 | 2000-09-13 | Merck Patent Gmbh | Circular UV polariser |
| TW373123B (en) | 1996-07-26 | 1999-11-01 | Merck Patent Gmbh | Combination of optical elements, means to produce substantially linear polarized light, optical retardation film and liquid crystal display device |
| US6046849A (en) | 1996-09-12 | 2000-04-04 | Sharp Kabushiki Kaisha | Parallax barrier, display, passive polarisation modulating optical element and method of making such an element |
| GB9806313D0 (en) | 1997-06-28 | 1998-05-20 | Sharp Kk | Method of making a spatial light modulator method of making a cell wall for a spatial light modulator spatial light modulator and cell wall for such aspatial |
| US6055103A (en) | 1997-06-28 | 2000-04-25 | Sharp Kabushiki Kaisha | Passive polarisation modulating optical element and method of making such an element |
| EP0940707B1 (en) | 1998-03-05 | 2006-07-12 | MERCK PATENT GmbH | Optical retardation film |
| US7060200B1 (en) | 1999-09-03 | 2006-06-13 | Merck Patent Gmbh | Multireactive polymerizable mesogenic compounds |
| EP1212655B1 (en) | 1999-09-16 | 2015-01-07 | Merck Patent GmbH | Optical compensator and liquid crystal display i |
| US7527746B2 (en) | 2005-01-28 | 2009-05-05 | Chisso Corporation | Liquid crystal polyfunctional acrylate derivative and polymer thereof |
| JP5354238B2 (en) | 2006-05-31 | 2013-11-27 | Dic株式会社 | Polymerizable liquid crystal composition |
| DE602008003417D1 (en) | 2007-03-30 | 2010-12-23 | Merck Patent Gmbh | DOUBLE-BREAKING POLYMER FILM WITH NEGATIVE OPTICAL DISPERSION |
| KR101540139B1 (en) | 2008-01-11 | 2015-07-28 | 메르크 파텐트 게엠베하 | Reactive mesogenic compounds and mixtures |
| WO2020035400A1 (en) * | 2018-08-13 | 2020-02-20 | Merck Patent Gmbh | Polymerisable liquid crystal material and polymerised liquid crystal film |
| JP2021534288A (en) * | 2018-08-13 | 2021-12-09 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Polymerizable liquid crystal materials and polymerized liquid crystal films |
-
2021
- 2021-04-27 TW TW110115201A patent/TWI893109B/en active
- 2021-04-29 WO PCT/EP2021/061211 patent/WO2021219765A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202003809A (en) * | 2018-05-30 | 2020-01-16 | 德商馬克專利公司 | Compounds and liquid-crystalline medium |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202200630A (en) | 2022-01-01 |
| WO2021219765A1 (en) | 2021-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102444325B1 (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| JP7179735B2 (en) | Polymerizable liquid crystal materials and polymerized liquid crystal films | |
| CN112041414B (en) | Polymerizable liquid crystal material and polymerized liquid crystal film | |
| TWI894125B (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| KR20210114498A (en) | Method for producing liquid crystal polymer film | |
| JP7430631B2 (en) | Polymerizable liquid crystal materials and polymerized liquid crystal films | |
| JP2024153654A (en) | Polymerizable liquid crystal material and polymerized liquid crystal film | |
| JP2024133528A (en) | Polymerizable liquid crystal material and polymerized liquid crystal film | |
| TWI863975B (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| JP7615026B2 (en) | Polymerizable liquid crystal material and polymerized liquid crystal film | |
| TWI740941B (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| EP4008759A1 (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| WO2021259825A1 (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| CN110023455B (en) | Polymerizable liquid crystal materials and polymerized liquid crystal films | |
| TWI893109B (en) | Polymerizable liquid crystal material and polymerized liquid crystal film | |
| TW202204580A (en) | Polymerisable liquid crystal material and polymerised liquid crystal film | |
| TW202428852A (en) | Polymerizable liquid crystal material and polymerized liquid crystal film |